ChEMBL ID,Receptor,Species,Purchasable,No. records,Assay type,Min.,Average,Max.,Unit,Mol. weight,Rot. Bonds,H don,H acc,LogP,Smiles,,,,,
57383409,109297,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccc(OC)c3)cc21,10.1021/jm500126s
CHEMBL3234238,109297,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccc(OC)c3)cc21,10.1021/jm500126s
57383437,109323,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,420,4,1,4,3.4,COc1ccc(CNC(=O)c2ccc3c(c2)N(C)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
CHEMBL3234511,109323,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,420,4,1,4,3.4,COc1ccc(CNC(=O)c2ccc3c(c2)N(C)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
57383415,109336,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,411,4,1,4,2.7,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCN3CCCCC3)cc21,10.1021/jm500126s
CHEMBL3234524,109336,0,None,-,1,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,411,4,1,4,2.7,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCN3CCCCC3)cc21,10.1021/jm500126s
57383414,109344,0,None,9,2,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,429,4,1,4,3.6,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21,10.1021/jm500126s
CHEMBL3234537,109344,0,None,9,2,Human,7,pAC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,429,4,1,4,3.6,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21,10.1021/jm500126s
57383402,109332,0,None,-,1,Human,5,pAC50,=,5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccn3)cc21,10.1021/jm500126s
CHEMBL3234520,109332,0,None,-,1,Human,5,pAC50,=,5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccn3)cc21,10.1021/jm500126s
57377245,109314,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,472,4,1,3,4.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C(F)(F)F)cc3)cc21,10.1021/jm500126s
CHEMBL3234502,109314,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,472,4,1,3,4.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C(F)(F)F)cc3)cc21,10.1021/jm500126s
57377247,109315,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,429,4,1,4,3.6,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21,10.1021/jm500126s
CHEMBL3234503,109315,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,429,4,1,4,3.6,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21,10.1021/jm500126s
57383428,109320,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,420,4,1,4,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234508,109320,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,420,4,1,4,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383411,109329,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
CHEMBL3234517,109329,0,None,-,1,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
57383403,109339,1,None,7,2,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234527,109339,1,None,7,2,Human,6.9,pAC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383424,109325,0,None,-,1,Human,5.8,pAC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,376,2,1,3,3.7,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccccc3)cc21,10.1021/jm500126s
CHEMBL3234513,109325,0,None,-,1,Human,5.8,pAC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,376,2,1,3,3.7,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccccc3)cc21,10.1021/jm500126s
16007816,45347,5,None,-,1,Human,6.8,pAC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,4,1,3,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C)cc3)cc21,10.1021/jm500126s
CHEMBL1529544,45347,5,None,-,1,Human,6.8,pAC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,4,1,3,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C)cc3)cc21,10.1021/jm500126s
57383429,109317,0,None,-,1,Human,5.8,pAC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,494,7,1,6,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cc(OC)c(OC)c(OC)c3)cc21,10.1021/jm500126s
CHEMBL3234505,109317,0,None,-,1,Human,5.8,pAC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,494,7,1,6,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cc(OC)c(OC)c(OC)c3)cc21,10.1021/jm500126s
57383435,109312,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,450,5,1,4,4.5,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(SC)cc3)cc21,10.1021/jm500126s
CHEMBL3234500,109312,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,450,5,1,4,4.5,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(SC)cc3)cc21,10.1021/jm500126s
57383416,109327,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,390,3,1,3,3.4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3)cc21,10.1021/jm500126s
CHEMBL3234515,109327,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,390,3,1,3,3.4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3)cc21,10.1021/jm500126s
57383398,109342,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,4.2,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(NC(=O)Cc3ccc(F)cc3)cc21,10.1021/jm500126s
CHEMBL3234535,109342,0,None,-,1,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,4.2,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(NC(=O)Cc3ccc(F)cc3)cc21,10.1021/jm500126s
57383397,109345,0,None,16,2,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,496,4,1,3,5.1,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc21,10.1021/jm500126s
CHEMBL3234538,109345,0,None,16,2,Human,6.7,pAC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,496,4,1,3,5.1,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc21,10.1021/jm500126s
16007814,42613,4,None,6,2,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL1503220,42613,4,None,6,2,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383420,109348,0,None,11,2,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
CHEMBL3234540,109348,0,None,11,2,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
57383413,109330,0,None,-,1,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccc(Cl)c3)cc21,10.1021/jm500126s
CHEMBL3234518,109330,0,None,-,1,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,424,3,1,3,4,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccc(Cl)c3)cc21,10.1021/jm500126s
57383422,109333,0,None,-,1,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21,10.1021/jm500126s
CHEMBL3234521,109333,0,None,-,1,Human,6.6,pAC50,=,6.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21,10.1021/jm500126s
57383400,109313,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,460,4,1,3,5.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C(C)(C)C)cc3)cc21,10.1021/jm500126s
CHEMBL3234501,109313,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,460,4,1,3,5.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(C(C)(C)C)cc3)cc21,10.1021/jm500126s
57383418,109316,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,482,5,1,5,3.2,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(S(C)(=O)=O)cc3)cc21,10.1021/jm500126s
CHEMBL3234504,109316,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,482,5,1,5,3.2,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(S(C)(=O)=O)cc3)cc21,10.1021/jm500126s
20861039,109318,4,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,4,1,5,3.5,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc4c(c3)OCO4)cc21,10.1021/jm500126s
CHEMBL3234506,109318,4,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,4,1,5,3.5,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc4c(c3)OCO4)cc21,10.1021/jm500126s
57383427,109321,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,6,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234509,109321,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,6,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383404,109326,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,406,3,1,4,3.7,COc1ccc(NC(=O)c2ccc3c(c2)N(C)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
CHEMBL3234514,109326,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,406,3,1,4,3.7,COc1ccc(NC(=O)c2ccc3c(c2)N(C)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
57383433,109328,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,408,3,1,3,3.5,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
CHEMBL3234516,109328,0,None,-,1,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,408,3,1,3,3.5,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
57383434,109346,0,None,32,2,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,4,1,3,5.5,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc4ccccc4c3)cc21,10.1021/jm500126s
CHEMBL3234539,109346,0,None,32,2,Human,6.5,pAC50,=,6.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,4,1,3,5.5,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc4ccccc4c3)cc21,10.1021/jm500126s
57383399,109298,0,None,-,1,Human,6.4,pAC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,404,4,1,3,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3)cc21,10.1021/jm500126s
CHEMBL3234239,109298,0,None,-,1,Human,6.4,pAC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,404,4,1,3,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3)cc21,10.1021/jm500126s
57383436,109350,0,None,12,2,Human,6.4,pAC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21,10.1021/jm500126s
CHEMBL3234542,109350,0,None,12,2,Human,6.4,pAC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,391,3,1,4,2.8,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21,10.1021/jm500126s
16007818,59418,5,None,-,1,Human,5.4,pAC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3OC)cc21,10.1021/jm500126s
CHEMBL1726600,59418,5,None,-,1,Human,5.4,pAC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,3.8,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccccc3OC)cc21,10.1021/jm500126s
16007812,59112,5,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,438,4,1,3,4.4,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
CHEMBL1714249,59112,5,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,438,4,1,3,4.4,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Cl)cc3)cc21,10.1021/jm500126s
57383430,109343,0,None,18,2,Human,7.3,pAC50,=,7.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,3.9,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
CHEMBL3234536,109343,0,None,18,2,Human,7.3,pAC50,=,7.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,3.9,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
20861041,109311,1,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,4,1,3,4.3,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NC(C)c3ccccc3)cc21,10.1021/jm500126s
CHEMBL3234499,109311,1,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,4,1,3,4.3,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NC(C)c3ccccc3)cc21,10.1021/jm500126s
57383406,109337,0,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,385,5,1,4,2.1,CN(C)CCCNC(=O)c1ccc2c(c1)N(C)C(=O)c1ccccc1[S+]2[O-],10.1021/jm500126s
CHEMBL3234525,109337,0,None,-,1,Human,6.3,pAC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,385,5,1,4,2.1,CN(C)CCCNC(=O)c1ccc2c(c1)N(C)C(=O)c1ccccc1[S+]2[O-],10.1021/jm500126s
57383417,109340,0,None,-,1,Human,4.3,pAC50,=,4.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,432,5,0,3,4.5,CCN(Cc1ccccc1)C(=O)c1ccc2c(c1)N(CC)C(=O)c1ccccc1[S+]2[O-],10.1021/jm500126s
CHEMBL3234532,109340,0,None,-,1,Human,4.3,pAC50,=,4.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,432,5,0,3,4.5,CCN(Cc1ccccc1)C(=O)c1ccc2c(c1)N(CC)C(=O)c1ccccc1[S+]2[O-],10.1021/jm500126s
57377246,2513,1,None,57,2,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,410,4,1,4,3.5,O=C(c1ccc2c(c1)N(C)C(=O)c1c([S@@]2=O)cccc1)NCCc1cccs1,10.1021/jm500126s
8368,2513,1,None,57,2,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,410,4,1,4,3.5,O=C(c1ccc2c(c1)N(C)C(=O)c1c([S@@]2=O)cccc1)NCCc1cccs1,10.1021/jm500126s
CHEMBL3234544,2513,1,None,57,2,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,410,4,1,4,3.5,O=C(c1ccc2c(c1)N(C)C(=O)c1c([S@@]2=O)cccc1)NCCc1cccs1,10.1021/jm500126s
57383401,109351,0,None,28,2,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,397,4,1,4,2.3,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21,10.1021/jm500126s
CHEMBL3234543,109351,0,None,28,2,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,397,4,1,4,2.3,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21,10.1021/jm500126s
57383423,109324,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,6,1,4,4.2,CCCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234512,109324,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,448,6,1,4,4.2,CCCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383432,109338,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,5,1,4,4.8,CCN1C(=O)c2ccccc2Sc2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234526,109338,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,418,5,1,4,4.8,CCN1C(=O)c2ccccc2Sc2ccc(C(=O)NCc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383419,109341,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,4,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(NC(=O)Cc3ccc(OC)cc3)cc21,10.1021/jm500126s
CHEMBL3234534,109341,0,None,-,1,Human,6.2,pAC50,=,6.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,434,5,1,4,4,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(NC(=O)Cc3ccc(OC)cc3)cc21,10.1021/jm500126s
57383421,109331,0,None,-,1,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,3,1,3,4.1,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21,10.1021/jm500126s
CHEMBL3234519,109331,0,None,-,1,Human,7.2,pAC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,3,1,3,4.1,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21,10.1021/jm500126s
57383426,109319,0,None,-,1,Human,6.1,pAC50,=,6.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,390,3,1,3,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccccc3)cc21,10.1021/jm500126s
CHEMBL3234507,109319,0,None,-,1,Human,6.1,pAC50,=,6.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,390,3,1,3,4.1,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)Nc3ccccc3)cc21,10.1021/jm500126s
57383425,109322,0,None,-,1,Human,6.1,pAC50,=,6.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,406,4,2,4,3.4,COc1ccc(CNC(=O)c2ccc3c(c2)NC(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
CHEMBL3234510,109322,0,None,-,1,Human,6.1,pAC50,=,6.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,406,4,2,4,3.4,COc1ccc(CNC(=O)c2ccc3c(c2)NC(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
16007752,58888,5,None,-,1,Human,5.1,pAC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,496,6,1,4,5,COc1ccc(CNC(=O)c2ccc3c(c2)N(Cc2ccccc2)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
CHEMBL1703877,58888,5,None,-,1,Human,5.1,pAC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,496,6,1,4,5,COc1ccc(CNC(=O)c2ccc3c(c2)N(Cc2ccccc2)C(=O)c2ccccc2[S+]3[O-])cc1,10.1021/jm500126s
16007820,67084,2,None,-,1,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,3.9,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
CHEMBL1894173,67084,2,None,-,1,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,422,4,1,3,3.9,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,10.1021/jm500126s
57383431,109334,0,None,70,2,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,410,4,1,4,3.5,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21,10.1021/jm500126s
CHEMBL3234522,109334,0,None,70,2,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,410,4,1,4,3.5,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21,10.1021/jm500126s
57383412,109335,0,None,-,1,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,397,4,1,4,2.3,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21,10.1021/jm500126s
CHEMBL3234523,109335,0,None,-,1,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,397,4,1,4,2.3,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21,10.1021/jm500126s
57383405,109349,0,None,15,2,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,3,1,3,4.1,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21,10.1021/jm500126s
CHEMBL3234541,109349,0,None,15,2,Human,7.1,pAC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysisAntagonistactivityatD2receptor(unknownorigin)expressedinFlp-InTREx293cellscoexpressingchimericGqi5proteinassessedascalciumaccumulationbyFluo-8AMdyebasedfluorescenceanalysis,ChEMBL,468,3,1,3,4.1,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21,10.1021/jm500126s
10378389,198908,1,None,-,1,Human,10.7,pEC50,=,10.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,269,4,2,3,2.9,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,10.1021/jm401384w
CHEMBL134807,198908,1,None,-,1,Human,10.7,pEC50,=,10.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,269,4,2,3,2.9,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,10.1021/jm401384w
CHEMBL64553,198908,1,None,-,1,Human,10.7,pEC50,=,10.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,269,4,2,3,2.9,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,10.1021/jm401384w
76325150,105846,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,10.1021/jm401384w
CHEMBL3115575,105846,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,10.1021/jm401384w
CHEMBL3139554,105846,0,None,-,1,Human,10.5,pEC50,=,10.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,10.1021/jm401384w
167715,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
969,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
CHEMBL225230,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
167715,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
969,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
CHEMBL225230,2807,11,None,6,4,Human,10.4,pEC50,=,10.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
76325156,105814,1,None,-,1,Human,10.3,pEC50,=,10.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,263,7,2,3,3.3,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,10.1021/jm401384w
CHEMBL3115585,105814,1,None,-,1,Human,10.3,pEC50,=,10.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,263,7,2,3,3.3,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,10.1021/jm401384w
CHEMBL3139393,105814,1,None,-,1,Human,10.3,pEC50,=,10.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,263,7,2,3,3.3,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,10.1021/jm401384w
137657882,158980,0,None,12589,2,Human,10,pEC50,=,10,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassayAgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassay,ChEMBL,408,5,1,6,2.1,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,10.1021/jm5013243
CHEMBL4104013,158980,0,None,12589,2,Human,10,pEC50,=,10,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassayAgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassay,ChEMBL,408,5,1,6,2.1,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,10.1021/jm5013243
137657882,158980,0,None,12589,2,Human,10,pEC50,=,10,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassayAgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassay,ChEMBL,408,5,1,6,2.1,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,10.1021/jm5013243
CHEMBL4104013,158980,0,None,12589,2,Human,10,pEC50,=,10,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassayAgonistactivityathumandopamineD2LreceptorexpressedinF1pInCHOcellsassessedasincreaseinforskolin-mediatedcAMPaccumulationincubatedfor30minsbyAlphaScreenassay,ChEMBL,408,5,1,6,2.1,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,10.1021/jm5013243
56599011,145761,0,None,-,1,Human,10,pEC50,=,10,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,449,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3921903,145761,0,None,-,1,Human,10,pEC50,=,10,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,449,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
44554472,105706,0,None,1071,2,Human,9.9,pEC50,=,9.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,247,2,1,3,2,CCCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099226,105706,0,None,1071,2,Human,9.9,pEC50,=,9.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,247,2,1,3,2,CCCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139040,105706,0,None,1071,2,Human,9.9,pEC50,=,9.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,247,2,1,3,2,CCCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
76328715,105796,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,429,9,2,6,2.8,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,10.1021/jm401384w
CHEMBL3115582,105796,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,429,9,2,6,2.8,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,10.1021/jm401384w
CHEMBL3139265,105796,0,None,-,1,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,429,9,2,6,2.8,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,10.1021/jm401384w
13851595,173784,2,None,489,2,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,2,3,CCCN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3098131,173784,2,None,489,2,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,2,3,CCCN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL455497,173784,2,None,489,2,Human,9.8,pEC50,=,9.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,2,3,CCCN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
66633659,152663,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,452,9,1,6,4.1,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3978288,152663,0,None,-,1,Human,9.7,pEC50,=,9.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,452,9,1,6,4.1,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
17449900,138885,10,None,-1,3,Human,9.7,pEC50,=,9.7,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,348,5,0,5,3.2,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,10.1016/j.bmcl.2006.02.075
CHEMBL379602,138885,10,None,-1,3,Human,9.7,pEC50,=,9.7,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,348,5,0,5,3.2,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,10.1016/j.bmcl.2006.02.075
132578416,173084,0,None,1,2,Human,9.6,pEC50,=,9.6,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,383,9,3,4,4.8,CCCN(CCCCCc1ccc(O)c(O)c1)[C@H]1CCc2c(O)cccc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4538230,173084,0,None,1,2,Human,9.6,pEC50,=,9.6,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,383,9,3,4,4.8,CCCN(CCCCCc1ccc(O)c(O)c1)[C@H]1CCc2c(O)cccc2C1,10.1016/j.bmc.2016.08.021
17449900,138885,10,None,-1,3,Human,9.6,pEC50,=,9.6,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,348,5,0,5,3.2,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,10.1016/j.bmcl.2006.02.075
CHEMBL379602,138885,10,None,-1,3,Human,9.6,pEC50,=,9.6,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,348,5,0,5,3.2,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,10.1016/j.bmcl.2006.02.075
127046922,139055,0,None,5,2,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)bycAMPaccumulationassayAgonistactivityatdopamineD2receptor(unknownorigin)bycAMPaccumulationassay,ChEMBL,417,7,3,4,2.9,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.8b00435
CHEMBL3798179,139055,0,None,5,2,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)bycAMPaccumulationassayAgonistactivityatdopamineD2receptor(unknownorigin)bycAMPaccumulationassay,ChEMBL,417,7,3,4,2.9,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.8b00435
90645289,111918,2,None,-,1,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumanD2LreceptorexpressedinFlpInCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductiontreatedfor30minsbyAlphaScreenassayAgonistactivityathumanD2LreceptorexpressedinFlpInCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductiontreatedfor30minsbyAlphaScreenassay,ChEMBL,519,8,2,6,5.5,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1,10.1021/jm500457x
CHEMBL3298895,111918,2,None,-,1,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumanD2LreceptorexpressedinFlpInCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductiontreatedfor30minsbyAlphaScreenassayAgonistactivityathumanD2LreceptorexpressedinFlpInCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductiontreatedfor30minsbyAlphaScreenassay,ChEMBL,519,8,2,6,5.5,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1,10.1021/jm500457x
10715828,53720,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,397,7,1,4,3.7,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1,10.1021/jm300603y
CHEMBL160630,53720,0,None,-,1,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,397,7,1,4,3.7,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1,10.1021/jm300603y
127046922,139055,0,None,5,2,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,417,7,3,4,2.9,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
CHEMBL3798179,139055,0,None,5,2,Human,9.5,pEC50,=,9.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,417,7,3,4,2.9,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
219050,3292,19,None,2,5,Human,9.4,pEC50,=,9.4,Functional,CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals)CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals),ChEMBL,346,6,2,2,5,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,10.1021/jm950721m
52,3292,19,None,2,5,Human,9.4,pEC50,=,9.4,Functional,CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals)CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals),ChEMBL,346,6,2,2,5,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,10.1021/jm950721m
CHEMBL431367,3292,19,None,2,5,Human,9.4,pEC50,=,9.4,Functional,CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals)CompoundwasevaluatedforeffectiveconcentrationinvivoforDopaminereceptorD2mitogenesis.(95%confidenceintervals),ChEMBL,346,6,2,2,5,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2,10.1021/jm950721m
3033200,173806,4,None,616,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,4,0,5,4.1,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3,10.1021/acsmedchemlett.9b00575
CHEMBL4555547,173806,4,None,616,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,4,0,5,4.1,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3,10.1021/acsmedchemlett.9b00575
3033200,173806,4,None,616,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,4,0,5,4.1,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3,10.1021/acsmedchemlett.9b00575
CHEMBL4555547,173806,4,None,616,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,4,0,5,4.1,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3,10.1021/acsmedchemlett.9b00575
76325152,105795,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,359,9,2,4,4,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,10.1021/jm401384w
CHEMBL3115579,105795,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,359,9,2,4,4,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,10.1021/jm401384w
CHEMBL3139262,105795,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,359,9,2,4,4,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,10.1021/jm401384w
12899503,53388,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,379,7,1,4,3.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,10.1021/jm300603y
CHEMBL160357,53388,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,379,7,1,4,3.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,10.1021/jm300603y
56597940,153281,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,450,7,2,6,2.9,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,nan
CHEMBL3983588,153281,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,450,7,2,6,2.9,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,nan
11154555,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
5037,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
7671,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
CHEMBL2028019,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
DB06016,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
21073553,144530,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,438,7,1,7,2.7,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,nan
CHEMBL3912435,144530,0,None,-,1,Human,9.4,pEC50,=,9.4,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,438,7,1,7,2.7,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,nan
137633863,155945,0,None,-12,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4069145,155945,0,None,-12,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
137633863,155945,0,None,-12,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4069145,155945,0,None,-12,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
71459660,83338,0,None,2,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,548,17,2,4,8.1,CCCN(CCCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
CHEMBL2206265,83338,0,None,2,2,Human,9.4,pEC50,=,9.4,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,548,17,2,4,8.1,CCCN(CCCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
11154555,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
5037,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
7671,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
CHEMBL2028019,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
DB06016,782,0,None,1,4,Human,9.4,pEC50,=,9.4,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.9b00508
44554649,103696,0,None,457,2,Human,9.3,pEC50,=,9.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,328,4,1,6,1.6,CCCN1C[C@@H](Cn2cncn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099235,103696,0,None,457,2,Human,9.3,pEC50,=,9.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,328,4,1,6,1.6,CCCN1C[C@@H](Cn2cncn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
10692886,53320,2,None,-,1,Human,9.3,pEC50,=,9.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL160296,53320,2,None,-,1,Human,9.3,pEC50,=,9.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL1813590,53320,2,None,-,1,Human,9.3,pEC50,=,9.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
52937876,60784,0,None,-489,2,Human,9.3,pEC50,=,9.3,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrsAgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrs,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
CHEMBL1765633,60784,0,None,-489,2,Human,9.3,pEC50,=,9.3,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrsAgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrs,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
44554820,105709,0,None,31,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,307,4,1,4,2.7,CCCN1C[C@H](CSC)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099222,105709,0,None,31,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,307,4,1,4,2.7,CCCN1C[C@H](CSC)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139044,105709,0,None,31,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,307,4,1,4,2.7,CCCN1C[C@H](CSC)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
21073553,144530,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,438,7,1,7,2.7,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,nan
CHEMBL3912435,144530,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,438,7,1,7,2.7,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,nan
10692886,53320,2,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL160296,53320,2,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL1813590,53320,2,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
681,1424,59,None,-17,11,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401384w
940,1424,59,None,-17,11,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401384w
947,1424,59,None,-17,11,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401384w
CHEMBL59,1424,59,None,-17,11,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401384w
DB00988,1424,59,None,-17,11,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401384w
76321554,105827,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,10.1021/jm401384w
CHEMBL3115574,105827,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,10.1021/jm401384w
CHEMBL3139450,105827,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,395,4,2,3,3.5,Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,10.1021/jm401384w
46882052,6135,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,287,4,0,2,2.8,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,10.1016/j.bmcl.2010.01.090
CHEMBL1081489,6135,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,287,4,0,2,2.8,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,10.1016/j.bmcl.2010.01.090
46881463,7112,0,None,794,3,Human,9.2,pEC50,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.7,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1085672,7112,0,None,794,3,Human,9.2,pEC50,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.7,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL4526364,172596,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,355,4,1,3,4,N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
21786101,155055,0,None,38,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,261,2,2,3,2.7,CCCN1CCC[C@@H]2Cc3c(ccc(O)c3O)C[C@H]21,10.1016/j.bmc.2007.06.036
CHEMBL405519,155055,0,None,38,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,261,2,2,3,2.7,CCCN1CCC[C@@H]2Cc3c(ccc(O)c3O)C[C@H]21,10.1016/j.bmc.2007.06.036
2407,3291,66,None,11,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1016/j.bmc.2013.11.012
59227,3291,66,None,11,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1016/j.bmc.2013.11.012
941,3291,66,None,11,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1016/j.bmc.2013.11.012
CHEMBL1303,3291,66,None,11,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1016/j.bmc.2013.11.012
DB05271,3291,66,None,11,2,Human,9.2,pEC50,=,9.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1016/j.bmc.2013.11.012
CHEMBL4526364,172596,0,None,-,1,Human,9.2,pEC50,=,9.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,355,4,1,3,4,N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
25093832,155203,0,None,2,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
25093832,155203,0,None,2,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
46882053,6136,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1cccc(F)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081490,6136,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1cccc(F)c1,10.1016/j.bmcl.2010.01.090
10715828,53720,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,397,7,1,4,3.7,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1,10.1021/jm300603y
CHEMBL160630,53720,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,397,7,1,4,3.7,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1,10.1021/jm300603y
10763756,54085,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,404,7,1,5,3.4,N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL160921,54085,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,404,7,1,5,3.4,N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
10502413,168766,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL443034,168766,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
681,1424,59,None,-17,11,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acsmedchemlett.9b00050
940,1424,59,None,-17,11,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acsmedchemlett.9b00050
947,1424,59,None,-17,11,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acsmedchemlett.9b00050
CHEMBL59,1424,59,None,-17,11,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acsmedchemlett.9b00050
DB00988,1424,59,None,-17,11,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acsmedchemlett.9b00050
12899503,53388,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,379,7,1,4,3.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,10.1021/jm300603y
CHEMBL160357,53388,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,379,7,1,4,3.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,10.1021/jm300603y
44554468,105691,0,None,151,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,233,1,1,3,1.6,CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099225,105691,0,None,151,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,233,1,1,3,1.6,CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139011,105691,0,None,151,2,Human,9.1,pEC50,=,9.1,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,233,1,1,3,1.6,CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
66633662,151346,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,7,1,6,3.3,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2[nH]1,nan
CHEMBL3966956,151346,0,None,-,1,Human,9.1,pEC50,=,9.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,7,1,6,3.3,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2[nH]1,nan
131801153,169276,0,None,-,1,Human,9,pEC50,=,9,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter1hrbyFLIPRassayAgonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter1hrbyFLIPRassay,ChEMBL,418,7,2,4,4,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]ccc45)CC3)cc2N1,10.1021/acs.jmedchem.8b00435
CHEMBL4442260,169276,0,None,-,1,Human,9,pEC50,=,9,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter1hrbyFLIPRassayAgonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter1hrbyFLIPRassay,ChEMBL,418,7,2,4,4,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]ccc45)CC3)cc2N1,10.1021/acs.jmedchem.8b00435
681,1424,59,None,-17,11,Human,9,pEC50,=,9,Functional,AgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2019.04.014
940,1424,59,None,-17,11,Human,9,pEC50,=,9,Functional,AgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2019.04.014
947,1424,59,None,-17,11,Human,9,pEC50,=,9,Functional,AgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2019.04.014
CHEMBL59,1424,59,None,-17,11,Human,9,pEC50,=,9,Functional,AgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2019.04.014
DB00988,1424,59,None,-17,11,Human,9,pEC50,=,9,Functional,AgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAgonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasincreaseincalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperaturemeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2019.04.014
242,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
34,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
60795,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
CHEMBL1112,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
DB01238,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
44554984,103692,0,None,208,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,327,4,1,5,2.2,CCCN1C[C@@H](Cn2cccn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099231,103692,0,None,208,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,327,4,1,5,2.2,CCCN1C[C@@H](Cn2cccn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
127047229,138908,0,None,-1,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,315,7,0,4,3.3,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,10.1021/acs.jmedchem.6b01875
CHEMBL3797209,138908,0,None,-1,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,315,7,0,4,3.3,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,10.1021/acs.jmedchem.6b01875
242,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,InverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassayInverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.8b00435
34,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,InverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassayInverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.8b00435
60795,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,InverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassayInverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.8b00435
CHEMBL1112,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,InverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassayInverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.8b00435
DB01238,467,113,None,-6,12,Human,9,pEC50,=,9,Functional,InverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassayInverseagonistactivityatdopamineD2receptor(unknownorigin)assessedasinhibitionofforskolin-mediatedcAMPaccumulationafter20minsbyradiometricassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.8b00435
46882004,5501,0,None,-,1,Human,9,pEC50,=,9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1077344,5501,0,None,-,1,Human,9,pEC50,=,9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
11154555,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
5037,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
7671,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL2028019,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB06016,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
11154555,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
5037,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
7671,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL2028019,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB06016,782,0,None,1,4,Human,9,pEC50,=,9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
44554474,105708,0,None,301,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,3,1.7,C=CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099227,105708,0,None,301,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,3,1.7,C=CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139043,105708,0,None,301,2,Human,9,pEC50,=,9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,245,2,1,3,1.7,C=CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
2,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acsmedchemlett.9b00050
54562,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acsmedchemlett.9b00050
CHEMBL240773,3181,17,None,-12,7,Human,8.9,pEC50,=,8.9,Functional,AgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassayAgonistactivityatD2R(unknownorigin)expressedinHEK293cellsassessedaseffectoncAMPaccumulationincubatedfor10minsbyGi-cAMPGlosensorassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acsmedchemlett.9b00050
2470,3566,41,None,-17,11,Human,8.9,pEC50,=,8.9,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,395,6,1,4,3.2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,nan
3300,3566,41,None,-17,11,Human,8.9,pEC50,=,8.9,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,395,6,1,4,3.2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,nan
5265,3566,41,None,-17,11,Human,8.9,pEC50,=,8.9,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,395,6,1,4,3.2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,nan
99,3566,41,None,-17,11,Human,8.9,pEC50,=,8.9,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,395,6,1,4,3.2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,nan
CHEMBL267930,3566,41,None,-17,11,Human,8.9,pEC50,=,8.9,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,395,6,1,4,3.2,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1,nan
44554982,103691,0,None,58,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,327,4,1,5,2.2,CCCN1C[C@H](Cn2cccn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099230,103691,0,None,58,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,327,4,1,5,2.2,CCCN1C[C@H](Cn2cccn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
56597227,153137,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,437,7,1,6,3.3,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,nan
CHEMBL3982360,153137,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,437,7,1,6,3.3,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,nan
24754400,153927,0,None,-19,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,423,8,1,5,3.8,CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1,10.1021/jm070860r
CHEMBL399164,153927,0,None,-19,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,423,8,1,5,3.8,CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1,10.1021/jm070860r
228,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
33,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
6005,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
CHEMBL53,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
DB00714,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
76321556,105801,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,493,6,2,5,3.1,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2,10.1021/jm401384w
CHEMBL3115578,105801,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,493,6,2,5,3.1,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2,10.1021/jm401384w
CHEMBL3139302,105801,0,None,-,1,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassayAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedcAMPaccumulationafter30minsbyLANCEassay,ChEMBL,493,6,2,5,3.1,Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2,10.1021/jm401384w
CHEMBL4863832,184858,0,None,10,3,Human,8.8,pEC50,=,8.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
56593482,3850,0,None,602,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
7650,3850,0,None,602,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
CHEMBL2165119,3850,0,None,602,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
2,3181,17,None,-12,7,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2016.04.028
54562,3181,17,None,-12,7,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2016.04.028
CHEMBL240773,3181,17,None,-12,7,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2016.04.028
CHEMBL4863832,184858,0,None,10,3,Human,8.8,pEC50,=,8.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
228,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
33,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
6005,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
CHEMBL53,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
DB00714,441,21,None,-2,8,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/acsmedchemlett.9b00575
45140376,196328,0,None,-2,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,460,7,2,6,4,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2ccc(O)cc2C1,10.1021/jm901618d
CHEMBL599635,196328,0,None,-2,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,460,7,2,6,4,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2ccc(O)cc2C1,10.1021/jm901618d
71459659,83337,0,None,-3,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,534,16,2,4,7.7,CCCN(CCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
CHEMBL2206264,83337,0,None,-3,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,534,16,2,4,7.7,CCCN(CCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
44554818,103695,0,None,89,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,328,4,1,6,1.6,CCCN1C[C@H](Cn2cncn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099234,103695,0,None,89,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,328,4,1,6,1.6,CCCN1C[C@H](Cn2cncn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
11761412,116347,0,None,2,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopaminereceptorD2longexpressedinCHO10001cellsassessedasstimulationofincorporation[3H]-thymidineincorporationAgonistactivityathumandopaminereceptorD2longexpressedinCHO10001cellsassessedasstimulationofincorporation[3H]-thymidineincorporation,ChEMBL,411,9,1,4,3.6,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1,10.1016/j.bmcl.2010.09.142
CHEMBL338606,116347,0,None,2,2,Human,8.8,pEC50,=,8.8,Functional,AgonistactivityathumandopaminereceptorD2longexpressedinCHO10001cellsassessedasstimulationofincorporation[3H]-thymidineincorporationAgonistactivityathumandopaminereceptorD2longexpressedinCHO10001cellsassessedasstimulationofincorporation[3H]-thymidineincorporation,ChEMBL,411,9,1,4,3.6,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1,10.1016/j.bmcl.2010.09.142
11983282,138287,0,None,-2,3,Human,8.8,pEC50,=,8.8,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
CHEMBL378455,138287,0,None,-2,3,Human,8.8,pEC50,=,8.8,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
228,441,21,None,-2,8,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
33,441,21,None,-2,8,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
6005,441,21,None,-2,8,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
CHEMBL53,441,21,None,-2,8,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
DB00714,441,21,None,-2,8,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
2,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.8b00671
54562,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.8b00671
CHEMBL240773,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.8b00671
2,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
54562,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
CHEMBL240773,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
56597940,153281,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,450,7,2,6,2.9,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,nan
CHEMBL3983588,153281,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,450,7,2,6,2.9,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,nan
2,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
54562,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
CHEMBL240773,3181,17,None,-12,7,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.9b00508
CHEMBL4852524,184120,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4852524,184120,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
183812,201378,17,None,-15,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanrecombinantdopamineD2SreceptorexpressedinHEKcellsbyGTPgammaSbindingassayAgonistactivityathumanrecombinantdopamineD2SreceptorexpressedinHEKcellsbyGTPgammaSbindingassay,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1021/ml4005232
CHEMBL82663,201378,17,None,-15,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanrecombinantdopamineD2SreceptorexpressedinHEKcellsbyGTPgammaSbindingassayAgonistactivityathumanrecombinantdopamineD2SreceptorexpressedinHEKcellsbyGTPgammaSbindingassay,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1021/ml4005232
66559778,81476,0,None,-,1,Human,8,pEC50,=,8,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,10.1021/jm300603y
CHEMBL2165123,81476,0,None,-,1,Human,8,pEC50,=,8,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,10.1021/jm300603y
121418538,170876,0,None,-,1,Human,8,pEC50,=,8,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,345,6,0,3,4.7,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)CC1,10.1021/acs.jmedchem.8b00435
CHEMBL4465147,170876,0,None,-,1,Human,8,pEC50,=,8,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,345,6,0,3,4.7,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)CC1,10.1021/acs.jmedchem.8b00435
11102013,11368,0,None,-,1,Human,8,pEC50,=,8,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,427,9,1,4,4.1,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1,10.1021/jm030836n
CHEMBL1180455,11368,0,None,-,1,Human,8,pEC50,=,8,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,427,9,1,4,4.1,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1,10.1021/jm030836n
CHEMBL126725,11368,0,None,-,1,Human,8,pEC50,=,8,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,427,9,1,4,4.1,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1,10.1021/jm030836n
2,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
54562,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL240773,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,IntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(short)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL4863992,184869,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,380,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
11978813,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
5014,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
7672,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL2105760,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
DB09128,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL4441636,169236,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,373,4,1,4,3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cc4c(cc3C2)OCO4)CC1,10.1021/acs.jmedchem.9b00508
46882009,6110,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081311,6110,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
46882054,6137,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)cc1,10.1016/j.bmcl.2010.01.090
CHEMBL1081491,6137,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)cc1,10.1016/j.bmcl.2010.01.090
46881408,6653,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,339,4,0,2,3.6,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1083813,6653,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,339,4,0,2,3.6,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2010.01.090
11978813,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
5014,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
7672,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL2105760,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
DB09128,709,67,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
128,149,6,None,-50,3,Human,8,pEC50,=,8,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1016/j.bmc.2009.04.031
172267,149,6,None,-50,3,Human,8,pEC50,=,8,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1016/j.bmc.2009.04.031
CHEMBL273273,149,6,None,-50,3,Human,8,pEC50,=,8,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1016/j.bmc.2009.04.031
90467323,158864,0,None,1,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,532,11,2,7,4.2,COc1cc(OC(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1-c1cccc(C(N)=O)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4102620,158864,0,None,1,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,532,11,2,7,4.2,COc1cc(OC(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1-c1cccc(C(N)=O)c1,10.1021/acs.jmedchem.6b01578
10047648,115171,0,None,6,2,Human,8,pEC50,=,8,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,418,4,1,4,4,O=C(N[C@@H]1CC[C@H]2C[C@@H](N3CCN(c4ccccn4)CC3)CC[C@@H]2C1)c1ccccc1,10.1021/jm00050a022
CHEMBL335403,115171,0,None,6,2,Human,8,pEC50,=,8,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,418,4,1,4,4,O=C(N[C@@H]1CC[C@H]2C[C@@H](N3CCN(c4ccccn4)CC3)CC[C@@H]2C1)c1ccccc1,10.1021/jm00050a022
CHEMBL4859410,184569,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4451797,169974,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1,10.1021/acs.jmedchem.9b00508
2,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.6b01875
54562,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.6b01875
CHEMBL240773,3181,17,None,-12,7,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.6b01875
CHEMBL4872467,185421,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4872467,185421,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
119570,3081,84,None,-10,6,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1021/acs.jmedchem.7b00363
2233,3081,84,None,-10,6,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1021/acs.jmedchem.7b00363
953,3081,84,None,-10,6,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1021/acs.jmedchem.7b00363
CHEMBL301265,3081,84,None,-10,6,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1021/acs.jmedchem.7b00363
DB00413,3081,84,None,-10,6,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1021/acs.jmedchem.7b00363
56599142,3851,2,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,nan
7652,3851,2,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,nan
CHEMBL2165138,3851,2,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,nan
56597091,81486,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165134,81486,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,10.1021/jm300603y
137651073,156783,0,None,-36,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4079301,156783,0,None,-36,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
56599147,81481,0,None,-,1,Human,6,pEC50,=,6,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL2165129,81481,0,None,-,1,Human,6,pEC50,=,6,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
137653359,158216,0,None,-,1,Human,6,pEC50,=,6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,524,14,2,9,2,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4095452,158216,0,None,-,1,Human,6,pEC50,=,6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,524,14,2,9,2,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
151086,91458,3,None,-,1,Human,5,pEC50,=,5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,267,0,2,3,2.9,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,10.1021/acs.jnatprod.9b00921
CHEMBL2414991,91458,3,None,-,1,Human,5,pEC50,=,5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,267,0,2,3,2.9,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,10.1021/acs.jnatprod.9b00921
151086,91458,3,None,-,1,Human,5,pEC50,=,5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,267,0,2,3,2.9,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,10.1021/acs.jnatprod.9b00921
CHEMBL2414991,91458,3,None,-,1,Human,5,pEC50,=,5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,267,0,2,3,2.9,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,10.1021/acs.jnatprod.9b00921
CHEMBL4860528,184634,0,None,-181,4,Human,6,pEC50,=,6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,326,8,4,4,1.8,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,10.1016/j.ejmech.2021.113190
56599143,81490,0,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165139,81490,0,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
137657115,159061,0,None,-11,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4105030,159061,0,None,-11,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4846380,183694,0,None,-109,4,Human,6,pEC50,=,6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,350,6,4,5,1.9,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1ccco1,10.1016/j.ejmech.2021.113190
16038360,16754,0,None,-104,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,469,8,1,4,5.5,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2ccc(O)cc2C1,10.1016/j.bmc.2010.06.025
CHEMBL1253770,16754,0,None,-104,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,469,8,1,4,5.5,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2ccc(O)cc2C1,10.1016/j.bmc.2010.06.025
25071692,111201,0,None,-9,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287405,111201,0,None,-9,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
122189392,122610,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,441,5,0,7,3.6,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL3613878,122610,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,441,5,0,7,3.6,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL4853107,184160,0,None,-12,3,Human,6,pEC50,=,6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,402,8,4,4,2.8,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2sc(N)nc2C)cc1,10.1016/j.ejmech.2021.113190
CHEMBL4859410,184569,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4451797,169974,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1,10.1021/acs.jmedchem.9b00508
56597226,147741,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,410,8,1,6,3,COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3937643,147741,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,410,8,1,6,3,COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL4850635,183987,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,378,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4850635,183987,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,378,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
127046952,139444,0,None,87,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,421,12,3,5,4.5,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800636,139444,0,None,87,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,421,12,3,5,4.5,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
11154555,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
5037,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
7671,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
CHEMBL2028019,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
DB06016,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
25071692,111201,0,None,-9,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287405,111201,0,None,-9,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
52937876,60784,0,None,-489,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPaccumulationbybioluminescenceassayAgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPaccumulationbybioluminescenceassay,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
CHEMBL1765633,60784,0,None,-489,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPaccumulationbybioluminescenceassayAgonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPaccumulationbybioluminescenceassay,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
122177641,120580,0,None,-,1,Human,7,pEC50,=,7,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577342,120580,0,None,-,1,Human,7,pEC50,=,7,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
137657115,159061,0,None,-11,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4105030,159061,0,None,-11,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
11154555,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
5037,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
7671,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
CHEMBL2028019,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
DB06016,782,0,None,1,4,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
118725996,116596,0,None,-,1,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,572,21,3,5,6.4,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394254,116596,0,None,-,1,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,572,21,3,5,6.4,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
122189393,122611,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,455,6,0,7,4,Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL3613879,122611,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,455,6,0,7,4,Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL4848815,183847,0,None,-27,3,Human,6,pEC50,=,6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,388,8,4,4,2.8,CCC(CNC(=O)/N=C(\N)NCCCc1sc(N)nc1C)c1ccccc1,10.1016/j.ejmech.2021.113190
60148494,80366,0,None,-446,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL2152747,80366,0,None,-446,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
44427818,91603,0,None,-38,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,444,9,1,5,4.1,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
CHEMBL241973,91603,0,None,-38,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,444,9,1,5,4.1,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
118725996,116596,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,572,21,3,5,6.4,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394254,116596,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,572,21,3,5,6.4,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
60165801,80365,0,None,-446,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C1CCc2nc(N)sc2C1,10.1016/j.bmc.2013.03.059
CHEMBL2152746,80365,0,None,-446,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C1CCc2nc(N)sc2C1,10.1016/j.bmc.2013.03.059
45486330,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL571992,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
45486330,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
CHEMBL571992,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
45486330,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2013.03.059
CHEMBL571992,193469,0,None,-173,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2013.03.059
25093832,155203,0,None,2,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL3085802,102988,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,329,4,1,2,3.3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
10939167,9381,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrsPartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrs,ChEMBL,443,9,1,4,4.7,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm101639t
CHEMBL112065,9381,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrsPartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrs,ChEMBL,443,9,1,4,4.7,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm101639t
CHEMBL129483,9381,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrsPartialagonistactivityathumandopamineD2longreceptorexpressedinCHOcellsassessedasinductionof[3H]thymidineincorporationafter2hrs,ChEMBL,443,9,1,4,4.7,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm101639t
CHEMBL3085802,102988,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,329,4,1,2,3.3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
10178704,49346,1,None,-17,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,393,7,1,4,3.8,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,10.1021/jm070860r
CHEMBL156639,49346,1,None,-17,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,393,7,1,4,3.8,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,10.1021/jm070860r
242,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
34,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
60795,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL1112,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB01238,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
242,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
34,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
60795,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL1112,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB01238,467,113,None,-6,12,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
201536,110885,3,None,-1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,351,2,0,5,3.3,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL3276140,110885,3,None,-1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,351,2,0,5,3.3,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
228,441,21,None,-2,8,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2018.04.059
33,441,21,None,-2,8,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2018.04.059
6005,441,21,None,-2,8,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2018.04.059
CHEMBL53,441,21,None,-2,8,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2018.04.059
DB00714,441,21,None,-2,8,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2018.04.059
201536,110885,3,None,-1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,351,2,0,5,3.3,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL3276140,110885,3,None,-1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,351,2,0,5,3.3,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
25072002,155437,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4063235,155437,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4852524,184120,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4852524,184120,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
121418441,173611,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,331,6,0,3,4.3,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)C1,10.1021/acs.jmedchem.8b00435
CHEMBL4550815,173611,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,331,6,0,3,4.3,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)C1,10.1021/acs.jmedchem.8b00435
25093832,155203,0,None,2,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4848451,183823,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,3,5.2,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4848451,183823,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,3,5.2,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,10.1021/acs.jmedchem.1c01327
132435,130064,5,None,-8,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparation,ChEMBL,345,3,3,4,3.6,C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL130795,130064,5,None,-8,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparation,ChEMBL,345,3,3,4,3.6,C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL368456,130064,5,None,-8,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionofreleaseofNEinanisolatedperfusedrabbiteararterypreparation,ChEMBL,345,3,3,4,3.6,C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
137662136,158663,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,423,12,1,6,3,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4100322,158663,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,423,12,1,6,3,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
46881411,6656,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,319,4,0,4,3.2,O=c1n(CCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1083816,6656,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,319,4,0,4,3.2,O=c1n(CCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
46881412,6752,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,357,4,0,3,2.6,O=S1(=O)N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1084121,6752,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,357,4,0,3,2.6,O=S1(=O)N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
56599143,81490,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165139,81490,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
56597938,3849,0,None,204,2,Human,6.9,pEC50,=,6.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
7651,3849,0,None,204,2,Human,6.9,pEC50,=,6.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
CHEMBL2165126,3849,0,None,204,2,Human,6.9,pEC50,=,6.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
71456928,81482,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,459,6,1,4,4.6,O=C1CCc2ccc(CO[C@@H]3C[C@H]3CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165130,81482,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,459,6,1,4,4.6,O=C1CCc2ccc(CO[C@@H]3C[C@H]3CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL4863920,184863,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,393,7,2,2,4.8,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1,10.1021/acs.jmedchem.1c01327
CHEMBL4473178,171432,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,407,4,1,2,4,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Br)c3C2)CC1,10.1021/acs.jmedchem.9b00508
25072632,111188,0,None,-30,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,10.1021/jm5004039
CHEMBL3287392,111188,0,None,-30,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,10.1021/jm5004039
CHEMBL4473178,171432,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,407,4,1,2,4,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Br)c3C2)CC1,10.1021/acs.jmedchem.9b00508
46917563,67922,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,561,18,1,7,5.5,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1,10.1021/jm2009919
CHEMBL1916551,67922,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,561,18,1,7,5.5,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1,10.1021/jm2009919
137636351,155196,0,None,2,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,459,7,1,6,4,O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/acs.jmedchem.6b01857
CHEMBL4060403,155196,0,None,2,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,459,7,1,6,4,O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/acs.jmedchem.6b01857
25072002,155437,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4063235,155437,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
44555137,103693,0,None,28,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,403,5,1,5,3.9,CCCN1C[C@H](Cn2ccc(-c3ccccc3)n2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099232,103693,0,None,28,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,403,5,1,5,3.9,CCCN1C[C@H](Cn2ccc(-c3ccccc3)n2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
85469680,156034,0,None,-5,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,526,8,2,5,5.1,NC(=O)c1cccc(-c2cccc(OC(=O)NCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4070196,156034,0,None,-5,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,526,8,2,5,5.1,NC(=O)c1cccc(-c2cccc(OC(=O)NCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2)c1,10.1021/acs.jmedchem.6b01578
90466574,157903,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,540,9,2,5,5.5,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4092052,157903,0,None,-3,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,540,9,2,5,5.5,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
56593482,3850,0,None,602,2,Human,7.9,pEC50,=,7.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
7650,3850,0,None,602,2,Human,7.9,pEC50,=,7.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
CHEMBL2165119,3850,0,None,602,2,Human,7.9,pEC50,=,7.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
56598074,145009,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,445,6,1,4,4.8,O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL3916047,145009,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,445,6,1,4,4.8,O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL4855583,184324,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,1,4,5.1,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL4855583,184324,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,1,4,5.1,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
24866114,177954,0,None,-223,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,467,7,1,6,4.4,CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2nc(N)sc2C1,10.1021/jm701524h
CHEMBL468017,177954,0,None,-223,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,467,7,1,6,4.4,CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2nc(N)sc2C1,10.1021/jm701524h
45486328,193040,0,None,-25,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2cccc3ncccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
CHEMBL569107,193040,0,None,-25,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2cccc3ncccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
90467021,155990,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,558,9,2,5,5.6,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2F)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4069565,155990,0,None,1,2,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,558,9,2,5,5.6,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2F)c1,10.1021/acs.jmedchem.6b01578
11316847,69930,0,None,-6,2,Human,7.9,pEC50,=,7.9,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,448,7,1,5,4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,10.1021/jm049465g
CHEMBL194493,69930,0,None,-6,2,Human,7.9,pEC50,=,7.9,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,448,7,1,5,4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,10.1021/jm049465g
242,467,113,None,-6,12,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.7b00363
34,467,113,None,-6,12,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.7b00363
60795,467,113,None,-6,12,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.7b00363
CHEMBL1112,467,113,None,-6,12,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.7b00363
DB01238,467,113,None,-6,12,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.7b00363
71733935,90465,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2396663,90465,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
25072632,111188,0,None,-30,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,10.1021/jm5004039
CHEMBL3287392,111188,0,None,-30,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,10.1021/jm5004039
71733935,90465,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2396663,90465,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL4461089,170600,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,314,5,1,2,3.5,CCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4461089,170600,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,314,5,1,2,3.5,CCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
90467171,160454,0,None,1,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,497,8,1,4,6.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccc(-c2ccccc2)cc1,10.1021/acs.jmedchem.6b01578
CHEMBL4079093,160454,0,None,1,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,497,8,1,4,6.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccc(-c2ccccc2)cc1,10.1021/acs.jmedchem.6b01578
CHEMBL4117318,160454,0,None,1,2,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,497,8,1,4,6.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccc(-c2ccccc2)cc1,10.1021/acs.jmedchem.6b01578
13720688,11421,0,None,-1,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,329,3,3,4,3.1,C=CCN1CCc2c(cc(O)c(O)c2F)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL1180542,11421,0,None,-1,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,329,3,3,4,3.1,C=CCN1CCc2c(cc(O)c(O)c2F)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL129634,11421,0,None,-1,2,Human,6.9,pEC50,=,6.9,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,329,3,3,4,3.1,C=CCN1CCc2c(cc(O)c(O)c2F)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL4863920,184863,0,None,-,1,Human,6.9,pEC50,=,6.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,393,7,2,2,4.8,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1,10.1021/acs.jmedchem.1c01327
118726003,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394259,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3559207,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
118726003,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394259,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3559207,120255,0,None,-1,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,878,31,5,13,7.1,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
101885476,120906,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,857,37,4,6,9.9,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585372,120906,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,857,37,4,6,9.9,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3085821,102998,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,455,5,1,4,5.6,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4447058,169613,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,355,4,1,2,3.8,O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)N1CCCC1,10.1021/acs.jmedchem.9b00508
CHEMBL4865389,184951,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,440,11,1,4,5,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
101885476,120906,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,857,37,4,6,9.9,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585372,120906,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,857,37,4,6,9.9,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL4865389,184951,0,None,-,1,Human,7.9,pEC50,=,7.9,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,440,11,1,4,5,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL3085821,102998,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,455,5,1,4,5.6,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4447058,169613,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,355,4,1,2,3.8,O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)N1CCCC1,10.1021/acs.jmedchem.9b00508
137658100,158922,0,None,2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,483,7,1,4,6,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccc(-c2ccccc2)cc1,10.1021/acs.jmedchem.6b01578
CHEMBL4103339,158922,0,None,2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,483,7,1,4,6,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccc(-c2ccccc2)cc1,10.1021/acs.jmedchem.6b01578
CHEMBL4852835,184143,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4859080,184543,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,430,9,2,3,5.4,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4852835,184143,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4864436,184897,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,398,9,2,4,3.9,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4859080,184543,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,430,9,2,3,5.4,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4864436,184897,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,398,9,2,4,3.9,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm2009919
54562,3181,17,None,-12,7,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm2009919
CHEMBL240773,3181,17,None,-12,7,Human,6.9,pEC50,=,6.9,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm2009919
137651073,156783,0,None,-36,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4079301,156783,0,None,-36,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
44554644,105705,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@@H]1OCCN(CC3CC3)[C@H]1C2,10.1016/j.bmc.2013.11.012
CHEMBL3099229,105705,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@@H]1OCCN(CC3CC3)[C@H]1C2,10.1016/j.bmc.2013.11.012
CHEMBL3139036,105705,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@@H]1OCCN(CC3CC3)[C@H]1C2,10.1016/j.bmc.2013.11.012
57335757,71129,0,None,-,1,Human,4.9,pEC50,=,4.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@H]1C2,10.1016/j.bmcl.2012.01.005
CHEMBL1950492,71129,0,None,-,1,Human,4.9,pEC50,=,4.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@H]1C2,10.1016/j.bmcl.2012.01.005
CHEMBL1963011,71129,0,None,-,1,Human,4.9,pEC50,=,4.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@H]1C2,10.1016/j.bmcl.2012.01.005
137651073,156783,0,None,-36,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4079301,156783,0,None,-36,2,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
122179562,120900,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,532,13,2,6,4.7,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2CCCNC(=O)OC(C)(C)C,10.1039/C4MD00066H
CHEMBL3585366,120900,0,None,-,1,Human,5.9,pEC50,=,5.9,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,532,13,2,6,4.7,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2CCCNC(=O)OC(C)(C)C,10.1039/C4MD00066H
CHEMBL3088211,103182,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,330,5,1,3,3.7,CCOC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL3088211,103182,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,330,5,1,3,3.7,CCOC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
122179562,120900,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,532,13,2,6,4.7,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2CCCNC(=O)OC(C)(C)C,10.1039/C4MD00066H
CHEMBL3585366,120900,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,532,13,2,6,4.7,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2CCCNC(=O)OC(C)(C)C,10.1039/C4MD00066H
137660751,158703,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,532,15,2,6,5.8,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4100734,158703,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,532,15,2,6,5.8,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
90466867,155633,0,None,-5,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,538,8,2,5,5.2,NC(=O)c1cccc(-c2ccc(OC(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4065510,155633,0,None,-5,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,538,8,2,5,5.2,NC(=O)c1cccc(-c2ccc(OC(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
118725997,116597,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,652,17,4,12,3.4,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394255,116597,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,652,17,4,12,3.4,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
118725997,116597,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,652,17,4,12,3.4,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394255,116597,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,652,17,4,12,3.4,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
29945476,173576,2,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4550010,173576,2,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4846472,183700,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4846472,183700,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
44438201,93087,1,None,2,2,Human,7.8,pEC50,=,7.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,5,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246637,93087,1,None,2,2,Human,7.8,pEC50,=,7.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,5,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
2,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
44427827,92756,0,None,-15,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,498,8,2,5,4.4,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
CHEMBL244990,92756,0,None,-15,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,498,8,2,5,4.4,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
25071385,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098236,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
2,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
56941366,105125,0,None,-158,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,491,8,2,7,4.5,CCCN(CCN1CCN(c2ccc(-c3cccc(O)c3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm401883v
CHEMBL3125990,105125,0,None,-158,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,491,8,2,7,4.5,CCCN(CCN1CCN(c2ccc(-c3cccc(O)c3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm401883v
2,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
54562,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
CHEMBL240773,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
25072941,155795,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4067439,155795,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
137643951,157569,0,None,-1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,421,8,1,7,2.7,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4088639,157569,0,None,-1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,421,8,1,7,2.7,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
44427841,85627,0,None,-21,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.2,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
CHEMBL231156,85627,0,None,-21,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.2,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
71733935,90465,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2396663,90465,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
2,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
54562,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
CHEMBL240773,3181,17,None,-12,7,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jnatprod.9b00921
CHEMBL4853772,184207,0,None,-16,4,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,376,6,4,4,2.5,Cc1nc(N)sc1CCCN/C(N)=N/C(=S)N[C@H](C)c1ccccc1,10.1016/j.ejmech.2021.113190
25072941,155795,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4067439,155795,0,None,1,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
70684207,75636,0,None,-5,2,Human,4.8,pEC50,=,4.8,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,323,2,0,3,4,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2,nan
CHEMBL2057452,75636,0,None,-5,2,Human,4.8,pEC50,=,4.8,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,323,2,0,3,4,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2,nan
10114519,54898,53,None,-,1,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,445,7,1,5,5.2,Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1,10.1021/jm300603y
CHEMBL161792,54898,53,None,-,1,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,445,7,1,5,5.2,Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1,10.1021/jm300603y
66559778,81476,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,10.1021/jm300603y
CHEMBL2165123,81476,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,10.1021/jm300603y
242,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
34,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
60795,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
CHEMBL1112,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
DB01238,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
242,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
34,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
60795,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
CHEMBL1112,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
DB01238,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
242,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
34,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
60795,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
CHEMBL1112,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
DB01238,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
CHEMBL2165128,81480,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,501,6,1,4,5.9,O=C1CCc2ccc(OC[C@H]3CC[C@H](CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,10.1021/jm300603y
29945476,173576,2,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4550010,173576,2,None,-,1,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
11794899,118958,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,393,7,1,4,3.9,Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL346129,118958,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,393,7,1,4,3.9,Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
25071385,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098236,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
56597095,81487,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,434,7,2,4,4.1,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
CHEMBL2165135,81487,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,434,7,2,4,4.1,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
11978813,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
5014,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
7672,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL2105760,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
DB09128,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
11978813,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
5014,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
7672,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL2105760,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
DB09128,709,67,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,433,7,1,5,4.7,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2,10.1021/acs.jmedchem.1c01327
CHEMBL4865118,184937,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,1,4,4.6,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL4865118,184937,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,1,4,4.6,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
242,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
34,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
60795,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
CHEMBL1112,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
DB01238,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
242,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
34,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
60795,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
CHEMBL1112,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
DB01238,467,113,None,-6,12,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm5004039
2,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
54562,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
CHEMBL240773,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
2,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
54562,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
CHEMBL240773,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
70682090,75635,0,None,-6,2,Human,4.8,pEC50,=,4.8,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,323,2,0,3,4,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,nan
CHEMBL2057451,75635,0,None,-6,2,Human,4.8,pEC50,=,4.8,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,323,2,0,3,4,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,nan
11307083,63159,0,None,-6,2,Human,6.8,pEC50,=,6.8,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,529,6,1,3,4.7,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm049465g
CHEMBL180060,63159,0,None,-6,2,Human,6.8,pEC50,=,6.8,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,529,6,1,3,4.7,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm049465g
2,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
54562,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
CHEMBL240773,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
2,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
54562,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
CHEMBL240773,3181,17,None,-12,7,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm5004039
5311189,200486,4,None,-16,4,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
CHEMBL7549,200486,4,None,-16,4,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
56598072,152086,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,423,8,1,5,4,COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL3973357,152086,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,423,8,1,5,4,COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
3949,3620,28,None,-4,3,Human,6.8,pEC50,=,6.8,Functional,InvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassayInvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/jm030505a
9818479,3620,28,None,-4,3,Human,6.8,pEC50,=,6.8,Functional,InvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassayInvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/jm030505a
CHEMBL419792,3620,28,None,-4,3,Human,6.8,pEC50,=,6.8,Functional,InvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassayInvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/jm030505a
DB06477,3620,28,None,-4,3,Human,6.8,pEC50,=,6.8,Functional,InvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassayInvitroeffectiveconcentrationtestedonHEK293cellsco-transfectedwithhumanDopaminereceptorD2usingFLIPRassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/jm030505a
CHEMBL4856005,184345,0,None,-48,3,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,346,6,4,4,1.8,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCc1ccccc1,10.1016/j.ejmech.2021.113190
44438237,93139,1,None,3,2,Human,6.8,pEC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,424,8,1,3,6.4,CCCCCCn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,10.1016/j.bmcl.2006.10.076
CHEMBL246855,93139,1,None,3,2,Human,6.8,pEC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,424,8,1,3,6.4,CCCCCCn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,10.1016/j.bmcl.2006.10.076
CHEMBL4848451,183823,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,3,5.2,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4848451,183823,0,None,-,1,Human,6.8,pEC50,=,6.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,3,5.2,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4857560,184454,0,None,-23,3,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,394,8,4,4,3.2,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CC1CCCCC1,10.1016/j.ejmech.2021.113190
127046949,139252,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,472,12,3,5,4.6,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3799455,139252,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,472,12,3,5,4.6,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
25071385,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098236,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
56597226,147741,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,410,8,1,6,3,COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3937643,147741,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,410,8,1,6,3,COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
25071385,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098236,158465,0,None,-2,2,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4871762,185368,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,390,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4871762,185368,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,390,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
127045855,139007,0,None,-3,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
CHEMBL3797876,139007,0,None,-3,3,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,319,8,4,6,1.8,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
122177643,120582,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577344,120582,0,None,-,1,Human,5.8,pEC50,=,5.8,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL4853668,184200,0,None,-109,4,Human,5.8,pEC50,=,5.8,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,340,9,4,4,2.2,CCCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,10.1016/j.ejmech.2021.113190
71722301,101907,0,None,4,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,400,3,2,4,4.5,CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1,10.1016/j.bmc.2013.05.014
CHEMBL3040157,101907,0,None,4,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,400,3,2,4,4.5,CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1,10.1016/j.bmc.2013.05.014
CHEMBL3216146,101907,0,None,4,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,400,3,2,4,4.5,CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1,10.1016/j.bmc.2013.05.014
13720686,11427,0,None,-3,2,Human,6.8,pEC50,=,6.8,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,389,3,3,4,3.7,C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL1180562,11427,0,None,-3,2,Human,6.8,pEC50,=,6.8,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,389,3,3,4,3.7,C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL131313,11427,0,None,-3,2,Human,6.8,pEC50,=,6.8,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,389,3,3,4,3.7,C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccc(O)cc2)C1,10.1021/jm00384a006
25071066,111186,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,10.1021/jm5004039
CHEMBL3287390,111186,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,10.1021/jm5004039
71660285,90098,0,None,-5,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,392,7,1,4,3.7,CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2ccc(N)cc2C1,10.1016/j.bmc.2013.03.059
CHEMBL2387709,90098,0,None,-5,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,392,7,1,4,3.7,CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2ccc(N)cc2C1,10.1016/j.bmc.2013.03.059
681,1424,59,None,-17,11,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
940,1424,59,None,-17,11,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
947,1424,59,None,-17,11,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
CHEMBL59,1424,59,None,-17,11,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
DB00988,1424,59,None,-17,11,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
44554643,105693,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@H]1OCCN(CC3CC3)[C@@H]1C2,10.1016/j.bmc.2013.11.012
CHEMBL3099228,105693,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@H]1OCCN(CC3CC3)[C@@H]1C2,10.1016/j.bmc.2013.11.012
CHEMBL3139013,105693,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,259,2,1,3,2,Oc1cccc2c1C[C@H]1OCCN(CC3CC3)[C@@H]1C2,10.1016/j.bmc.2013.11.012
56599145,81485,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL2165133,81485,0,None,-,1,Human,7.8,pEC50,=,7.8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
681,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2020.112709
940,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2020.112709
947,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2020.112709
CHEMBL59,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2020.112709
DB00988,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsbycalcium4dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2020.112709
CHEMBL4852808,184141,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4852808,184141,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
242,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
34,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
60795,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL1112,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB01238,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL4861553,184699,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
25071066,111186,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,10.1021/jm5004039
CHEMBL3287390,111186,0,None,-2,2,Human,6.8,pEC50,=,6.8,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,0,5,4.6,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,10.1021/jm5004039
71452040,1066,0,None,-5,3,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,295,8,1,2,3.9,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1,10.1021/jm301258w
9190,1066,0,None,-5,3,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,295,8,1,2,3.9,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1,10.1021/jm301258w
CHEMBL2180638,1066,0,None,-5,3,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,295,8,1,2,3.9,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1,10.1021/jm301258w
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.5b01031
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.5b01031
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.5b01031
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.5b01031
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.5b01031
24936042,156904,0,None,-2,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4080762,156904,0,None,-2,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
122189389,122607,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,497,8,0,8,4.2,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613875,122607,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,497,8,0,8,4.2,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
681,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassayAgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.8b01096
940,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassayAgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.8b01096
947,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassayAgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.8b01096
CHEMBL59,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassayAgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.8b01096
DB00988,1424,59,None,-17,11,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassayAgonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinductionofcalciumfluxafter60minbycalcium4-dyebasedFLIPRassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.8b01096
2,3181,17,None,-12,7,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm301258w
54562,3181,17,None,-12,7,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm301258w
CHEMBL240773,3181,17,None,-12,7,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm301258w
CHEMBL4460025,170530,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,359,5,1,3,3.3,COc1cccc2c1CN(CC[C@H]1CC[C@H](NC(=O)N(C)C)CC1)CC2,10.1021/acs.jmedchem.9b00508
242,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
34,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
60795,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL1112,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB01238,467,113,None,-6,12,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL4861553,184699,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4460025,170530,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,359,5,1,3,3.3,COc1cccc2c1CN(CC[C@H]1CC[C@H](NC(=O)N(C)C)CC1)CC2,10.1021/acs.jmedchem.9b00508
24866612,188859,0,None,-72,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
CHEMBL514885,188859,0,None,-72,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
24936081,177905,0,None,-234,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2nc(N)sc2C1,10.1021/jm701524h
CHEMBL467540,177905,0,None,-234,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2nc(N)sc2C1,10.1021/jm701524h
24936042,156904,0,None,-2,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4080762,156904,0,None,-2,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
137640203,156280,0,None,-7,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
CHEMBL4072821,156280,0,None,-7,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
122189388,122606,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,483,7,0,8,3.8,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613874,122606,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,483,7,0,8,3.8,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
137640203,156280,0,None,-7,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
CHEMBL4072821,156280,0,None,-7,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
CHEMBL4871774,185370,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,406,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4871774,185370,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,406,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
122177642,120581,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577343,120581,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
21852778,174357,1,None,-,1,Human,5.7,pEC50,=,5.7,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4568388,174357,1,None,-,1,Human,5.7,pEC50,=,5.7,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4867794,185113,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4867794,185113,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
56599147,81481,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165129,81481,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
122189390,122608,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,469,6,0,8,3.4,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613876,122608,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,469,6,0,8,3.4,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
21852778,174357,1,None,-,1,Human,5.7,pEC50,=,5.7,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4568388,174357,1,None,-,1,Human,5.7,pEC50,=,5.7,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,295,2,0,3,3.5,COc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
10549689,50784,14,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,413,7,1,4,4.2,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL157923,50784,14,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,413,7,1,4,4.2,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1,10.1021/jm300603y
15124098,81474,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,437,9,1,5,4.3,CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL2165121,81474,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,437,9,1,5,4.3,CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
66559782,81478,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,446,7,1,3,5.9,O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165125,81478,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,446,7,1,3,5.9,O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
137660837,158388,0,None,-4,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4097330,158388,0,None,-4,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
57242,3179,13,None,-9,4,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1016/j.bmcl.2007.10.059
954,3179,13,None,-9,4,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1016/j.bmcl.2007.10.059
CHEMBL155731,3179,13,None,-9,4,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1016/j.bmcl.2007.10.059
56597938,3849,0,None,204,2,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
7651,3849,0,None,204,2,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
CHEMBL2165126,3849,0,None,204,2,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
CHEMBL4872467,185421,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4875081,185604,0,None,10,3,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
137660837,158388,0,None,-4,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4097330,158388,0,None,-4,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4875081,185604,0,None,10,3,Human,8.7,pEC50,=,8.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
155522454,169998,0,None,-2,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,403,10,2,6,4.4,CCCN(CCCCCc1ccc(O)c(OC)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4452046,169998,0,None,-2,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,403,10,2,6,4.4,CCCN(CCCCCc1ccc(O)c(OC)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
44554986,105707,0,None,35,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,361,4,1,5,2.9,CCCN1C[C@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099236,105707,0,None,35,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,361,4,1,5,2.9,CCCN1C[C@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139041,105707,0,None,35,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,361,4,1,5,2.9,CCCN1C[C@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
122177645,120584,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577346,120584,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
44438230,93037,2,None,9,2,Human,8.7,pEC50,=,8.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,2,2,4.6,Cc1[nH]c2ccccc2c1CN1CCC(O)(c2ccc(Cl)cc2)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246439,93037,2,None,9,2,Human,8.7,pEC50,=,8.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,2,2,4.6,Cc1[nH]c2ccccc2c1CN1CCC(O)(c2ccc(Cl)cc2)CC1,10.1016/j.bmcl.2006.10.076
56598074,145009,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,445,6,1,4,4.8,O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL3916047,145009,0,None,-,1,Human,8.7,pEC50,=,8.7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,445,6,1,4,4.8,O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
24742011,93791,0,None,-18,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,393,7,1,4,3.8,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1,10.1021/jm070860r
CHEMBL250552,93791,0,None,-18,2,Human,8.7,pEC50,=,8.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,393,7,1,4,3.8,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1,10.1021/jm070860r
11154555,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
5037,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
7671,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL2028019,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB06016,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
11154555,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
5037,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
7671,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
CHEMBL2028019,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
DB06016,782,0,None,1,4,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,5,1,3,4.3,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.1c01327
66559588,81473,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,459,7,1,4,5.2,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
CHEMBL2165120,81473,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,459,7,1,4,5.2,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
66559777,81475,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165122,81475,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1,10.1021/jm300603y
66633791,150195,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,421,8,1,5,3.9,COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3957278,150195,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,421,8,1,5,3.9,COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
10895039,18300,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,418,8,1,5,3.6,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1,10.1021/jm030836n
CHEMBL127400,18300,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,418,8,1,5,3.6,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1,10.1021/jm030836n
CHEMBL129022,18300,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,EffectiveconcentrationforDopaminereceptorD3wasdeterminedEffectiveconcentrationforDopaminereceptorD3wasdetermined,ChEMBL,418,8,1,5,3.6,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1,10.1021/jm030836n
CHEMBL4862770,184782,0,None,8,3,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
10692886,53320,2,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayPartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL160296,53320,2,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayPartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL1813590,53320,2,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayPartialagonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,409,8,1,5,3.6,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL4862770,184782,0,None,8,3,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4872467,185421,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
46882005,5742,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,307,3,0,2,3.1,CN1CCCCC1CN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2010.01.090
CHEMBL1079190,5742,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,307,3,0,2,3.1,CN1CCCCC1CN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2010.01.090
127047859,139394,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,476,12,3,6,4.1,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800341,139394,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,476,12,3,6,4.1,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL4846472,183700,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4467173,171018,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,397,4,1,2,4.6,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3c(ccc(Cl)c3Cl)C2)CC1,10.1021/acs.jmedchem.9b00508
71722299,101914,0,None,3,2,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,373,2,3,4,4.1,CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL2397383,101914,0,None,3,2,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,373,2,3,4,4.1,CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL3040217,101914,0,None,3,2,Human,8.6,pEC50,=,8.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,373,2,3,4,4.1,CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
66559588,81473,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,459,7,1,4,5.2,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL2165120,81473,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,459,7,1,4,5.2,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL423499,164631,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,Inhibitionof[3H]thymidineuptakebyDopaminereceptorD2Inhibitionof[3H]thymidineuptakebyDopaminereceptorD2,ChEMBL,388,5,1,3,5,c1ccc(N2CCN(CC[C@H]3CC[C@H](c4c[nH]c5ccccc54)CC3)CC2)nc1,10.1021/jm960597m
CHEMBL4457507,170372,0,None,-,1,Human,8.6,pEC50,=,8.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3c(Cl)cccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4877827,185796,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
137633863,155945,0,None,-12,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4069145,155945,0,None,-12,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4877827,185796,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
137633863,155945,0,None,-12,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4069145,155945,0,None,-12,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
122177645,120584,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577346,120584,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
60148497,80358,0,None,-2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,438,7,2,6,3.6,CCCN(CCN1CCN(c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL2152633,80358,0,None,-2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,438,7,2,6,3.6,CCCN(CCN1CCN(c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
2,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
56599144,81469,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,7,2,3,5.2,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
CHEMBL2165115,81469,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,7,2,3,5.2,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,10.1021/jm300603y
56597092,81471,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,6,1,4,3.9,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
CHEMBL2165117,81471,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,6,1,4,3.9,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
228,441,21,None,-2,8,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2007.10.059
33,441,21,None,-2,8,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2007.10.059
6005,441,21,None,-2,8,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2007.10.059
CHEMBL53,441,21,None,-2,8,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2007.10.059
DB00714,441,21,None,-2,8,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmcl.2007.10.059
44438236,154225,1,None,4,2,Human,7.7,pEC50,=,7.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,1,3,4.3,Cn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,10.1016/j.bmcl.2006.10.076
CHEMBL400827,154225,1,None,4,2,Human,7.7,pEC50,=,7.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,1,3,4.3,Cn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,10.1016/j.bmcl.2006.10.076
56597939,81470,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165116,81470,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,10.1021/jm300603y
10811378,53876,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,407,7,1,4,4.2,Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C,10.1021/jm300603y
CHEMBL160744,53876,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,407,7,1,4,4.2,Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C,10.1021/jm300603y
127046950,139388,0,None,2,3,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3800303,139388,0,None,2,3,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,437,12,4,6,4,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.7b00363
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.7b00363
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.7b00363
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.7b00363
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/acs.jmedchem.7b00363
118725999,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394256,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3559222,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
118725999,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394256,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3559222,120259,0,None,-11,2,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,680,19,4,12,4.1,CCCN(CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2009.04.031
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2009.04.031
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2009.04.031
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2009.04.031
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2009.04.031
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm070860r
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm070860r
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm070860r
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm070860r
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumancloneddopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm070860r
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2010.06.025
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2010.06.025
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2010.06.025
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2010.06.025
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2010.06.025
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901618d
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901618d
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901618d
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901618d
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901618d
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901184n
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901184n
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901184n
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901184n
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm901184n
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm701524h
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm701524h
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm701524h
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm701524h
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm701524h
56597090,81489,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165137,81489,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
90466717,156228,0,None,-5,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,488,9,2,6,3.8,COc1ccccc1N1CCN(CCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4072282,156228,0,None,-5,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,488,9,2,6,3.8,COc1ccccc1N1CCN(CCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
127037828,136274,0,None,-30,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3740778,136274,0,None,-30,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742429,136274,0,None,-30,2,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL4849780,183923,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,456,11,1,4,5.5,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL4849780,183923,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,456,11,1,4,5.5,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
56599146,143434,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,501,6,1,4,5.9,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,nan
CHEMBL3903542,143434,0,None,-,1,Human,5.7,pEC50,=,5.7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,501,6,1,4,5.9,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,nan
44438209,153292,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,406,9,2,3,5.6,CCCCCCOc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,10.1016/j.bmcl.2006.10.076
CHEMBL398368,153292,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,406,9,2,3,5.6,CCCCCCOc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,10.1016/j.bmcl.2006.10.076
681,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401883v
940,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401883v
947,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401883v
CHEMBL59,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401883v
DB00988,1424,59,None,-17,11,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm401883v
122179561,120899,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,9,2,4,3.4,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585365,120899,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,9,2,4,3.4,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
122179561,120899,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,9,2,4,3.4,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585365,120899,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,9,2,4,3.4,CCCN(CCCNC(=O)OC(C)(C)C)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
101885473,120903,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,688,25,4,6,5.2,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585369,120903,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,688,25,4,6,5.2,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
101885473,120903,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,688,25,4,6,5.2,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585369,120903,0,None,-,1,Human,7.7,pEC50,=,7.7,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,688,25,4,6,5.2,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
155525527,170351,0,None,-8,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,389,9,3,6,4.1,CCCN(CCCCCc1ccc(O)c(O)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4457171,170351,0,None,-8,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,389,9,3,6,4.1,CCCN(CCCCCc1ccc(O)c(O)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4855775,184333,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
25072633,158529,0,None,7,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098803,158529,0,None,7,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4855775,184333,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
56598877,146726,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,424,8,1,6,3.3,COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3929710,146726,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,424,8,1,6,3.3,COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
44438222,92971,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,349,3,1,2,4.9,N#CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246230,92971,0,None,-,1,Human,6.7,pEC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,349,3,1,2,4.9,N#CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
681,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm300268s
940,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm300268s
947,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm300268s
CHEMBL59,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm300268s
DB00988,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm300268s
681,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.03.059
940,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.03.059
947,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.03.059
CHEMBL59,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.03.059
DB00988,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysisAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingafter60minsbyscintillationcountinganalysis,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.03.059
131801150,171040,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingluciferasebasedcAMPbiosensorassessedasinhibitionofforskolin-mediatedcAMPaccumulationafter15minsbymicrobetaluminescencecountingassayAgonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingluciferasebasedcAMPbiosensorassessedasinhibitionofforskolin-mediatedcAMPaccumulationafter15minsbymicrobetaluminescencecountingassay,ChEMBL,446,7,1,5,4.4,Cc1cc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc2n1C,10.1021/acs.jmedchem.8b00435
CHEMBL4467404,171040,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingluciferasebasedcAMPbiosensorassessedasinhibitionofforskolin-mediatedcAMPaccumulationafter15minsbymicrobetaluminescencecountingassayAgonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingluciferasebasedcAMPbiosensorassessedasinhibitionofforskolin-mediatedcAMPaccumulationafter15minsbymicrobetaluminescencecountingassay,ChEMBL,446,7,1,5,4.4,Cc1cc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc2n1C,10.1021/acs.jmedchem.8b00435
25072633,158529,0,None,7,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098803,158529,0,None,7,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
56598070,81468,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,7,0,5,6,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165114,81468,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,7,0,5,6,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL4859567,184579,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,420,9,2,5,3.9,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4859567,184579,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,420,9,2,5,3.9,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,IntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
54562,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,IntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL240773,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,IntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
2,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
54562,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
CHEMBL240773,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
44427823,92704,0,None,-60,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,1,4,4.4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,10.1021/jm0704200
CHEMBL244774,92704,0,None,-60,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,1,4,4.4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,10.1021/jm0704200
25071691,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287403,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
44438220,92930,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,381,4,2,2,4.4,CC(=O)NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246021,92930,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,381,4,2,2,4.4,CC(=O)NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
2,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayAgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2009.06.019
54562,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayAgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2009.06.019
CHEMBL240773,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayAgonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2009.06.019
137642380,157816,0,None,-5,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,431,6,1,5,4.2,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1,10.1021/acs.jmedchem.6b01857
CHEMBL4091155,157816,0,None,-5,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,431,6,1,5,4.2,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1,10.1021/acs.jmedchem.6b01857
681,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/ml3002117
940,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/ml3002117
947,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/ml3002117
CHEMBL59,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/ml3002117
DB00988,1424,59,None,-17,11,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/ml3002117
25071691,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287403,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
10025039,78318,0,None,4,2,Human,6.6,pEC50,=,6.6,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,418,4,1,4,4,O=C(N[C@H]1CC[C@H]2C[C@@H](N3CCN(c4ccccn4)CC3)CC[C@@H]2C1)c1ccccc1,10.1021/jm00050a022
CHEMBL2112745,78318,0,None,4,2,Human,6.6,pEC50,=,6.6,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,418,4,1,4,4,O=C(N[C@H]1CC[C@H]2C[C@@H](N3CCN(c4ccccn4)CC3)CC[C@@H]2C1)c1ccccc1,10.1021/jm00050a022
71733932,90534,0,None,-,1,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2397389,90534,0,None,-,1,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
56598070,81468,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,449,7,0,5,6,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165114,81468,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,449,7,0,5,6,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
15124098,81474,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,437,9,1,5,4.3,CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL2165121,81474,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,437,9,1,5,4.3,CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
66559777,81475,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165122,81475,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,447,7,1,4,4.6,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1,10.1021/jm300603y
127047996,138989,0,None,28,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,303,8,3,5,2.3,COc1ccccc1OCCNCCc1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
CHEMBL3797758,138989,0,None,28,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,303,8,3,5,2.3,COc1ccccc1OCCNCCc1ccc(O)c(O)c1,10.1016/j.bmc.2016.04.028
13851600,129988,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,217,0,1,2,2.2,CN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099223,129988,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,217,0,1,2,2.2,CN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL368188,129988,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,217,0,1,2,2.2,CN1CCC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
56599144,81469,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,433,7,2,3,5.2,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL2165115,81469,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,433,7,2,3,5.2,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
56597094,147388,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,420,6,2,4,3.8,O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL3934712,147388,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,420,6,2,4,3.8,O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
11983282,138287,0,None,-2,3,Human,7.6,pEC50,=,7.6,Functional,IntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
CHEMBL378455,138287,0,None,-2,3,Human,7.6,pEC50,=,7.6,Functional,IntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
167715,2807,11,None,6,4,Human,7.6,pEC50,=,7.6,Functional,ActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassayActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm049484q
969,2807,11,None,6,4,Human,7.6,pEC50,=,7.6,Functional,ActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassayActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm049484q
CHEMBL225230,2807,11,None,6,4,Human,7.6,pEC50,=,7.6,Functional,ActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassayActivityathumandopamineD2receptorinNIH/3T3cellsassessedasbeta-galactosidaseactivityafter5daysbyR-SATassay,ChEMBL,295,2,2,3,3.6,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm049484q
137635157,155115,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,435,13,1,5,4.5,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4059581,155115,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,435,13,1,5,4.5,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
137660837,158388,0,None,-4,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4097330,158388,0,None,-4,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
25072002,155437,0,None,-3,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4063235,155437,0,None,-3,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
71460601,81477,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,10.1021/jm300603y
CHEMBL2165124,81477,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,10.1021/jm300603y
14289494,81479,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,433,6,1,4,4.5,O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165127,81479,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,433,6,1,4,4.5,O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
25072002,155437,0,None,-3,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4063235,155437,0,None,-3,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
13720690,12949,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,311,3,3,4,3,C=CCN1CCc2cc(O)c(O)cc2C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL1190300,12949,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,311,3,3,4,3,C=CCN1CCc2cc(O)c(O)cc2C(c2ccc(O)cc2)C1,10.1021/jm00384a006
CHEMBL540575,12949,0,None,1,2,Human,6.6,pEC50,=,6.6,Functional,DopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparationDopaminereceptorD2agonistactivitywasdeterminedforinhibitionoftheconstrictorresponsetoelectricalstimulationinanisolatedperfusedrabbiteararterypreparation,ChEMBL,311,3,3,4,3,C=CCN1CCc2cc(O)c(O)cc2C(c2ccc(O)cc2)C1,10.1021/jm00384a006
137649770,156642,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,420,7,2,6,2.7,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4077430,156642,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,420,7,2,6,2.7,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,10.1021/acs.jmedchem.6b01875
CHEMBL3085816,102993,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,329,4,1,2,3.3,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL3085816,102993,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,329,4,1,2,3.3,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
137660837,158388,0,None,-4,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4097330,158388,0,None,-4,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
52937876,60784,0,None,-489,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphao1assessedasincorporationof[35S]GTPgammaSintoGalphao1after30minsbyscintillationcountingAgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphao1assessedasincorporationof[35S]GTPgammaSintoGalphao1after30minsbyscintillationcounting,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
CHEMBL1765633,60784,0,None,-489,2,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphao1assessedasincorporationof[35S]GTPgammaSintoGalphao1after30minsbyscintillationcountingAgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphao1assessedasincorporationof[35S]GTPgammaSintoGalphao1after30minsbyscintillationcounting,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
66633745,142602,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,445,6,1,4,4.6,O=C1CCc2ccc(OC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL3896746,142602,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,445,6,1,4,4.6,O=C1CCc2ccc(OC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL4859567,184579,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,420,9,2,5,3.9,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4872548,185425,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4532767,172851,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,347,4,1,2,3.4,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(F)c3C2)CC1,10.1021/acs.jmedchem.9b00508
44438211,146792,1,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,2,2,4.7,OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL393027,146792,1,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,3,2,2,4.7,OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
24759792,183666,0,None,-190,2,Human,6.6,pEC50,=,6.6,Functional,ActivationofhumandopamineD2receptorexpressedinCHOcellsassessedas[35S]GTPgammaSbindingbyscintillationproximityassayActivationofhumandopamineD2receptorexpressedinCHOcellsassessedas[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,286,2,1,3,2,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CNC4=O,10.1016/j.bmcl.2009.03.015
CHEMBL484598,183666,0,None,-190,2,Human,6.6,pEC50,=,6.6,Functional,ActivationofhumandopamineD2receptorexpressedinCHOcellsassessedas[35S]GTPgammaSbindingbyscintillationproximityassayActivationofhumandopamineD2receptorexpressedinCHOcellsassessedas[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,286,2,1,3,2,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CNC4=O,10.1016/j.bmcl.2009.03.015
CHEMBL4867962,185119,0,None,-114,3,Human,5.6,pEC50,=,5.6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,360,6,4,4,2.3,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@@H](C)c1ccccc1,10.1016/j.ejmech.2021.113190
119570,3081,84,None,-10,6,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmcl.2007.10.059
2233,3081,84,None,-10,6,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmcl.2007.10.059
953,3081,84,None,-10,6,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmcl.2007.10.059
CHEMBL301265,3081,84,None,-10,6,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmcl.2007.10.059
DB00413,3081,84,None,-10,6,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmcl.2007.10.059
CHEMBL4532767,172851,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,347,4,1,2,3.4,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(F)c3C2)CC1,10.1021/acs.jmedchem.9b00508
66633584,148539,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,435,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3944009,148539,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,435,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL4859080,184543,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,430,9,2,3,5.4,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1,10.1021/acs.jmedchem.1c01327
CHEMBL4859080,184543,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,430,9,2,3,5.4,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.7b00363
54562,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.7b00363
CHEMBL240773,3181,17,None,-12,7,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.7b00363
25093832,155203,0,None,2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
25071691,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287403,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
2,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
54562,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
CHEMBL240773,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
25093832,155203,0,None,2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
25071691,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287403,111199,0,None,-2,2,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,461,8,1,7,4.4,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
137647058,157307,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,467,15,1,7,3,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4085282,157307,0,None,-,1,Human,6.6,pEC50,=,6.6,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,467,15,1,7,3,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
101885474,120902,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,632,21,4,6,3.7,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585368,120902,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,632,21,4,6,3.7,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
122177641,120580,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577342,120580,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
101885474,120902,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,632,21,4,6,3.7,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585368,120902,0,None,-,1,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,632,21,4,6,3.7,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
2,3181,17,None,-12,7,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2021.113190
54562,3181,17,None,-12,7,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2021.113190
CHEMBL240773,3181,17,None,-12,7,Human,7.6,pEC50,=,7.6,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2021.113190
2,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
54562,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
CHEMBL240773,3181,17,None,-12,7,Human,5.6,pEC50,=,5.6,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm501889t
CHEMBL4871762,185368,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,390,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
137644833,157449,0,None,-95,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4087187,157449,0,None,-95,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
122177642,120581,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577343,120581,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL4748201,179351,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,1205,38,2,15,10.9,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
155568278,175382,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,347,2,2,3,3.6,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br,10.1021/acs.jnatprod.9b00921
CHEMBL4591554,175382,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,347,2,2,3,3.6,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br,10.1021/acs.jnatprod.9b00921
155568278,175382,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,347,2,2,3,3.6,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br,10.1021/acs.jnatprod.9b00921
CHEMBL4591554,175382,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrolAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionpreincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayrelativetocontrol,ChEMBL,347,2,2,3,3.6,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br,10.1021/acs.jnatprod.9b00921
CHEMBL4846201,183683,0,None,-7,3,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,416,10,4,4,3.2,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCCc1ccccc1,10.1016/j.ejmech.2021.113190
145986176,164874,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,404,9,2,3,4.6,C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1,10.1021/acs.jmedchem.8b00671
CHEMBL4242192,164874,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,404,9,2,3,4.6,C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1,10.1021/acs.jmedchem.8b00671
11983282,138287,0,None,-2,3,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
CHEMBL378455,138287,0,None,-2,3,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
CHEMBL3085826,103003,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4457507,170372,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3c(Cl)cccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4467173,171018,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,397,4,1,2,4.6,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3c(ccc(Cl)c3Cl)C2)CC1,10.1021/acs.jmedchem.9b00508
2,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
54562,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
CHEMBL240773,3181,17,None,-12,7,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/acs.jmedchem.1c01327
137655953,158310,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,420,7,2,5,2.9,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4096422,158310,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,420,7,2,5,2.9,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
56597937,145374,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,6,1,4,4.9,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL3918805,145374,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,6,1,4,4.9,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
122177645,120584,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577346,120584,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
11213062,61535,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,448,7,1,5,4.3,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1,10.1021/jm300603y
CHEMBL1774063,61535,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,448,7,1,5,4.3,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1,10.1021/jm300603y
11794899,118958,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,393,7,1,4,3.9,Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL346129,118958,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,393,7,1,4,3.9,Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL4755336,179934,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,843,34,0,13,6.1,CCCN(CCCCc1cn(CCOCCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
2407,3291,66,None,11,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1021/acs.jmedchem.7b00363
59227,3291,66,None,11,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1021/acs.jmedchem.7b00363
941,3291,66,None,11,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1021/acs.jmedchem.7b00363
CHEMBL1303,3291,66,None,11,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1021/acs.jmedchem.7b00363
DB05271,3291,66,None,11,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,315,6,1,3,4.3,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1,10.1021/acs.jmedchem.7b00363
127037825,136271,0,None,-2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3740041,136271,0,None,-2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742426,136271,0,None,-2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3085826,103003,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,426,5,1,3,4.3,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,10.1021/acs.jmedchem.9b00508
145984484,164856,0,None,51,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,930,28,3,12,8.6,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
CHEMBL4241844,164856,0,None,51,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,930,28,3,12,8.6,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
56597938,3849,0,None,204,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
7651,3849,0,None,204,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
CHEMBL2165126,3849,0,None,204,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
56593482,3850,0,None,602,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
7650,3850,0,None,602,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
CHEMBL2165119,3850,0,None,602,2,Human,8.5,pEC50,=,8.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,nan
25093832,155203,0,None,2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4875081,185604,0,None,10,3,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4781480,181331,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,255,7,0,1,3.7,C#CCCCCN(CCC)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
25093832,155203,0,None,2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4060461,155203,0,None,2,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
71722297,101906,0,None,34,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,297,1,3,4,2.3,CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL2397382,101906,0,None,34,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,297,1,3,4,2.3,CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL3040156,101906,0,None,34,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,297,1,3,4,2.3,CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL4875081,185604,0,None,10,3,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4864436,184897,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,398,9,2,4,3.9,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4864436,184897,0,None,-,1,Human,8.5,pEC50,=,8.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,398,9,2,4,3.9,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
44554987,103697,0,None,114,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,361,4,1,5,2.9,CCCN1C[C@@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099239,103697,0,None,114,2,Human,8.5,pEC50,=,8.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,361,4,1,5,2.9,CCCN1C[C@@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL4862890,184794,0,None,2,3,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4862890,184794,0,None,2,3,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
101885475,120904,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,745,29,4,6,6.8,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585370,120904,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,745,29,4,6,6.8,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
101885475,120904,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,745,29,4,6,6.8,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585370,120904,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,745,29,4,6,6.8,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
56597092,81471,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,433,6,1,4,3.9,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL2165117,81471,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,433,6,1,4,3.9,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
137644833,157449,0,None,-95,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4087187,157449,0,None,-95,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmc.2010.06.025
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmc.2010.06.025
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmc.2010.06.025
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmc.2010.06.025
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmc.2010.06.025
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901618d
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901618d
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901618d
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901618d
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901618d
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm501254d
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901184n
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901184n
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901184n
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901184n
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/jm901184n
66633791,150195,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,421,8,1,5,3.9,COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3957278,150195,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,421,8,1,5,3.9,COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
118726007,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394262,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3547017,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
118726007,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394262,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3547017,120055,0,None,-2,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,774,18,4,17,4.1,CCCN(CCCNc1nc(Oc2ccc(CCNc3nc(N)n4nc(-c5ccco5)nc4n3)cc2)nc(N2CCOCC2)n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
44438218,92929,0,None,1,2,Human,6.5,pEC50,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,338,3,1,1,5.4,CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246020,92929,0,None,1,2,Human,6.5,pEC50,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,338,3,1,1,5.4,CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
66559506,81483,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,10.1021/jm300603y
CHEMBL2165131,81483,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,10.1021/jm300603y
11983282,138287,0,None,-2,3,Human,7.5,pEC50,=,7.5,Functional,IntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
CHEMBL378455,138287,0,None,-2,3,Human,7.5,pEC50,=,7.5,Functional,IntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(short)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,315,4,0,3,4.2,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,10.1016/j.bmcl.2006.02.075
3949,3620,28,None,-4,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/acs.jmedchem.6b01875
9818479,3620,28,None,-4,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/acs.jmedchem.6b01875
CHEMBL419792,3620,28,None,-4,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/acs.jmedchem.6b01875
DB06477,3620,28,None,-4,3,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,203,1,2,3,0.5,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3,10.1021/acs.jmedchem.6b01875
CHEMBL4872548,185425,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4872548,185425,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
127037826,136272,0,None,-8,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2c(Cl)ccc3[nH]ccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3740286,136272,0,None,-8,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2c(Cl)ccc3[nH]ccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742427,136272,0,None,-8,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,472,7,2,6,4.3,CCCN(CCN1CCN(c2c(Cl)ccc3[nH]ccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
46176231,63568,0,None,-1,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatdopamineD2receptorexpressedinHEK293cellsassessedasstimulationof[35S]GTPgammaSbindingafter30minsAgonistactivityatdopamineD2receptorexpressedinHEK293cellsassessedasstimulationof[35S]GTPgammaSbindingafter30mins,ChEMBL,467,8,0,5,6.8,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3,10.1021/jm200347t
CHEMBL1806874,63568,0,None,-1,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityatdopamineD2receptorexpressedinHEK293cellsassessedasstimulationof[35S]GTPgammaSbindingafter30minsAgonistactivityatdopamineD2receptorexpressedinHEK293cellsassessedasstimulationof[35S]GTPgammaSbindingafter30mins,ChEMBL,467,8,0,5,6.8,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3,10.1021/jm200347t
CHEMBL4794870,182375,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,480,12,1,3,5.8,C#CCOc1ccc(-c2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2)cc1,10.1016/j.ejmech.2020.113151
CHEMBL4846638,183712,0,None,-46,3,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,380,7,4,4,2.8,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)C1CCCCC1,10.1016/j.ejmech.2021.113190
44555138,103694,0,None,117,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,403,5,1,5,3.9,CCCN1C[C@@H](Cn2ccc(-c3ccccc3)n2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099233,103694,0,None,117,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,403,5,1,5,3.9,CCCN1C[C@@H](Cn2ccc(-c3ccccc3)n2)O[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3088209,103180,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,358,4,1,3,4.5,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
24866612,188859,0,None,-72,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL514885,188859,0,None,-72,2,Human,7.5,pEC50,=,7.5,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,475,8,1,6,4.8,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL3088209,103180,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,358,4,1,3,4.5,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
2402,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/acs.jmedchem.7b00363
5095,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/acs.jmedchem.7b00363
7295,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/acs.jmedchem.7b00363
CHEMBL589,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/acs.jmedchem.7b00363
DB00268,3289,53,None,-7,7,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1021/acs.jmedchem.7b00363
2,3181,17,None,-12,7,Human,6.5,pEC50,=,6.5,Functional,IntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
54562,3181,17,None,-12,7,Human,6.5,pEC50,=,6.5,Functional,IntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL240773,3181,17,None,-12,7,Human,6.5,pEC50,=,6.5,Functional,IntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassayIntrinsicactivityagainstdopamineD2(long)receptorexpressedinCHOcellsbyGTPgammaSassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
71110290,146492,0,None,-8,2,Human,5.5,pEC50,=,5.5,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)C1Cc3c(OC)ccc(OC)c3CN1CC2,nan
CHEMBL3927835,146492,0,None,-8,2,Human,5.5,pEC50,=,5.5,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)C1Cc3c(OC)ccc(OC)c3CN1CC2,nan
137653034,158032,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,487,11,2,5,4.5,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4093477,158032,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,487,11,2,5,4.5,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4863636,184846,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,3,5.3,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,10.1021/acs.jmedchem.1c01327
25072635,111195,0,None,-3,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,10.1021/jm5004039
CHEMBL3287399,111195,0,None,-3,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,10.1021/jm5004039
CHEMBL4856059,184355,0,None,-44,4,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,360,6,4,4,2.3,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@H](C)c1ccccc1,10.1016/j.ejmech.2021.113190
CHEMBL4863636,184846,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,3,5.3,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,10.1021/acs.jmedchem.1c01327
44438197,152602,1,None,6,2,Human,7.5,pEC50,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,5,OC1(c2cccc(Cl)c2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL397770,152602,1,None,6,2,Human,7.5,pEC50,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,5,OC1(c2cccc(Cl)c2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL4871833,185377,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,432,9,2,3,5.4,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1,10.1021/acs.jmedchem.1c01327
44438228,93036,0,None,7,2,Human,7.5,pEC50,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,4,1,2,5,COC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246438,93036,0,None,7,2,Human,7.5,pEC50,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,354,4,1,2,5,COC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL4871833,185377,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,432,9,2,3,5.4,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1,10.1021/acs.jmedchem.1c01327
25072635,111195,0,None,-3,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,10.1021/jm5004039
CHEMBL3287399,111195,0,None,-3,2,Human,6.5,pEC50,=,6.5,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,10.1021/jm5004039
56598071,81491,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165140,81491,0,None,-,1,Human,6.5,pEC50,=,6.5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL4861553,184699,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4861553,184699,0,None,-,1,Human,7.5,pEC50,=,7.5,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
122189390,122608,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,469,6,0,8,3.4,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613876,122608,0,None,-,1,Human,5.5,pEC50,=,5.5,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,469,6,0,8,3.4,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
146025821,168955,0,None,-100,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,3,0,5,3.9,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4437552,168955,0,None,-100,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,3,0,5,3.9,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
146025821,168955,0,None,-100,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,3,0,5,3.9,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4437552,168955,0,None,-100,2,Human,5.5,pEC50,=,5.5,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,379,3,0,5,3.9,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
681,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.11.012
940,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.11.012
947,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.11.012
CHEMBL59,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.11.012
DB00988,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2013.11.012
76329028,105122,0,None,-10,2,Human,7.4,pEC50,=,7.4,Functional,PartialagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingPartialagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,505,9,1,7,4.8,CCCN(CCN1CCN(c2ccc(-c3cccc(OC)c3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm401883v
CHEMBL3125987,105122,0,None,-10,2,Human,7.4,pEC50,=,7.4,Functional,PartialagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingPartialagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,505,9,1,7,4.8,CCCN(CCN1CCN(c2ccc(-c3cccc(OC)c3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm401883v
66559782,81478,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,446,7,1,3,5.9,O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165125,81478,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,446,7,1,3,5.9,O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
11849820,77516,0,None,-10,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanrecombinantD2receptorexpressedinHEK293cellsbyFLIPRassayAgonistactivityathumanrecombinantD2receptorexpressedinHEK293cellsbyFLIPRassay,ChEMBL,356,7,0,5,3.2,CO/N=C(/CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,10.1021/jm060279f
CHEMBL209645,77516,0,None,-10,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanrecombinantD2receptorexpressedinHEK293cellsbyFLIPRassayAgonistactivityathumanrecombinantD2receptorexpressedinHEK293cellsbyFLIPRassay,ChEMBL,356,7,0,5,3.2,CO/N=C(/CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,10.1021/jm060279f
118726011,116605,0,None,46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,517,14,3,10,3.8,CCCN(CCCCCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394266,116605,0,None,46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,517,14,3,10,3.8,CCCN(CCCCCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
155563589,174596,0,None,-1,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,401,9,2,6,4.5,CCCN(CCC/C=C/c1ccc(O)c(OC)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4573578,174596,0,None,-1,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,401,9,2,6,4.5,CCCN(CCC/C=C/c1ccc(O)c(OC)c1)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
52937876,60784,0,None,-489,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphai2assessedasincorporationof[35S]GTPgammaSintoGalphai2after30minsbyscintillationcountingAgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphai2assessedasincorporationof[35S]GTPgammaSintoGalphai2after30minsbyscintillationcounting,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
CHEMBL1765633,60784,0,None,-489,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphai2assessedasincorporationof[35S]GTPgammaSintoGalphai2after30minsbyscintillationcountingAgonistactivityathumandopamineD2longreceptorexpressedinHEK293cellsco-expressingGalphai2assessedasincorporationof[35S]GTPgammaSintoGalphai2after30minsbyscintillationcounting,ChEMBL,430,10,1,4,4.8,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,10.1021/jm101639t
56599145,81485,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL2165133,81485,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
681,1424,59,None,-17,11,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2016.08.021
940,1424,59,None,-17,11,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2016.08.021
947,1424,59,None,-17,11,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2016.08.021
CHEMBL59,1424,59,None,-17,11,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2016.08.021
DB00988,1424,59,None,-17,11,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2016.08.021
5311189,200486,4,None,-16,4,Human,6.4,pEC50,=,6.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at200nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at200nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
CHEMBL7549,200486,4,None,-16,4,Human,6.4,pEC50,=,6.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at200nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at200nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
118726011,116605,0,None,46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,517,14,3,10,3.8,CCCN(CCCCCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394266,116605,0,None,46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,517,14,3,10,3.8,CCCN(CCCCCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
242,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
34,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
60795,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
CHEMBL1112,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
DB01238,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmc.2015.07.050
242,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
34,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
60795,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
CHEMBL1112,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
DB01238,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
46917637,67919,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayPartialagonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,1053,34,1,15,9.7,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,10.1021/jm2009919
CHEMBL1916548,67919,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayPartialagonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,1053,34,1,15,9.7,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,10.1021/jm2009919
122177643,120582,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577344,120582,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
118726009,116603,0,None,2,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,447,9,3,10,1.8,CN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394264,116603,0,None,2,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,447,9,3,10,1.8,CN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
118726009,116603,0,None,2,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,447,9,3,10,1.8,CN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394264,116603,0,None,2,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,447,9,3,10,1.8,CN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
242,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
34,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
60795,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
CHEMBL1112,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
DB01238,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/acs.jmedchem.6b01857
114876,12654,4,None,-7,6,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,283,8,1,2,3.9,CCCN(CCc1ccccc1)CCc1cccc(O)c1,10.1021/jm301258w
CHEMBL1188090,12654,4,None,-7,6,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,283,8,1,2,3.9,CCCN(CCc1ccccc1)CCc1cccc(O)c1,10.1021/jm301258w
CHEMBL545783,12654,4,None,-7,6,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,283,8,1,2,3.9,CCCN(CCc1ccccc1)CCc1cccc(O)c1,10.1021/jm301258w
127038171,136275,0,None,-46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742140,136275,0,None,-46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742430,136275,0,None,-46,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3cc[nH]c3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL4871762,185368,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,390,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
11957566,183,18,None,-56,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,10.1021/jm701524h
1219,183,18,None,-56,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,10.1021/jm701524h
3296,183,18,None,-56,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,10.1021/jm701524h
950,183,18,None,-56,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,10.1021/jm701524h
CHEMBL285755,183,18,None,-56,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cc(cc2)O)CCC,10.1021/jm701524h
90466573,157845,0,None,-16,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,526,8,2,5,5.1,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4091498,157845,0,None,-16,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,526,8,2,5,5.1,NC(=O)c1cccc(-c2ccc(OC(=O)NCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)c1,10.1021/acs.jmedchem.6b01578
127037828,136274,0,None,-30,2,Human,5.4,pEC50,=,5.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3740778,136274,0,None,-30,2,Human,5.4,pEC50,=,5.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742429,136274,0,None,-30,2,Human,5.4,pEC50,=,5.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at300nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
137657115,159061,0,None,-11,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4105030,159061,0,None,-11,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
66559507,81484,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,nan
CHEMBL2165132,81484,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,nan
242,467,113,None,-6,12,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
34,467,113,None,-6,12,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
60795,467,113,None,-6,12,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
CHEMBL1112,467,113,None,-6,12,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
DB01238,467,113,None,-6,12,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm300603y
44554470,105692,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,219,0,1,3,1.2,CN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3099224,105692,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,219,0,1,3,1.2,CN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
CHEMBL3139012,105692,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20minsAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseofforskolin-inducedcAMPproductionafter20mins,ChEMBL,219,0,1,3,1.2,CN1CCO[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1016/j.bmc.2013.11.012
228,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2007.06.036
33,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2007.06.036
6005,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2007.06.036
CHEMBL53,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2007.06.036
DB00714,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2007.06.036
228,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2013.05.014
33,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2013.05.014
6005,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2013.05.014
CHEMBL53,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2013.05.014
DB00714,441,21,None,-2,8,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.bmc.2013.05.014
56598073,147433,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,438,9,1,6,3.7,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3935170,147433,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,438,9,1,6,3.7,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
122177645,120584,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577346,120584,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
56599145,81485,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
CHEMBL2165133,81485,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,7,1,4,4.3,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
CHEMBL4865118,184937,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,1,4,4.6,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
25072633,158529,0,None,7,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098803,158529,0,None,7,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4865118,184937,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,1,4,4.6,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL4863832,184858,0,None,10,3,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
25072633,158529,0,None,7,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4098803,158529,0,None,7,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4863832,184858,0,None,10,3,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4852808,184141,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4852808,184141,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,4,4.4,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4862439,184759,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,10,2,4,4.3,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4874021,185530,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
56599011,145761,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3921903,145761,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
56598075,149624,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,451,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL3952761,149624,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,451,9,1,5,4.7,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL4874021,185530,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4862439,184759,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,10,2,4,4.3,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
56598878,141958,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,437,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL3891542,141958,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,437,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
133633,2187,40,None,20,4,Human,8.4,pEC50,=,8.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1016/j.bmcl.2006.10.076
177,2187,40,None,20,4,Human,8.4,pEC50,=,8.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1016/j.bmcl.2006.10.076
CHEMBL445102,2187,40,None,20,4,Human,8.4,pEC50,=,8.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1016/j.bmcl.2006.10.076
CHEMBL4857759,184470,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,2,4,4.7,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4857759,184470,0,None,-,1,Human,8.4,pEC50,=,8.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,2,4,4.7,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
183812,201378,17,None,-15,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseinGTPgamma35SbindingbyscintillationproximityassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseinGTPgamma35Sbindingbyscintillationproximityassay,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2012.07.096
CHEMBL82663,201378,17,None,-15,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseinGTPgamma35SbindingbyscintillationproximityassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasincreaseinGTPgamma35Sbindingbyscintillationproximityassay,ChEMBL,464,13,3,8,2.9,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,10.1016/j.bmcl.2012.07.096
45140377,196329,0,None,-2,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,460,7,2,6,4,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1,10.1021/jm901618d
CHEMBL599636,196329,0,None,-2,2,Human,8.4,pEC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,460,7,2,6,4,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1,10.1021/jm901618d
56598072,152086,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,423,8,1,5,4,COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
CHEMBL3973357,152086,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,423,8,1,5,4,COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,nan
66633659,152663,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,452,9,1,6,4.1,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3978288,152663,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,452,9,1,6,4.1,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL4863832,184858,0,None,10,3,Human,8.3,pEC50,=,8.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4863832,184858,0,None,10,3,Human,8.3,pEC50,=,8.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
66633584,148539,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
CHEMBL3944009,148539,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,9,1,5,4.3,CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,nan
137651936,156707,0,None,-5,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4078348,156707,0,None,-5,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
137651936,156707,0,None,-5,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4078348,156707,0,None,-5,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL135387,25676,0,None,91,2,Human,8.3,pEC50,=,8.3,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,392,6,1,4,3.6,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccn3)CC2)CC1)c1ccccc1,10.1021/jm00050a022
681,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2019.07.050
940,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2019.07.050
947,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2019.07.050
CHEMBL59,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2019.07.050
DB00988,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassayAgonistactivityathumanD2SreceptorexpressedinCHOK1cellsassessedasinhibitionofforskolininducedcAMPproductionincubatedfor10minsfollowedbyforskolinadditionandmeasuredafter5minsbyHTRFassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.ejmech.2019.07.050
137657115,159061,0,None,-11,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4105030,159061,0,None,-11,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,423,9,1,8,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
71733932,90534,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2397389,90534,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
71109989,153105,0,None,-26,2,Human,5.4,pEC50,=,5.4,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2,nan
CHEMBL3982119,153105,0,None,-26,2,Human,5.4,pEC50,=,5.4,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2,nan
CHEMBL4863920,184863,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,393,7,2,2,4.8,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1,10.1021/acs.jmedchem.1c01327
CHEMBL4863920,184863,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,393,7,2,2,4.8,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1,10.1021/acs.jmedchem.1c01327
11299620,96747,2,None,-64,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,247,5,1,2,3.4,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
CHEMBL269004,96747,2,None,-64,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,247,5,1,2,3.4,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,10.1021/ml3002117
45273211,191308,0,None,-33,2,Human,7.4,pEC50,=,7.4,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,460,7,2,4,3.9,CCCN(CCN1CCN(C(=O)c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2c(O)cccc2C1,10.1016/j.bmc.2009.04.031
CHEMBL556269,191308,0,None,-33,2,Human,7.4,pEC50,=,7.4,Functional,ActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingActivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,460,7,2,4,3.9,CCCN(CCN1CCN(C(=O)c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2c(O)cccc2C1,10.1016/j.bmc.2009.04.031
128,149,6,None,-50,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1021/jm901184n
172267,149,6,None,-50,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1021/jm901184n
CHEMBL273273,149,6,None,-50,3,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,247,5,1,2,3.4,CCCN(C1CCc2c(C1)cccc2O)CCC,10.1021/jm901184n
24936042,156904,0,None,-2,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4080762,156904,0,None,-2,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
122179563,120901,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,429,17,2,3,5.1,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585367,120901,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,429,17,2,3,5.1,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
122177642,120581,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577343,120581,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL4859394,184565,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4859394,184565,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
24936042,156904,0,None,-2,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4080762,156904,0,None,-2,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,380,8,0,6,3.3,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
122179563,120901,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,429,17,2,3,5.1,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585367,120901,0,None,-,1,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,429,17,2,3,5.1,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
127037828,136274,0,None,-30,2,Human,6.4,pEC50,=,6.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3740778,136274,0,None,-30,2,Human,6.4,pEC50,=,6.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
CHEMBL3742429,136274,0,None,-30,2,Human,6.4,pEC50,=,6.4,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at50nMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,469,6,2,7,3.4,N#CCN(CCN1CCN(c2ccc3[nH]ccc3c2Cl)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/acs.jmedchem.5b01031
681,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2007.06.036
940,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2007.06.036
947,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2007.06.036
CHEMBL59,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2007.06.036
DB00988,1424,59,None,-17,11,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1016/j.bmc.2007.06.036
90644226,111191,0,None,-7,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,490,9,0,7,4.8,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287395,111191,0,None,-7,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,490,9,0,7,4.8,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
122189391,122609,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,431,7,0,9,2.1,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
CHEMBL3613877,122609,0,None,-,1,Human,5.4,pEC50,=,5.4,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,431,7,0,9,2.1,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
57242,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
954,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
CHEMBL155731,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
57242,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
954,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
CHEMBL155731,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
56833378,67920,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,1121,39,2,14,10.7,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,10.1021/jm2009919
CHEMBL1916549,67920,0,None,-,1,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassayAgonistactivityatDRD2LongreceptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationbybioluminescenceassay,ChEMBL,1121,39,2,14,10.7,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,10.1021/jm2009919
90644226,111191,0,None,-7,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,490,9,0,7,4.8,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287395,111191,0,None,-7,2,Human,6.4,pEC50,=,6.4,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,490,9,0,7,4.8,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
85470564,156141,0,None,-37,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,540,9,2,5,5.5,NC(=O)c1cccc(-c2cccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4071240,156141,0,None,-37,2,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,540,9,2,5,5.5,NC(=O)c1cccc(-c2cccc(OC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2)c1,10.1021/acs.jmedchem.6b01578
57242,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
954,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
CHEMBL155731,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1039/C4MD00066H
57242,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
954,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
CHEMBL155731,3179,13,None,-9,4,Human,7.4,pEC50,=,7.4,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,246,2,1,4,1.6,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N,10.1021/jm501254d
CHEMBL4465281,170882,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,357,6,1,2,4,CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
56599146,143434,0,None,-,1,Human,4.3,pEC50,=,4.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,501,6,1,4,5.9,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,nan
CHEMBL3903542,143434,0,None,-,1,Human,4.3,pEC50,=,4.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,501,6,1,4,5.9,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,nan
681,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
940,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
947,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
CHEMBL59,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
DB00988,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
122179564,120907,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,12,3,4,1.8,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585373,120907,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,12,3,4,1.8,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
122179564,120907,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,12,3,4,1.8,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585373,120907,0,None,-,1,Human,5.3,pEC50,=,5.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,375,12,3,4,1.8,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL4465281,170882,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,357,6,1,2,4,CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
137655735,158300,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,436,8,2,8,2.7,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4096353,158300,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,436,8,2,8,2.7,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1,10.1021/acs.jmedchem.6b01857
681,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
940,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
947,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
CHEMBL59,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
DB00988,1424,59,None,-17,11,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm5004039
122189392,122610,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,441,5,0,7,3.6,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL3613878,122610,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,441,5,0,7,3.6,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
118725995,116595,0,None,-13,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,708,19,4,13,4,CCCN(CCCNC(=O)CCCC(=O)Oc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394253,116595,0,None,-13,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,708,19,4,13,4,CCCN(CCCNC(=O)CCCC(=O)Oc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL4855583,184324,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,1,4,5.1,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
CHEMBL4862301,184747,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,394,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
118725995,116595,0,None,-13,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,708,19,4,13,4,CCCN(CCCNC(=O)CCCC(=O)Oc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394253,116595,0,None,-13,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,708,19,4,13,4,CCCN(CCCNC(=O)CCCC(=O)Oc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
71722295,101901,0,None,1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,357,2,2,3,4.4,CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL2397381,101901,0,None,1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,357,2,2,3,4.4,CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL3040115,101901,0,None,1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,357,2,2,3,4.4,CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL4862301,184747,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,394,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
90467453,158151,0,None,-3,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,486,9,2,5,4.5,Cc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4094794,158151,0,None,-3,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,486,9,2,5,4.5,Cc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4855583,184324,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,1,4,5.1,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,10.1021/acs.jmedchem.1c01327
10811378,53876,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,407,7,1,4,4.2,Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C,10.1021/jm300603y
CHEMBL160744,53876,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,407,7,1,4,4.2,Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C,10.1021/jm300603y
10763756,54085,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,404,7,1,5,3.4,N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL160921,54085,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,404,7,1,5,3.4,N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
119570,3081,84,None,-10,6,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmc.2007.06.036
2233,3081,84,None,-10,6,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmc.2007.06.036
953,3081,84,None,-10,6,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmc.2007.06.036
CHEMBL301265,3081,84,None,-10,6,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmc.2007.06.036
DB00413,3081,84,None,-10,6,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproductionAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofforskolin-stimulatedcAMPproduction,ChEMBL,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,10.1016/j.bmc.2007.06.036
CHEMBL4517517,172240,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cc(Cl)ccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4862439,184759,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,10,2,4,4.3,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
2,3181,17,None,-12,7,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2020.113151
54562,3181,17,None,-12,7,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2020.113151
CHEMBL240773,3181,17,None,-12,7,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.ejmech.2020.113151
71722293,101909,0,None,4,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,281,0,2,3,3.2,Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2,10.1016/j.bmc.2013.05.014
CHEMBL2397380,101909,0,None,4,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,281,0,2,3,3.2,Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2,10.1016/j.bmc.2013.05.014
CHEMBL3040164,101909,0,None,4,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,281,0,2,3,3.2,Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2,10.1016/j.bmc.2013.05.014
CHEMBL4517517,172240,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cc(Cl)ccc3C2)CC1,10.1021/acs.jmedchem.9b00508
145985295,165032,0,None,57,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,958,30,3,12,9.3,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
CHEMBL4246185,165032,0,None,57,2,Human,8.3,pEC50,=,8.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,958,30,3,12,9.3,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
66559587,81472,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL2165118,81472,0,None,-,1,Human,8.3,pEC50,=,8.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
66559507,81484,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,nan
CHEMBL2165132,81484,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,nan
56597091,81486,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL2165134,81486,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL4862439,184759,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,10,2,4,4.3,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
228,441,21,None,-2,8,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
33,441,21,None,-2,8,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
6005,441,21,None,-2,8,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
CHEMBL53,441,21,None,-2,8,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
DB00714,441,21,None,-2,8,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1021/jm060662k
25072941,155795,0,None,1,2,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4067439,155795,0,None,1,2,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
25072941,155795,0,None,1,2,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4067439,155795,0,None,1,2,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,10.1021/acs.jmedchem.6b01857
56599142,3851,2,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,10.1021/jm300603y
7652,3851,2,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,10.1021/jm300603y
CHEMBL2165138,3851,2,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,10.1021/jm300603y
71460601,81477,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,10.1021/jm300603y
CHEMBL2165124,81477,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,10.1021/jm300603y
46882006,5743,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1ccc(Cl)cc1,10.1016/j.bmcl.2010.01.090
CHEMBL1079191,5743,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1ccc(Cl)cc1,10.1016/j.bmcl.2010.01.090
118726001,116599,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,821,27,5,13,5.6,CCCN(CCCNC(=O)CCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394258,116599,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,821,27,5,13,5.6,CCCN(CCCNC(=O)CCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
66559507,81484,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,10.1021/jm300603y
CHEMBL2165132,81484,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,10.1021/jm300603y
118726001,116599,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,821,27,5,13,5.6,CCCN(CCCNC(=O)CCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394258,116599,0,None,-12,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,821,27,5,13,5.6,CCCN(CCCNC(=O)CCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
46881467,5488,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,260,3,1,3,1.5,O=C1N(CC2CCCCN2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
CHEMBL1077197,5488,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,260,3,1,3,1.5,O=C1N(CC2CCCCN2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
56597094,147388,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,420,6,2,4,3.8,O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL3934712,147388,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,420,6,2,4,3.8,O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
122177641,120580,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577342,120580,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
52941006,16884,0,None,-208,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,469,8,1,4,5.5,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2c(O)cccc2C1,10.1016/j.bmc.2010.06.025
CHEMBL1254947,16884,0,None,-208,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbindingAgonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammaSbinding,ChEMBL,469,8,1,4,5.5,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)C1CCc2c(O)cccc2C1,10.1016/j.bmc.2010.06.025
90466716,160309,0,None,-1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,502,10,2,6,4.2,COc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4099236,160309,0,None,-1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,502,10,2,6,4.2,COc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4116199,160309,0,None,-1,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,502,10,2,6,4.2,COc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc(-c3cccc(C(N)=O)c3)cc2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4846101,183674,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,472,11,1,3,6.5,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl,10.1021/acs.jmedchem.1c01327
CHEMBL4846101,183674,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,472,11,1,3,6.5,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl,10.1021/acs.jmedchem.1c01327
137631807,155885,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,487,11,2,5,4.5,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4068455,155885,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,487,11,2,5,4.5,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,10.1021/acs.jmedchem.6b01875
122177644,120583,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577345,120583,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
90644227,111192,0,None,-91,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,448,8,1,6,4.1,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287396,111192,0,None,-91,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,448,8,1,6,4.1,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL4865765,184979,0,None,-52,3,Human,5.3,pEC50,=,5.3,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,402,9,4,4,2.8,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCc1ccccc1,10.1016/j.ejmech.2021.113190
71151588,117651,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAgonistactivityathumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,518,9,1,7,3.6,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,10.1016/j.ejmech.2014.12.045
CHEMBL3409256,117651,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAgonistactivityathumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,518,9,1,7,3.6,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,10.1016/j.ejmech.2014.12.045
CHEMBL3088210,103181,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,300,4,1,2,3.1,CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
90467024,157003,0,None,-10,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,488,9,2,6,3.8,COc1ccccc1N1CCN(CCCNC(=O)Oc2cccc(-c3cccc(C(N)=O)c3)c2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4081780,157003,0,None,-10,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,488,9,2,6,3.8,COc1ccccc1N1CCN(CCCNC(=O)Oc2cccc(-c3cccc(C(N)=O)c3)c2)CC1,10.1021/acs.jmedchem.6b01578
137651936,156707,0,None,-5,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4078348,156707,0,None,-5,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
10854042,120898,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,332,10,1,4,2.8,CCCN(CCCC(=O)OCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585364,120898,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,332,10,1,4,2.8,CCCN(CCCC(=O)OCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3088210,103181,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,300,4,1,2,3.1,CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
90644227,111192,0,None,-91,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,448,8,1,6,4.1,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287396,111192,0,None,-91,2,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,448,8,1,6,4.1,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL4792999,182223,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,1249,41,2,16,10.9,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
122189391,122609,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,431,7,0,9,2.1,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
CHEMBL3613877,122609,0,None,-,1,Human,6.3,pEC50,=,6.3,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,431,7,0,9,2.1,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
137651936,156707,0,None,-5,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
CHEMBL4078348,156707,0,None,-5,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,9,1,5,4.5,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.6b01857
10854042,120898,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,332,10,1,4,2.8,CCCN(CCCC(=O)OCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585364,120898,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,332,10,1,4,2.8,CCCN(CCCC(=O)OCC)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
71733932,90534,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2397389,90534,0,None,-,1,Human,7.3,pEC50,=,7.3,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
90466425,158621,0,None,-10,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,502,10,2,6,4.2,COc1ccccc1N1CCN(CCCCNC(=O)Oc2cccc(-c3cccc(C(N)=O)c3)c2)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4099798,158621,0,None,-10,2,Human,7.3,pEC50,=,7.3,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,502,10,2,6,4.2,COc1ccccc1N1CCN(CCCCNC(=O)Oc2cccc(-c3cccc(C(N)=O)c3)c2)CC1,10.1021/acs.jmedchem.6b01578
6453963,71120,5,None,-10000,2,Human,4.3,pEC50,=,4.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,10.1016/j.bmcl.2012.01.005
CHEMBL1950491,71120,5,None,-10000,2,Human,4.3,pEC50,=,4.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,10.1016/j.bmcl.2012.01.005
CHEMBL1962947,71120,5,None,-10000,2,Human,4.3,pEC50,=,4.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1O)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,10.1016/j.bmcl.2012.01.005
90467322,156128,0,None,6,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,472,8,2,5,5,COc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc3c(c2)[nH]c2ccccc23)CC1,10.1021/acs.jmedchem.6b01578
CHEMBL4071121,156128,0,None,6,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,472,8,2,5,5,COc1ccccc1N1CCN(CCCCNC(=O)Oc2ccc3c(c2)[nH]c2ccccc23)CC1,10.1021/acs.jmedchem.6b01578
146025820,172500,0,None,-6,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,365,2,0,5,3.6,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4523054,172500,0,None,-6,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,365,2,0,5,3.6,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
146025820,172500,0,None,-6,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,365,2,0,5,3.6,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4523054,172500,0,None,-6,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,365,2,0,5,3.6,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
66559506,81483,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,nan
CHEMBL2165131,81483,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,481,5,1,4,6,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,nan
44438186,146540,2,None,-,1,Human,6.2,pEC50,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,OC1(c2ccccc2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL392822,146540,2,None,-,1,Human,6.2,pEC50,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,OC1(c2ccccc2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL4875600,185635,0,None,-22,4,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassayAgonistactivityathumanhistamineD2LreceptorreceptorexpressedinHEK293Tcellsco-expressingELucCbybetaarrestin2recruitmentassay,ChEMBL,378,6,4,4,2.5,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1cccc(F)c1,10.1016/j.ejmech.2021.113190
56597939,81470,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL2165116,81470,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
71474024,143802,0,None,2,2,Human,6.2,pEC50,=,6.2,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1OC)CN1CCc3cc(O)c(O)cc3C1C2,nan
CHEMBL3906676,143802,0,None,2,2,Human,6.2,pEC50,=,6.2,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,327,2,2,5,2.8,COc1cc2c(cc1OC)CN1CCc3cc(O)c(O)cc3C1C2,nan
56598877,146726,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,424,8,1,6,3.3,COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
CHEMBL3929710,146726,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,424,8,1,6,3.3,COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,nan
56597937,145374,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,6,1,4,4.9,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL3918805,145374,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,447,6,1,4,4.9,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
101885477,120905,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,801,33,4,6,8.4,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585371,120905,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,801,33,4,6,8.4,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
101885477,120905,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,801,33,4,6,8.4,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585371,120905,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,801,33,4,6,8.4,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2c1CC(=O)N2)CCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
56598210,148525,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,461,7,1,4,4.7,O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL3943838,148525,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,461,7,1,4,4.7,O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
10114519,54898,53,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,445,7,1,5,5.2,Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1,10.1021/jm300603y
CHEMBL161792,54898,53,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,445,7,1,5,5.2,Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1,10.1021/jm300603y
66559587,81472,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
CHEMBL2165118,81472,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,10.1021/jm300603y
CHEMBL4862770,184782,0,None,8,3,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4862770,184782,0,None,8,3,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4874021,185530,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4874021,185530,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4859410,184569,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
146025765,171206,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,386,7,1,3,3.6,CN(C)C(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4470060,171206,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,386,7,1,3,3.6,CN(C)C(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4859410,184569,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4855775,184333,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
137633705,155938,0,None,-158,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,474,7,2,7,4,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1,10.1021/acs.jmedchem.6b01857
CHEMBL4069091,155938,0,None,-158,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,474,7,2,7,4,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1,10.1021/acs.jmedchem.6b01857
121418491,171070,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,413,6,0,3,5.7,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2C(F)(F)F)CC1,10.1021/acs.jmedchem.8b00435
CHEMBL4467883,171070,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulationAgonistactivityatdopamineD2longreceptor(unknownorigin)assessedasincreasedincAMPaccumulation,ChEMBL,413,6,0,3,5.7,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2C(F)(F)F)CC1,10.1021/acs.jmedchem.8b00435
CHEMBL4855775,184333,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,392,9,2,4,3.9,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4854391,184251,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,422,9,2,5,3.9,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1,10.1021/acs.jmedchem.1c01327
CHEMBL4852835,184143,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4854391,184251,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,422,9,2,5,3.9,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1,10.1021/acs.jmedchem.1c01327
11224283,132859,0,None,-12,2,Human,7.2,pEC50,=,7.2,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,433,7,1,4,4.1,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm049465g
CHEMBL370713,132859,0,None,-12,2,Human,7.2,pEC50,=,7.2,Functional,InhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycellsInhibitionofquinpirolestimulationofmitogenesisathumandopamineD2receptorsexpressedinChinesehamsterovarycells,ChEMBL,433,7,1,4,4.1,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm049465g
56599147,81481,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
CHEMBL2165129,81481,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,443,4,1,4,4.1,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,nan
2,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
54562,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
CHEMBL240773,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2015.07.050
CHEMBL4852835,184143,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,396,9,2,4,3.8,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
56598071,81491,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165140,81491,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
56598071,81491,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165140,81491,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,6,0,5,5.6,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
56597225,81488,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,435,7,0,5,5.6,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165136,81488,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayPartialagonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,435,7,0,5,5.6,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
137636460,155443,0,None,-9,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,7,1,6,2.9,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4063282,155443,0,None,-9,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,393,7,1,6,2.9,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1,10.1021/acs.jmedchem.6b01857
56597225,81488,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,7,0,5,5.6,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165136,81488,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,435,7,0,5,5.6,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
56597093,142746,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,446,7,1,3,5.3,O=C1NCCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL3898054,142746,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,446,7,1,3,5.3,O=C1NCCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc21,nan
25071384,111193,0,None,-251,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287397,111193,0,None,-251,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL4740785,178725,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,1293,44,2,17,10.9,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
681,1424,59,None,-17,11,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm301258w
940,1424,59,None,-17,11,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm301258w
947,1424,59,None,-17,11,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm301258w
CHEMBL59,1424,59,None,-17,11,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm301258w
DB00988,1424,59,None,-17,11,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAgonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasstimulationofmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm301258w
56597095,81487,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,7,2,4,4.1,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL2165135,81487,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,7,2,4,4.1,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
127047230,139443,0,None,-1,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,418,7,2,5,3.1,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
CHEMBL3800633,139443,0,None,-1,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,418,7,2,5,3.1,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,10.1021/acs.jmedchem.6b01875
25071384,111193,0,None,-251,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
CHEMBL3287397,111193,0,None,-251,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,446,8,0,6,4.4,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/jm5004039
71733932,90534,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2397389,90534,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
90467020,157431,0,None,-8,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,556,8,2,5,5.4,NC(=O)c1cccc(-c2ccc(OC(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2F)c1,10.1021/acs.jmedchem.6b01578
CHEMBL4086944,157431,0,None,-8,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassayAgonistactivityathumandopamineD2receptor-shortexpressedinCHO-K1cellsassessedasreductioninadenylylcyclaseactivatorNKH477inducedcAMPaccumulationpreincubatedfor10minsfollowedbyNKH477additionbyHTRFassay,ChEMBL,556,8,2,5,5.4,NC(=O)c1cccc(-c2ccc(OC(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2F)c1,10.1021/acs.jmedchem.6b01578
122177641,120580,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577342,120580,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL4863636,184846,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,3,5.3,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,10.1021/acs.jmedchem.1c01327
CHEMBL4863636,184846,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,414,9,2,3,5.3,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,10.1021/acs.jmedchem.1c01327
137657427,158865,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,476,7,3,6,3.5,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,10.1021/acs.jmedchem.7b00363
CHEMBL4102628,158865,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,476,7,3,6,3.5,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,10.1021/acs.jmedchem.7b00363
CHEMBL4590026,175300,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,343,4,1,2,3.6,Cc1cccc2c1CN(CC[C@H]1CC[C@H](NC(=O)N(C)C)CC1)CC2,10.1021/acs.jmedchem.9b00508
CHEMBL4862301,184747,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,394,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4862301,184747,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,394,10,2,4,4.1,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4590026,175300,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,343,4,1,2,3.6,Cc1cccc2c1CN(CC[C@H]1CC[C@H](NC(=O)N(C)C)CC1)CC2,10.1021/acs.jmedchem.9b00508
2,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayAgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2014.09.024
54562,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayAgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2014.09.024
CHEMBL240773,3181,17,None,-12,7,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayAgonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmc.2014.09.024
44438203,93135,1,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,4.7,OC1(c2cccc(C(F)(F)F)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246848,93135,1,None,-,1,Human,7.2,pEC50,=,7.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,374,3,2,2,4.7,OC1(c2cccc(C(F)(F)F)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
137640203,156280,0,None,-7,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
CHEMBL4072821,156280,0,None,-7,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
122189389,122607,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,497,8,0,8,4.2,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613875,122607,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,497,8,0,8,4.2,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
137640203,156280,0,None,-7,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
CHEMBL4072821,156280,0,None,-7,2,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,452,10,0,8,3.5,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,10.1021/acs.jmedchem.6b01857
146025765,171206,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,386,7,1,3,3.6,CN(C)C(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4470060,171206,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,386,7,1,3,3.6,CN(C)C(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4850635,183987,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,378,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4850635,183987,0,None,-,1,Human,8.2,pEC50,=,8.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,378,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4862890,184794,0,None,2,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4790018,182001,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,755,28,0,11,6,CCCN(CCCCc1cn(CCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
CHEMBL4862890,184794,0,None,2,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGalphaoApreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
127045854,138907,0,None,3,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3797205,138907,0,None,3,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
2,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
54562,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL240773,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,IntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassayIntrinsicactivityagainstdopamineD2(long)receptorassessedas[3H]thymidineuptakeinCHOcellsbymitogenesisassay,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1016/j.bmcl.2006.02.075
CHEMBL4877827,185796,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4877827,185796,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,10,2,4,4.8,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4437205,168923,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,362,5,1,2,4.4,O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)c1ccccc1,10.1021/acs.jmedchem.9b00508
145982756,164780,0,None,208,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,802,20,3,11,6.7,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
CHEMBL4239987,164780,0,None,208,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassayAgonistactivityathumandopamineD2receptorexpressedinHEK293Tcellsassessedasreductioninforskolin-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyforskolinadditionbyGloSensor-basedassay,ChEMBL,802,20,3,11,6.7,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,10.1021/acs.jmedchem.8b00671
2,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm00050a022
54562,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm00050a022
CHEMBL240773,3181,17,None,-12,7,Human,8.1,pEC50,=,8.1,Functional,Invitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptorInvitroinhibitionofforskolin-stimulatedcAMPaccumulationinGH4C1cellstransfectedwiththehumanDopamineD2receptor,ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,10.1021/jm00050a022
133642,171235,6,None,9,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,307,2,0,3,3.9,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2,10.1021/acsmedchemlett.9b00575
CHEMBL4470553,171235,6,None,9,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,307,2,0,3,3.9,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2,10.1021/acsmedchemlett.9b00575
133642,171235,6,None,9,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,307,2,0,3,3.9,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2,10.1021/acsmedchemlett.9b00575
CHEMBL4470553,171235,6,None,9,2,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,307,2,0,3,3.9,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2,10.1021/acsmedchemlett.9b00575
CHEMBL4857759,184470,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,2,4,4.7,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4857759,184470,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,426,10,2,4,4.7,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
10549689,50784,14,None,-,1,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,413,7,1,4,4.2,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL157923,50784,14,None,-,1,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,413,7,1,4,4.2,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1,10.1021/jm300603y
10502413,168766,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL443034,168766,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassayAgonistactivityathumanD2LreceptorexpressedinHEK293TcellscoexpressingGisubunitassessedasinhibitionofisoproterenol-stimulatedcAMPproductionbyluminescenceassay,ChEMBL,423,9,1,5,4,CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,10.1021/jm300603y
CHEMBL4446533,169582,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3C2)CC1,10.1021/acs.jmedchem.9b00508
46881409,6654,1,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
CHEMBL1083814,6654,1,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
CHEMBL4867794,185113,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
60148495,80374,0,None,-125,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL2152755,80374,0,None,-125,2,Human,7.2,pEC50,=,7.2,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2ccc3[nH]ccc3c2)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL4867794,185113,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4587909,175224,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,385,6,1,2,4.8,CC(C)N(C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)C(C)C,10.1021/acs.jmedchem.9b00508
137652517,156533,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,491,17,1,5,6.1,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4076129,156533,0,None,-,1,Human,6.2,pEC50,=,6.2,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,491,17,1,5,6.1,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,10.1021/acs.jmedchem.6b01875
CHEMBL4587909,175224,0,None,-,1,Human,7.2,pEC50,=,7.2,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,385,6,1,2,4.8,CC(C)N(C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)C(C)C,10.1021/acs.jmedchem.9b00508
137659303,158611,0,None,-9,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4099711,158611,0,None,-9,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
44443901,154318,19,None,-8,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,179,1,2,3,1.1,Oc1cccc(C2CNCCO2)c1,10.1016/j.bmcl.2007.10.059
CHEMBL401328,154318,19,None,-8,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,179,1,2,3,1.1,Oc1cccc(C2CNCCO2)c1,10.1016/j.bmcl.2007.10.059
137659303,158611,0,None,-9,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4099711,158611,0,None,-9,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
122177643,120582,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577344,120582,0,None,-,1,Human,5.1,pEC50,=,5.1,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalphai2assessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL3088212,103183,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,344,5,1,3,4.1,CC(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL3088212,103183,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,344,5,1,3,4.1,CC(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,10.1021/acs.jmedchem.9b00508
122189394,122612,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,469,7,0,7,4.4,Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
CHEMBL3613880,122612,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,469,7,0,7,4.4,Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,10.1016/j.bmc.2015.07.050
145947560,167000,0,None,-2,4,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,344,6,0,3,4.2,Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl,10.1016/j.bmcl.2018.04.059
CHEMBL4212812,167000,0,None,-2,4,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,344,6,0,3,4.2,Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl,10.1016/j.bmcl.2018.04.059
CHEMBL4302457,167000,0,None,-2,4,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassayAgonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasincreaseincalciummobilizationmeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,344,6,0,3,4.2,Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl,10.1016/j.bmcl.2018.04.059
71722291,101894,0,None,4,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,423,2,3,4,5.3,CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL2397385,101894,0,None,4,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,423,2,3,4,5.3,CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
CHEMBL3040059,101894,0,None,4,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15minsAgonistactivityathumandopamineD2LreceptorexpressedinHEK293cellsassessedasforskolin-stimulatedcAMPaccumulationafter15mins,ChEMBL,423,2,3,4,5.3,CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,10.1016/j.bmc.2013.05.014
44438223,92972,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,382,4,1,3,4.5,COC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL246231,92972,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,382,4,1,3,4.5,COC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
45486325,194097,0,None,-158,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
CHEMBL577073,194097,0,None,-158,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabindingAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasstimulationof[35S]GTPgammabinding,ChEMBL,450,7,1,7,3.7,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm901184n
CHEMBL4871774,185370,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,406,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4871774,185370,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,406,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
118726000,116598,0,None,-7,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,765,23,5,13,4,CCCN(CCCNC(=O)CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394257,116598,0,None,-7,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,765,23,5,13,4,CCCN(CCCNC(=O)CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
137636066,155556,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,480,7,3,7,3,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,10.1021/acs.jmedchem.7b00363
CHEMBL4064742,155556,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,480,7,3,7,3,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,10.1021/acs.jmedchem.7b00363
118726000,116598,0,None,-7,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,765,23,5,13,4,CCCN(CCCNC(=O)CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394257,116598,0,None,-7,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,765,23,5,13,4,CCCN(CCCNC(=O)CCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(-c4ccco4)nc3n2)cc1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
14289494,81479,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,6,1,4,4.5,O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
CHEMBL2165127,81479,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,433,6,1,4,4.5,O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,10.1021/jm300603y
56597090,81489,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
CHEMBL2165137,81489,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassayAgonistactivityatD2LreceptorinhumanHTLAcellsassessedasbetaarrestinrecruitmentat6uMafter18hrsbyluminescenceassay,ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,10.1021/jm300603y
681,1424,59,None,-17,11,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
940,1424,59,None,-17,11,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
947,1424,59,None,-17,11,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
CHEMBL59,1424,59,None,-17,11,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
DB00988,1424,59,None,-17,11,Human,8.1,pEC50,=,8.1,Functional,AgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPRAgonistactivityatferretD2receptorinHEK293cellscoexpressingGalphaqo5byFLIPR,ChEMBL,153,2,3,3,0.6,NCCc1ccc(c(c1)O)O,10.1021/jm060662k
66559587,81472,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL2165118,81472,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,447,6,1,4,4.3,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL4437205,168923,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,362,5,1,2,4.4,O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)c1ccccc1,10.1021/acs.jmedchem.9b00508
CHEMBL4446533,169582,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,363,4,1,2,3.9,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4875081,185604,0,None,10,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4875081,185604,0,None,10,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,412,9,2,4,4.4,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4864369,184892,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,2,4,4.3,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1,10.1021/acs.jmedchem.1c01327
56599012,144987,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,6,2,4,4.1,O=c1[nH]c2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL3915863,144987,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,6,2,4,4.1,O=c1[nH]c2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,nan
CHEMBL4864369,184892,0,None,-,1,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,2,4,4.3,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1,10.1021/acs.jmedchem.1c01327
CHEMBL4862770,184782,0,None,8,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4862770,184782,0,None,8,3,Human,8.1,pEC50,=,8.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,428,10,2,4,4.8,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
56597090,81489,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165137,81489,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,434,7,0,4,6.6,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,nan
3045992,175351,1,None,-1,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,355,6,0,5,3.4,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4591021,175351,1,None,-1,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,355,6,0,5,3.4,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
2402,3289,53,None,-7,7,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmcl.2007.10.059
5095,3289,53,None,-7,7,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmcl.2007.10.059
7295,3289,53,None,-7,7,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmcl.2007.10.059
CHEMBL589,3289,53,None,-7,7,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmcl.2007.10.059
DB00268,3289,53,None,-7,7,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulationAgonistactivityathumanrecombinantdopamineD2receptorexpressedinratpituitarycellsassessedasinhibitionofforskolin-stimulatedcAMPaccumulation,ChEMBL,260,7,1,2,3.5,CCCN(CCC)CCc1cccc2c1CC(=N2)O,10.1016/j.bmcl.2007.10.059
44438199,150649,2,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,OC1(c2cccc(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
CHEMBL396092,150649,2,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirolestimulatedmitogenesis,ChEMBL,340,3,2,2,4.3,OC1(c2cccc(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,10.1016/j.bmcl.2006.10.076
122177644,120583,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577345,120583,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,591,18,2,8,5.6,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,10.1021/jm501889t
3045992,175351,1,None,-1,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,355,6,0,5,3.4,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4591021,175351,1,None,-1,2,Human,5.1,pEC50,=,5.1,Functional,AgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAgonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,355,6,0,5,3.4,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
137640391,156024,0,None,-1,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,1,7,2.8,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4070091,156024,0,None,-1,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,418,7,1,7,2.8,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1,10.1021/acs.jmedchem.6b01857
5311189,200486,4,None,-16,4,Human,6.1,pEC50,=,6.1,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at1uMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at1uMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
CHEMBL7549,200486,4,None,-16,4,Human,6.1,pEC50,=,6.1,Functional,AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at1uMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM)AntagonistactivityagainsthumanD2receptorexpressedinCHOcellsassessedasdopamineEC50at1uMby[35S]GTPgammaSbindingassay(Rvb=225+/-45nM),ChEMBL,219,3,1,2,3,CCCN1CCC[C@@H](c2cccc(O)c2)C1,10.1021/acs.jmedchem.5b01031
10398490,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585363,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3586727,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
10398490,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3585363,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL3586727,121050,53,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesafter1hrby[35S]-GTPgammaSbindingassay,ChEMBL,218,5,2,2,1.7,CCCNCCc1cccc2c1CC(=O)N2,10.1039/C4MD00066H
CHEMBL4448960,169756,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,397,4,1,2,4.3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(C(F)(F)F)c3C2)CC1,10.1021/acs.jmedchem.9b00508
CHEMBL4448960,169756,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,397,4,1,2,4.3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(C(F)(F)F)c3C2)CC1,10.1021/acs.jmedchem.9b00508
60148496,80371,0,None,-100,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2c[nH]c3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
CHEMBL2152752,80371,0,None,-100,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumancloneddopamineD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,466,7,2,6,3.2,CCCN(CCN1CCN(C(=O)c2c[nH]c3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,10.1021/jm300268s
137644833,157449,0,None,-95,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4087187,157449,0,None,-95,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
118726010,116604,0,None,10,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,475,11,3,10,2.6,CCCN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394265,116604,0,None,10,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,475,11,3,10,2.6,CCCN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
137644966,157803,0,None,-14,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,456,6,1,6,4.1,N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/acs.jmedchem.6b01857
CHEMBL4091064,157803,0,None,-14,2,Human,6.1,pEC50,=,6.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,456,6,1,6,4.1,N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,10.1021/acs.jmedchem.6b01857
137644833,157449,0,None,-95,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4087187,157449,0,None,-95,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphaoAincubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,408,9,0,7,3.1,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
118726010,116604,0,None,10,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,475,11,3,10,2.6,CCCN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL3394265,116604,0,None,10,2,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2LreceptorexpressedinCHOcellmembranesincubatedfor1hrby[35S]GTPgammaSbindingassay,ChEMBL,475,11,3,10,2.6,CCCN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2,10.1021/jm501254d
CHEMBL4859394,184565,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4859394,184565,0,None,-,1,Human,6.1,pEC50,=,6.1,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,408,11,2,4,4.5,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
132955,167681,9,None,-4,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,231,3,2,4,1.7,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1,10.1021/acs.jmedchem.6b01875
CHEMBL434665,167681,9,None,-4,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsassessedascAMPinhibitionbyBRETassay,ChEMBL,231,3,2,4,1.7,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1,10.1021/acs.jmedchem.6b01875
56597942,142886,0,None,-,1,Human,8,pEC50,=,8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,8,1,4,5.2,CC(=O)Nc1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,nan
CHEMBL3899117,142886,0,None,-,1,Human,8,pEC50,=,8,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,449,8,1,4,5.2,CC(=O)Nc1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,nan
155531663,170953,0,None,-7,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,389,9,3,6,4.1,CCCN(CCCCCc1cc(O)ccc1O)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4466245,170953,0,None,-7,2,Human,8,pEC50,=,8,Functional,AgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2dopaminereceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,389,9,3,6,4.1,CCCN(CCCCCc1cc(O)ccc1O)[C@H]1CCc2nc(N)sc2C1,10.1016/j.bmc.2016.08.021
CHEMBL4863992,184869,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,380,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4862890,184794,0,None,2,3,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4863992,184869,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,380,9,2,4,3.7,COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,10.1021/acs.jmedchem.1c01327
CHEMBL4786420,181723,0,None,-,1,Human,8,pEC50,=,8,Functional,AgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassayAgonistactivityathumanD2Risoform2stablyexpressedinHEK293cellsassessedasinhibitionofforskolin-inducedincreaseofcAMPaccumulationpreincubatedfor10minsfollowedbyforskolinadditionbyGlosensorcAMPreagentbasedluminescenceassay,ChEMBL,799,31,0,12,6,CCCN(CCCCc1cn(CCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,10.1016/j.ejmech.2020.113151
CHEMBL4862890,184794,0,None,2,3,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,410,10,2,4,4.2,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,10.1021/acs.jmedchem.1c01327
CHEMBL4864369,184892,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,2,4,4.3,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1,10.1021/acs.jmedchem.1c01327
CHEMBL4864369,184892,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,442,10,2,4,4.3,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1,10.1021/acs.jmedchem.1c01327
56597939,81470,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL2165116,81470,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,404,6,1,4,4.5,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL4441636,169236,0,None,-,1,Human,8,pEC50,=,8,Functional,PartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassayPartialagonistactivityathumanGi/o-coupledD2RexpressedinHEK293Tcellsassessedasinhibitionofisoproterenol-inducedcAMPaccumulationpreincubatedfor15minsfollowedbyisoproterenol-stimulationandmeasuredbyGlosensor-basedluminescenceassay,ChEMBL,373,4,1,4,3,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cc4c(cc3C2)OCO4)CC1,10.1021/acs.jmedchem.9b00508
56599143,81490,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
CHEMBL2165139,81490,0,None,-,1,Human,8,pEC50,=,8,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,421,6,0,5,5.2,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,nan
137655556,157848,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,2,7,3.3,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,10.1021/acs.jmedchem.7b00363
CHEMBL4091507,157848,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassayAgonistactivityathumanD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphao1assessedasinductionofnucleotideexchangepreincubatedfor30minsfollowedbyadditionof[35S]GTPgammaSmeasuredafter30minsby[35S]GTPgammaSbindingassay,ChEMBL,447,7,2,7,3.3,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,10.1021/acs.jmedchem.7b00363
122177642,120581,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
CHEMBL3577343,120581,0,None,-,1,Human,7.1,pEC50,=,7.1,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,551,18,1,8,4.6,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,10.1021/jm501889t
9826580,199629,5,None,-14,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,482,8,1,4,5.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
CHEMBL69451,199629,5,None,-14,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAgonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,482,8,1,4,5.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
56597091,81486,0,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
CHEMBL2165134,81486,0,None,-,1,Human,7,pEC50,=,7,Functional,"Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).Beta-ArrestinRecruitment(Tango)Assay:Recruitmentofβ-arrestintoagonist-stimulatedD2receptorswasperformedusingapreviouslydescribedTango-typeassay(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Briefly,HTLAcellsstablyexpressingβ-arrestin-TEVproteaseandatetracyclinetransactivator-drivenluciferasewereplatedin15-cmdishesinDMEMcontaining10%fetalbovineserumandtransfected(viacalciumphosphate)with20μgofaD2V2-TCS-tTAconstruct(Barneaetal.,Proc.Natl.Acad.Sci.USA105:64(2008)).Thenextday,cellswereplatedinwhite,clear-bottom,384-wellplates(Greiner,10,000cells/well,50μl/well)inDMEMcontaining1%dialyzedfetalbovineserum.Thefollowingday,thecellswerechallengedwith10μl/wellofreferenceagonist(6μM)orD2testligand(6μM)±referenceagonistpreparedinHBS,20mMHEPES,pH7.4,18%DMSO(finalligandconcentrationswere1μM,finalDMSOconcentrationwas3%).",ChEMBL,418,7,1,4,4.9,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,nan
71733935,90465,0,None,-,1,Human,7,pEC50,=,7,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL2396663,90465,0,None,-,1,Human,7,pEC50,=,7,Functional,IntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2LreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,414,10,1,2,5.7,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,10.1021/jm501889t
CHEMBL4871833,185377,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,432,9,2,3,5.4,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1,10.1021/acs.jmedchem.1c01327
CHEMBL4871833,185377,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,432,9,2,3,5.4,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1,10.1021/acs.jmedchem.1c01327
CHEMBL4854391,184251,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingRluc8-taggedGalpahi1assessedasGalphai1dissociationpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,422,9,2,5,3.9,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1,10.1021/acs.jmedchem.1c01327
51356569,61562,2,None,-10,3,Human,6,pEC50,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirole-inducedeffectAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirole-inducedeffect,ChEMBL,335,4,0,4,4,COc1ccccc1C1CCN(Cc2nc3ccccc3n2C)CC1,10.1021/jm101414h
CHEMBL1774101,61562,2,None,-10,3,Human,6,pEC50,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirole-inducedeffectAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsassessedasinhibitionofquinpirole-inducedeffect,ChEMBL,335,4,0,4,4,COc1ccccc1C1CCN(Cc2nc3ccccc3n2C)CC1,10.1021/jm101414h
122189388,122606,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,483,7,0,8,3.8,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
CHEMBL3613874,122606,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphai2by[35S]GTPgammaSbindingassay,ChEMBL,483,7,0,8,3.8,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,10.1016/j.bmc.2015.07.050
137659303,158611,0,None,-9,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4099711,158611,0,None,-9,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
137659303,158611,0,None,-9,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4099711,158611,0,None,-9,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,410,9,1,7,2.8,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4846101,183674,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,472,11,1,3,6.5,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl,10.1021/acs.jmedchem.1c01327
90644230,111202,0,None,-2,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287406,111202,0,None,-2,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL4846101,183674,0,None,-,1,Human,7,pEC50,=,7,Functional,PartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassayPartialagonistactivityatD2receptor(unknownorigin)expressedinHEK293Tcellsco-expressingGFP2-beta-arrestin2assessedasbeta-arrestin2recruitmentpreincubatedfor2minswithcoelenterazinefollowedbycompoundadditionandmeasuredafter2minsbyBRETassay,ChEMBL,472,11,1,3,6.5,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl,10.1021/acs.jmedchem.1c01327
71110293,142714,0,None,-33,3,Human,5,pEC50,=,5,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,339,2,0,5,3.1,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4,nan
CHEMBL3897805,142714,0,None,-33,3,Human,5,pEC50,=,5,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,339,2,0,5,3.1,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4,nan
122189387,122605,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,417,7,0,8,2.7,COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
CHEMBL3613873,122605,0,None,-,1,Human,6,pEC50,=,6,Functional,ActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassayActivityatdopamineD2Sreceptor(unknownorigin)expressedinHEK293cellmembranesco-expressingGalphaproteinsubunitGalphao1by[35S]GTPgammaSbindingassay,ChEMBL,417,7,0,8,2.7,COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1,10.1016/j.bmc.2015.07.050
127045853,139136,0,None,-117,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
CHEMBL3798748,139136,0,None,-117,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositolAgonistactivityathumanD2SreceptorexpressedinHEK293cellscotransfectedwithGqi5proteinassessedas[3H]IP3accumulationafter120minsbyscintillationcountingassayinpresenceofmyo-[3H]-inositol,ChEMBL,492,12,4,7,3.6,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,10.1016/j.bmc.2016.04.028
90644230,111202,0,None,-2,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
CHEMBL3287406,111202,0,None,-2,2,Human,7,pEC50,=,7,Functional,AgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassayAgonistactivityathumandopamineD2shortreceptortransientlyexpressedinHEK293cellsco-expressingGalphai2after30minsby[35S]GTPgammaSbindingassay,ChEMBL,443,7,0,6,4.5,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,10.1021/jm5004039
137651073,156783,0,None,-36,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
CHEMBL4079301,156783,0,None,-36,2,Human,6,pEC50,=,6,Functional,AgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassayAgonistactivityathumanDopamineD2SreceptorexpressedinHEK293TcellmembranescoexpressingGalphai2incubatedfor30minsmeasuredafter75minsby[35S]GTPgammaSbindingassay,ChEMBL,405,8,0,7,3.2,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,10.1021/acs.jmedchem.6b01857
122177643,120582,0,None,-,1,Human,6,pEC50,=,6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
CHEMBL3577344,120582,0,None,-,1,Human,6,pEC50,=,6,Functional,IntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassayIntrinsicactivityathumandopamineD2SreceptorexpressedinHEK293cellsco-transfectedwithGalpha0iassessedas[35S]GTPgammaSbindingafter30minsby[35S]GTPgammaSincorporationassay,ChEMBL,632,20,3,9,5.1,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,10.1021/jm501889t
56598210,148525,0,None,-,1,Human,5,pEC50,=,5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,461,7,1,4,4.7,O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
CHEMBL3943838,148525,0,None,-,1,Human,5,pEC50,=,5,Functional,"cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.cAMPGloSensorAssay:HEK293Tcellsco-expressingthecAMPbiosensorGloSensor-22F(Promega)andhD2receptorswereseeded(10,000cells/20ul/well)intowhite,clear-bottom,tissuecultureplatesinHBSS,10%FBS,20mMHEPES,pH7.4.Afteraone-totwo-hourrecovery,cellsweretreatedwith10ulof3xtestorreferencedrugpreparedinHBSS,10%FBS,20mMHEPES,pH7.4.After30minutes,cellswerechallengedwith10ulof1,200nM(4x)isoproterenolin8%(4x)GloSensorreagent.LuminescenceperwellpersecondwasreadonaWallacTriLuxmicrobetaplatecounter.Datawerenormalizedtotheisoproterenolresponse(100%)andthemaximalquinpirole-inducedinhibitionthereof(0%)andregressedusingthesigmoidaldose-responsefunctionbuiltintoGraphPadPrism4.0.Notably,HEK293TcellsexpressingtheGloSensor-22Falone(nohD2)wereassayedinparallelanddisplayednoinhibitionofisoproterenol-stimulatedcAMP.",ChEMBL,461,7,1,4,4.7,O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,nan
146025811,171045,0,None,416,2,Human,9.9,pIC50,=,9.9,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4467483,171045,0,None,416,2,Human,9.9,pIC50,=,9.9,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
146025811,171045,0,None,416,2,Human,9.9,pIC50,=,9.9,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4467483,171045,0,None,416,2,Human,9.9,pIC50,=,9.9,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
52942303,18360,0,None,-,1,Human,9.5,pIC50,=,9.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,434,6,2,5,2.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(I)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276325,18360,0,None,-,1,Human,9.5,pIC50,=,9.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,434,6,2,5,2.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(I)c1OC,10.1016/j.ejmech.2010.07.056
15167701,18391,0,None,-,1,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,320,7,2,4,2.6,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
CHEMBL1276585,18391,0,None,-,1,Human,9.3,pIC50,=,9.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,320,7,2,4,2.6,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
13493784,87555,0,None,4168,2,Human,9.2,pIC50,=,9.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,418,6,1,4,2.5,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL23464,87555,0,None,4168,2,Human,9.2,pIC50,=,9.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,418,6,1,4,2.5,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1OC,10.1016/j.ejmech.2010.07.056
52943464,18389,0,None,-,1,Human,9,pIC50,=,9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,6,2,4,2.8,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
CHEMBL1276560,18389,0,None,-,1,Human,9,pIC50,=,9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,6,2,4,2.8,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
2726,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
621,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
83,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
CHEMBL71,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
DB00477,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethodAntagonistactivityagainsthumanrecombinantdopmaineD2LreceptorexpressedinCHOK1cellsassessedasreductioninapomorphine-inducedincreaseinintracellularCa2+levelsbyaequorinbasedradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
2726,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethodAntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
621,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethodAntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
83,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethodAntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
CHEMBL71,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethodAntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
DB00477,900,58,None,-3,35,Human,9,pIC50,=,9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethodAntagonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedasinhibitionofapomorphine-inducedcalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.ejmech.2014.12.045
156018685,177141,0,None,1,6,Human,9,pIC50,=,9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1,10.1016/j.bmcl.2020.127027
CHEMBL4644391,177141,0,None,1,6,Human,9,pIC50,=,9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1,10.1016/j.bmcl.2020.127027
52941075,18361,0,None,-,1,Human,9,pIC50,=,9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,338,7,1,5,2.6,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(SC)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276326,18361,0,None,-,1,Human,9,pIC50,=,9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,338,7,1,5,2.6,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(SC)c1OC,10.1016/j.ejmech.2010.07.056
118710459,113069,0,None,-14,2,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,445,7,1,5,4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,10.1021/jm500801r
CHEMBL3322994,113069,0,None,-14,2,Human,9,pIC50,=,9,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,445,7,1,5,4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,10.1021/jm500801r
54477,84145,28,None,12,3,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,6,1,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL22242,84145,28,None,12,3,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,6,1,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,10.1016/j.ejmech.2010.07.056
52941076,18362,0,None,-,1,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,336,7,2,5,2.2,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276327,18362,0,None,-,1,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,336,7,2,5,2.2,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
13493791,98887,0,None,707,2,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,320,7,1,4,2.5,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL282925,98887,0,None,707,2,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,320,7,1,4,2.5,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
10000260,18380,3,None,-,1,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,386,6,2,5,2.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276494,18380,3,None,-,1,Human,8.9,pIC50,=,8.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,386,6,2,5,2.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1OC,10.1016/j.ejmech.2010.07.056
156011408,176685,0,None,-1,3,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,10.1016/j.bmcl.2020.127027
CHEMBL4638430,176685,0,None,-1,3,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,10.1016/j.bmcl.2020.127027
52949578,18387,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,324,6,2,4,2.3,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1F,10.1016/j.ejmech.2010.07.056
CHEMBL1276559,18387,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,324,6,2,4,2.3,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1F,10.1016/j.ejmech.2010.07.056
52949580,18406,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,342,6,2,5,2.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Cl)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276712,18406,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,342,6,2,5,2.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Cl)c1OC,10.1016/j.ejmech.2010.07.056
52942307,18399,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.7,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276647,18399,0,None,-,1,Human,8.8,pIC50,=,8.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.7,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1CC,10.1016/j.ejmech.2010.07.056
CHEMBL3084515,102738,0,None,-2,2,Human,8.7,pIC50,=,8.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,367,3,1,3,5.1,O[C@]1(c2ccc(Cl)cc2)C[C@@H]2CC[C@H](C1)N2Cc1coc2ccccc12,10.1021/jm800532x
94688,98912,13,None,1,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1O,10.1016/j.ejmech.2010.07.056
CHEMBL283099,98912,13,None,1,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1O,10.1016/j.ejmech.2010.07.056
127049864,139623,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805860,139623,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
1577,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
164512405,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
2537,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
5355,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
5501,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
643497,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
688272,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
958,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
960,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
CHEMBL196677,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
CHEMBL26,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
CHEMBL267044,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
DB00391,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
DB16021,3617,102,None,-1,6,Human,8,pIC50,=,8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,341,6,2,5,0.6,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N,10.1021/jm200288r
129186541,160512,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,407,4,0,5,4.5,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4078409,160512,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,407,4,0,5,4.5,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4117823,160512,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,407,4,0,5,4.5,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
145993117,166222,0,None,-8,6,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,7,0,5,4.4,CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,10.1016/j.ejmech.2017.12.099
CHEMBL4286717,166222,0,None,-8,6,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,7,0,5,4.4,CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,10.1016/j.ejmech.2017.12.099
52944656,18405,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,326,5,2,4,2.6,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276711,18405,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,326,5,2,4,2.6,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
52950130,18408,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,368,6,1,3,3.2,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,10.1016/j.ejmech.2010.07.056
CHEMBL1276739,18408,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,368,6,1,3,3.2,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,10.1016/j.ejmech.2010.07.056
52943468,18410,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,5,2,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276741,18410,0,None,-,1,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,5,2,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
3033769,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
3299,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
94,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
CHEMBL8809,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
DB12518,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
3246443,37414,2,None,13,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,325,1,1,5,2.8,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,10.1016/j.bmc.2012.12.016
CHEMBL1457510,37414,2,None,13,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,325,1,1,5,2.8,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,10.1016/j.bmc.2012.12.016
71541178,86623,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,380,3,1,5,3.2,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,10.1016/j.bmcl.2012.11.023
CHEMBL2326482,86623,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,380,3,1,5,3.2,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,10.1016/j.bmcl.2012.11.023
71541279,86612,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,301,2,1,7,1.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326471,86612,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,301,2,1,7,1.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,10.1016/j.bmcl.2012.11.023
71541081,86615,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,263,2,2,5,1.3,Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326474,86615,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,263,2,2,5,1.3,Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,10.1016/j.bmcl.2012.11.023
71541082,86616,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,323,1,1,4,3.1,Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326475,86616,0,None,-,1,Human,5,pIC50,=,5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,323,1,1,4,3.1,Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,10.1016/j.bmcl.2012.11.023
71562966,87060,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,2,1,3,3.9,COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21,10.1016/j.bmcl.2012.12.046
CHEMBL2335738,87060,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,2,1,3,3.9,COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21,10.1016/j.bmcl.2012.12.046
156017961,177147,0,None,-46,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,437,7,0,8,3.3,COc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,10.1016/j.bmcl.2020.127027
CHEMBL4644500,177147,0,None,-46,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,437,7,0,8,3.3,COc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,10.1016/j.bmcl.2020.127027
3033769,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
3299,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
94,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
CHEMBL8809,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
DB12518,3200,49,None,-3,2,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl,10.1021/acsmedchemlett.9b00575
156015516,176837,0,None,-14,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,485,6,0,7,4.1,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Br)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4640409,176837,0,None,-14,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,485,6,0,7,4.1,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Br)cccn12,10.1016/j.bmcl.2020.127027
44427818,91603,0,None,-38,2,Human,7,pIC50,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,444,9,1,5,4.1,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
CHEMBL241973,91603,0,None,-38,2,Human,7,pIC50,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,444,9,1,5,4.1,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
155552483,173337,0,None,6,2,Human,6,pIC50,=,6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,355,2,1,6,2.8,COc1cc2c(c(OC)c1O)CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
CHEMBL4544045,173337,0,None,6,2,Human,6,pIC50,=,6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,355,2,1,6,2.8,COc1cc2c(c(OC)c1O)CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
52947127,18413,0,None,-,1,Human,7,pIC50,=,7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,354,7,2,4,3.2,CCCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276764,18413,0,None,-,1,Human,7,pIC50,=,7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,354,7,2,4,3.2,CCCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
145993577,166686,0,None,-9,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.9,O=C1CC2(CCCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4295055,166686,0,None,-9,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.9,O=C1CC2(CCCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
156021344,177443,0,None,-7,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,443,6,0,7,3.6,O=c1n(CCCCN2CCN(c3cccc4sc(F)cc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4649106,177443,0,None,-7,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,443,6,0,7,3.6,O=c1n(CCCCN2CCN(c3cccc4sc(F)cc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4867978,185120,0,None,2,6,Human,8,pIC50,=,8,Functional,AntagonistactivityatD2receptor(unknownorigin)AntagonistactivityatD2receptor(unknownorigin),ChEMBL,467,9,0,6,4.5,Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,10.1016/j.bmcl.2021.127909
145963961,163705,0,None,-5,6,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,425,8,1,7,3,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4213342,163705,0,None,-5,6,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,425,8,1,7,3,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
145972513,163808,0,None,1,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
CHEMBL4214642,163808,0,None,1,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
137643395,157457,0,None,2,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,7,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3CCS4)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4087246,157457,0,None,2,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,7,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3CCS4)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
44589644,185797,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,537,4,2,5,5.4,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4c(F)cccc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL487788,185797,0,None,-,1,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,537,4,2,5,5.4,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4c(F)cccc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
66574145,113086,0,None,-81,2,Human,7,pIC50,=,7,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,503,7,1,7,3.8,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,10.1021/jm500801r
CHEMBL3323011,113086,0,None,-81,2,Human,7,pIC50,=,7,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,503,7,1,7,3.8,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,10.1021/jm500801r
11408148,128075,0,None,-5,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,443,6,1,4,4.8,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,10.1021/jm040190e
CHEMBL366904,128075,0,None,-5,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,443,6,1,4,4.8,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,10.1021/jm040190e
127051039,139616,0,None,-1,3,Human,6.9,pIC50,=,6.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,9,1,4,4.7,CCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805772,139616,0,None,-1,3,Human,6.9,pIC50,=,6.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,9,1,4,4.7,CCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
156013636,176520,0,None,-41,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,408,6,0,8,2.7,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
CHEMBL4635890,176520,0,None,-41,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,408,6,0,8,2.7,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
9980998,30783,0,None,-12,2,Human,6.9,pIC50,=,6.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,445,7,1,4,5.1,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,10.1021/jm040190e
CHEMBL139926,30783,0,None,-12,2,Human,6.9,pIC50,=,6.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,445,7,1,4,5.1,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,10.1021/jm040190e
CHEMBL2112911,30783,0,None,-12,2,Human,6.9,pIC50,=,6.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,445,7,1,4,5.1,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,10.1021/jm040190e
145991746,166152,0,None,-8,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,407,4,0,5,2.8,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4285479,166152,0,None,-8,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,407,4,0,5,2.8,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
127049517,139545,0,None,2,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,9,1,5,4.3,CNC(=O)c1ccc(OC)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3804943,139545,0,None,2,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,9,1,5,4.3,CNC(=O)c1ccc(OC)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
127049865,139559,0,None,-4,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,442,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
CHEMBL3805099,139559,0,None,-4,3,Human,7.9,pIC50,=,7.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,442,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
52948320,18375,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,6,2,4,2.8,CCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276428,18375,0,None,-,1,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,6,2,4,2.8,CCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
156011035,176422,0,None,-6,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,437,7,0,8,3.3,COc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,10.1016/j.bmcl.2020.127027
CHEMBL4634009,176422,0,None,-6,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,437,7,0,8,3.3,COc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,10.1016/j.bmcl.2020.127027
156011945,176701,0,None,-7,5,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,407,6,0,7,3.3,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
CHEMBL4638599,176701,0,None,-7,5,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,407,6,0,7,3.3,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
71541277,86610,0,None,-,1,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,316,2,1,6,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326469,86610,0,None,-,1,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,316,2,1,6,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,10.1016/j.bmcl.2012.11.023
145963975,163725,0,None,-1,2,Human,6.9,pIC50,=,6.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4213586,163725,0,None,-1,2,Human,6.9,pIC50,=,6.9,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4777098,180987,0,None,-11,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,462,6,0,5,3.9,CN1CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc2C1=O,10.1016/j.ejmech.2020.112572
52947128,18414,0,None,-,1,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,2,4,2.2,CCc1ccc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276765,18414,0,None,-,1,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,2,4,2.2,CCc1ccc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
11696813,187173,9,None,-5,3,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2SreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumandopamineD2SreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,391,7,1,4,4.1,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,10.1021/jm800689g
CHEMBL496739,187173,9,None,-5,3,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2SreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumandopamineD2SreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,391,7,1,4,4.1,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,10.1021/jm800689g
71457372,82392,0,None,-1,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,325,11,1,2,5.1,CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1,10.1021/jm301258w
CHEMBL2180641,82392,0,None,-1,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,325,11,1,2,5.1,CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1,10.1021/jm301258w
6674,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
9891901,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
CHEMBL300780,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
6674,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
9891901,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
CHEMBL300780,2754,10,None,-151,2,Human,5.9,pIC50,=,5.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,493,7,1,3,5.9,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
145988497,166492,0,None,-11,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,411,6,0,5,3.6,O=C1C2CCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4291387,166492,0,None,-11,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,411,6,0,5,3.6,O=C1C2CCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
11316847,69930,0,None,-6,2,Human,7.9,pIC50,=,7.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,448,7,1,5,4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,10.1021/jm040190e
CHEMBL194493,69930,0,None,-6,2,Human,7.9,pIC50,=,7.9,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,448,7,1,5,4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,10.1021/jm040190e
44427821,153063,0,None,-190,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.5,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,10.1021/jm0704200
CHEMBL398175,153063,0,None,-190,2,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.5,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,10.1021/jm0704200
91242334,166672,3,None,-6,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,419,6,0,5,4.1,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4294797,166672,3,None,-6,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,419,6,0,5,4.1,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
156010883,176418,0,None,-14,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,441,6,0,7,4,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(Cl)cn12,10.1016/j.bmcl.2020.127027
CHEMBL4633978,176418,0,None,-14,3,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,441,6,0,7,4,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(Cl)cn12,10.1016/j.bmcl.2020.127027
145978965,165859,0,None,1,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,469,6,2,7,1.8,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sccc34)CC1)[C@@H]1C[C@H]2[C@@H](O)[C@H]1O,10.1016/j.ejmech.2017.12.099
CHEMBL4279645,165859,0,None,1,3,Human,7.9,pIC50,=,7.9,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,469,6,2,7,1.8,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sccc34)CC1)[C@@H]1C[C@H]2[C@@H](O)[C@H]1O,10.1016/j.ejmech.2017.12.099
10436285,101390,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,507,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,10.1021/jm040190e
CHEMBL301242,101390,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,507,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,10.1021/jm040190e
71541076,86629,0,None,-,1,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,233,0,1,4,1.9,CN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
CHEMBL2326488,86629,0,None,-,1,Human,5.9,pIC50,=,5.9,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,233,0,1,4,1.9,CN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
52942266,18415,0,None,-,1,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.9,CCCc1c(C)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276766,18415,0,None,-,1,Human,6.9,pIC50,=,6.9,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.9,CCCc1c(C)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
156021805,177429,0,None,-24,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1ccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc2c1,10.1016/j.bmcl.2020.127027
CHEMBL4648979,177429,0,None,-24,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1ccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc2c1,10.1016/j.bmcl.2020.127027
71563082,86768,0,None,5,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,1,2,3,3.9,Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
CHEMBL2331599,86768,0,None,5,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,1,2,3,3.9,Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
71541278,86611,0,None,-,1,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,299,2,2,5,2.2,Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326470,86611,0,None,-,1,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,299,2,2,5,2.2,Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,10.1016/j.bmcl.2012.11.023
24837531,174053,0,None,4,2,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,311,2,1,4,3.1,COc1cc2c(cc1OC)C1Cc3ccc(O)cc3CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL4561303,174053,0,None,4,2,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,311,2,1,4,3.1,COc1cc2c(cc1OC)C1Cc3ccc(O)cc3CN1CC2,10.1016/j.bmc.2019.04.014
137631570,155805,0,None,-5,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,430,4,1,8,3,Cc1nc2n(c(=O)c1CCN1CCN(c3csc4ccsc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4067506,155805,0,None,-5,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,430,4,1,8,3,Cc1nc2n(c(=O)c1CCN1CCN(c3csc4ccsc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
44537925,194421,0,None,-7,3,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpiroleAntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpirole,ChEMBL,624,12,2,9,5.2,COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,10.1016/j.bmc.2009.06.019
CHEMBL582945,194421,0,None,-7,3,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpiroleAntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpirole,ChEMBL,624,12,2,9,5.2,COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,10.1016/j.bmc.2009.06.019
127048532,139573,0,None,-4,3,Human,5.8,pIC50,=,5.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cc(F)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805262,139573,0,None,-4,3,Human,5.8,pIC50,=,5.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cc(F)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
10001256,199941,0,None,-2,2,Human,7.8,pIC50,=,7.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,403,6,1,3,4.1,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,10.1021/jm040190e
CHEMBL71327,199941,0,None,-2,2,Human,7.8,pIC50,=,7.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,403,6,1,3,4.1,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,10.1021/jm040190e
127051040,139620,0,None,28,3,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,491,12,1,4,5.9,CCCCCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805826,139620,0,None,28,3,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,491,12,1,4,5.9,CCCCCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
52944651,18378,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,390,5,2,4,3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276460,18378,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,390,5,2,4,3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
52944078,18398,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,384,6,2,4,2.9,CCc1c(Br)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
CHEMBL1276646,18398,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,384,6,2,4,2.9,CCc1c(Br)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,10.1016/j.ejmech.2010.07.056
72699716,114591,0,None,3,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,343,3,1,4,4.3,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2,10.1016/j.bmc.2014.09.024
CHEMBL3344459,114591,0,None,3,3,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,343,3,1,4,4.3,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2,10.1016/j.bmc.2014.09.024
53248211,61640,0,None,-1,2,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,493,8,1,5,5,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,10.1021/jm200288r
CHEMBL1774533,61640,0,None,-1,2,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,493,8,1,5,5,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,10.1021/jm200288r
11307083,63159,0,None,-6,2,Human,6.8,pIC50,=,6.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,529,6,1,3,4.7,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm040190e
CHEMBL180060,63159,0,None,-6,2,Human,6.8,pIC50,=,6.8,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,529,6,1,3,4.7,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm040190e
71452041,1891,3,None,-125,3,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,309,8,1,2,4.3,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1,10.1021/jm301258w
9189,1891,3,None,-125,3,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,309,8,1,2,4.3,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1,10.1021/jm301258w
CHEMBL2180639,1891,3,None,-125,3,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassayAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirol-inducedmitogenesisincubatedfor24hrsby[3H]thymidineincorporationassay,ChEMBL,309,8,1,2,4.3,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1,10.1021/jm301258w
127049522,139546,0,None,1,3,Human,6.8,pIC50,=,6.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1ccccc1OCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1016/j.bmcl.2016.04.087
CHEMBL3804954,139546,0,None,1,3,Human,6.8,pIC50,=,6.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1ccccc1OCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,10.1016/j.bmcl.2016.04.087
44586762,187668,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,380,10,1,4,3.3,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCCl)cc(OC)c1OC,10.1016/j.bmcl.2008.07.065
CHEMBL502017,187668,0,None,-,1,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,380,10,1,4,3.3,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCCl)cc(OC)c1OC,10.1016/j.bmcl.2008.07.065
242,467,113,None,-6,12,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2016.04.087
34,467,113,None,-6,12,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2016.04.087
60795,467,113,None,-6,12,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2016.04.087
CHEMBL1112,467,113,None,-6,12,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2016.04.087
DB01238,467,113,None,-6,12,Human,7.8,pIC50,=,7.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2016.04.087
145946966,166889,0,None,-2,3,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,354,7,0,4,3.9,COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4209888,166889,0,None,-2,3,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,354,7,0,4,3.9,COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4300899,166889,0,None,-2,3,Human,7.8,pIC50,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,354,7,0,4,3.9,COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
71541180,86625,0,None,-,1,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326484,86625,0,None,-,1,Human,5.8,pIC50,=,5.8,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,10.1016/j.bmcl.2012.11.023
127051340,139554,0,None,-5,3,Human,6.8,pIC50,=,6.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1F,10.1016/j.bmcl.2016.04.087
CHEMBL3805046,139554,0,None,-5,3,Human,6.8,pIC50,=,6.8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1F,10.1016/j.bmcl.2016.04.087
44427825,148709,0,None,-4,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,442,8,1,5,3.9,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
CHEMBL394541,148709,0,None,-4,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,442,8,1,5,3.9,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,10.1021/jm0704200
44427826,92754,0,None,-9,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,453,7,1,4,4.4,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,10.1021/jm0704200
CHEMBL244989,92754,0,None,-9,2,Human,6.8,pIC50,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,453,7,1,4,4.4,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,10.1021/jm0704200
52944701,18381,0,None,-,1,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,401,6,2,6,2.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1[N+](=O)[O-],10.1016/j.ejmech.2010.07.056
CHEMBL1276495,18381,0,None,-,1,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,401,6,2,6,2.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1[N+](=O)[O-],10.1016/j.ejmech.2010.07.056
161665,171866,29,None,-97,3,Human,4.7,pIC50,=,4.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,10.1016/j.bmc.2012.12.016
CHEMBL448891,171866,29,None,-97,3,Human,4.7,pIC50,=,4.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,10.1016/j.bmc.2012.12.016
52949582,18411,0,None,-,1,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,292,5,2,4,1.9,CCN1CCC[C@H]1CNC(=O)c1cc(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276742,18411,0,None,-,1,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,292,5,2,4,1.9,CCN1CCC[C@H]1CNC(=O)c1cc(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL4759331,180291,0,None,-17,3,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,471,6,1,6,3.9,O=S1(=O)CCc2ccc(O)cc2N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2020.112572
52941078,18365,0,None,-,1,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,330,5,1,3,3.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Cl,10.1016/j.ejmech.2010.07.056
CHEMBL1276352,18365,0,None,-,1,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,330,5,1,3,3.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Cl,10.1016/j.ejmech.2010.07.056
155561845,174995,0,None,5,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,295,0,1,4,2.8,Oc1cccc2c1CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
CHEMBL4582377,174995,0,None,5,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,295,0,1,4,2.8,Oc1cccc2c1CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
44589645,185885,0,None,5,2,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,537,4,2,5,5.4,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4ccc(F)cc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL487985,185885,0,None,5,2,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,537,4,2,5,5.4,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4ccc(F)cc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
71541077,86630,0,None,-,1,Human,4.7,pIC50,=,4.7,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,247,1,1,4,2.3,CCN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
CHEMBL2326489,86630,0,None,-,1,Human,4.7,pIC50,=,4.7,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,247,1,1,4,2.3,CCN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
145989451,166596,0,None,3,3,Human,8.7,pIC50,=,8.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,459,6,0,6,2.7,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3c2OC(F)(F)O3)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4293718,166596,0,None,3,3,Human,8.7,pIC50,=,8.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,459,6,0,6,2.7,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3c2OC(F)(F)O3)CC1,10.1016/j.ejmech.2017.12.099
52944652,18390,0,None,-,1,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,384,6,2,4,2.9,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,10.1016/j.ejmech.2010.07.056
CHEMBL1276561,18390,0,None,-,1,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,384,6,2,4,2.9,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,10.1016/j.ejmech.2010.07.056
137635433,155261,0,None,1,3,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,4,1,8,2.5,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
CHEMBL4061068,155261,0,None,1,3,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,4,1,8,2.5,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
145987942,166362,0,None,4,3,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,3.8,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sc(F)cc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4289238,166362,0,None,4,3,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,3.8,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sc(F)cc23)CC1,10.1016/j.ejmech.2017.12.099
129186554,157132,0,None,-2,6,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,408,4,0,6,3.5,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4083333,157132,0,None,-2,6,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,408,4,0,6,3.5,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
13493795,18363,0,None,-,1,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,348,9,1,4,3.3,CCCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276350,18363,0,None,-,1,Human,8.6,pIC50,=,8.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,348,9,1,4,3.3,CCCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,10.1016/j.ejmech.2010.07.056
137641944,157788,0,None,7,2,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,444,4,0,6,4.3,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
CHEMBL4090872,157788,0,None,7,2,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,444,4,0,6,4.3,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
52942259,18386,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,2,4,2.2,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
CHEMBL1276529,18386,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,2,4,2.2,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
208951,82548,28,None,112,2,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,385,4,1,4,4.1,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,10.1016/j.bmcl.2012.11.023
CHEMBL218166,82548,28,None,112,2,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,385,4,1,4,4.1,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,10.1016/j.bmcl.2012.11.023
137660385,158396,0,None,1,3,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4097395,158396,0,None,1,3,Human,7.7,pIC50,=,7.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
127048533,139592,0,None,-1,3,Human,6.7,pIC50,=,6.7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,9,1,5,4.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,10.1016/j.bmcl.2016.04.087
CHEMBL3805515,139592,0,None,-1,3,Human,6.7,pIC50,=,6.7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,9,1,5,4.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,10.1016/j.bmcl.2016.04.087
52941643,18392,0,None,-,1,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,308,6,2,5,1.6,CCN1CCC[C@H]1CNC(=O)c1cc(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276586,18392,0,None,-,1,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,308,6,2,5,1.6,CCN1CCC[C@H]1CNC(=O)c1cc(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
3036864,198421,12,None,-295,6,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.bmc.2019.04.014
CHEMBL1256645,198421,12,None,-295,6,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.bmc.2019.04.014
CHEMBL1814790,198421,12,None,-295,6,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.bmc.2019.04.014
CHEMBL62,198421,12,None,-295,6,Human,5.7,pIC50,=,5.7,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.bmc.2019.04.014
CHEMBL3084503,102726,0,None,-20,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,400,3,2,2,5.5,O[C@]1(c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H](C1)N2Cc1c[nH]c2ccccc12,10.1021/jm800532x
145984151,165748,0,None,-16,3,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,4.2,O=C1c2ccc(F)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4277751,165748,0,None,-16,3,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,4.2,O=C1c2ccc(F)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4741908,178831,0,None,-416,3,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,421,6,0,5,4.2,O=C1COc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2020.112572
44427823,92704,0,None,-60,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,1,4,4.4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,10.1021/jm0704200
CHEMBL244774,92704,0,None,-60,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,1,4,4.4,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,10.1021/jm0704200
71563083,87059,0,None,-19,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,1,2,3,3.9,Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
CHEMBL2335737,87059,0,None,-19,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,343,1,2,3,3.9,Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
11676873,9077,0,None,-21,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,455,8,1,4,4.6,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,10.1021/jm0704200
CHEMBL110365,9077,0,None,-21,2,Human,6.7,pIC50,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,455,8,1,4,4.6,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,10.1021/jm0704200
127049863,139593,0,None,-1,6,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,443,8,1,5,4.5,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
CHEMBL3805518,139593,0,None,-1,6,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,443,8,1,5,4.5,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
44589596,189618,0,None,1,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,474,4,1,5,3.5,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL521030,189618,0,None,1,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,474,4,1,5,3.5,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
145966333,163362,0,None,-19,6,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4209188,163362,0,None,-19,6,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
145993493,166657,0,None,-3,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,6,0,5,4.5,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4294617,166657,0,None,-3,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,6,0,5,4.5,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
73671217,113091,0,None,-27,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,504,7,1,8,3.2,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,10.1021/jm500801r
CHEMBL3323016,113091,0,None,-27,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassayAntagonistactivityagainsthumanD2LRexpressedinCHOcellsassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbydopaminepotencyshiftassay,ChEMBL,504,7,1,8,3.2,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,10.1021/jm500801r
52941039,18379,0,None,-,1,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,434,5,2,4,3.1,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276461,18379,0,None,-,1,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,434,5,2,4,3.1,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
52945905,18384,0,None,-,1,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,326,5,2,4,2.6,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276527,18384,0,None,-,1,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,326,5,2,4,2.6,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
3036864,198421,12,None,-295,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.ejmech.2020.112709
CHEMBL1256645,198421,12,None,-295,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.ejmech.2020.112709
CHEMBL1814790,198421,12,None,-295,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.ejmech.2020.112709
CHEMBL62,198421,12,None,-295,6,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1016/j.ejmech.2020.112709
71541276,86609,0,None,-,1,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,300,2,1,6,2.5,Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326468,86609,0,None,-,1,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,300,2,1,6,2.5,Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,10.1016/j.bmcl.2012.11.023
11351639,60137,0,None,-26,2,Human,6.6,pIC50,=,6.6,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,459,6,1,4,5.3,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,10.1021/jm040190e
CHEMBL175734,60137,0,None,-26,2,Human,6.6,pIC50,=,6.6,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,459,6,1,4,5.3,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,10.1021/jm040190e
15167695,18353,0,None,-,1,Human,6.6,pIC50,=,6.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,296,5,1,3,2.6,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)ccc1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276238,18353,0,None,-,1,Human,6.6,pIC50,=,6.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,296,5,1,3,2.6,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)ccc1OC,10.1016/j.ejmech.2010.07.056
9549058,172428,0,None,-3,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1O)CC1c3cc(OC)c(OC)cc3CCN1C2,10.1016/j.bmc.2019.04.014
CHEMBL4521450,172428,0,None,-3,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1O)CC1c3cc(OC)c(OC)cc3CCN1C2,10.1016/j.bmc.2019.04.014
CHEMBL3084512,102735,0,None,-6,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,383,3,1,3,5.6,O[C@]1(c2ccc(Cl)cc2)C[C@@H]2CC[C@H](C1)N2Cc1csc2ccccc12,10.1021/jm800532x
156020913,177310,0,None,-263,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,425,6,0,7,3.5,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(F)cn12,10.1016/j.bmcl.2020.127027
CHEMBL4647011,177310,0,None,-263,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,425,6,0,7,3.5,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(F)cn12,10.1016/j.bmcl.2020.127027
145971556,163800,0,None,-29,3,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,436,8,1,5,3.7,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4214528,163800,0,None,-29,3,Human,7.6,pIC50,=,7.6,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,436,8,1,5,3.7,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccn1,10.1016/j.bmcl.2018.01.038
137657949,158855,0,None,-2,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,420,4,1,7,3.3,Cc1nc2c(O)cccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.bmc.2017.07.040
CHEMBL4102561,158855,0,None,-2,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,420,4,1,7,3.3,Cc1nc2c(O)cccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.bmc.2017.07.040
137658832,158646,0,None,-1,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,448,4,1,8,2.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4100152,158646,0,None,-1,3,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,448,4,1,8,2.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
44589643,185884,0,None,1,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,518,4,1,5,3.6,O=c1[nH]c2cc(Br)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL487984,185884,0,None,1,2,Human,5.6,pIC50,=,5.6,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,518,4,1,5,3.6,O=c1[nH]c2cc(Br)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
145981310,165984,0,None,11,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,449,7,0,5,4,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4282051,165984,0,None,11,2,Human,7.6,pIC50,=,7.6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,449,7,0,5,4,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4777475,181008,0,None,-8,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,434,6,1,6,3.5,O=c1[nH]c(=O)n(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc12,10.1016/j.ejmech.2020.112572
71541083,86617,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,309,2,1,4,3.5,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326476,86617,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,309,2,1,4,3.5,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,10.1016/j.bmcl.2012.11.023
145975595,162991,0,None,-4,2,Human,6.5,pIC50,=,6.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4204832,162991,0,None,-4,2,Human,6.5,pIC50,=,6.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
2726,900,58,None,-3,35,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.bmcl.2018.04.059
621,900,58,None,-3,35,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.bmcl.2018.04.059
83,900,58,None,-3,35,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.bmcl.2018.04.059
CHEMBL71,900,58,None,-3,35,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.bmcl.2018.04.059
DB00477,900,58,None,-3,35,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,318,4,0,3,4.9,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,10.1016/j.bmcl.2018.04.059
52949614,18382,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,404,5,2,4,2.2,CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276496,18382,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,404,5,2,4,2.2,CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
179,396,103,None,13182,2,Human,8.5,pIC50,=,8.5,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,369,7,2,6,1.3,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,10.1016/j.ejmech.2016.07.038
2159,396,103,None,13182,2,Human,8.5,pIC50,=,8.5,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,369,7,2,6,1.3,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,10.1016/j.ejmech.2016.07.038
963,396,103,None,13182,2,Human,8.5,pIC50,=,8.5,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,369,7,2,6,1.3,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,10.1016/j.ejmech.2016.07.038
CHEMBL243712,396,103,None,13182,2,Human,8.5,pIC50,=,8.5,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,369,7,2,6,1.3,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,10.1016/j.ejmech.2016.07.038
DB06288,396,103,None,13182,2,Human,8.5,pIC50,=,8.5,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,369,7,2,6,1.3,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC,10.1016/j.ejmech.2016.07.038
52945907,18395,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,354,7,2,4,3.2,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
CHEMBL1276615,18395,0,None,-,1,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,354,7,2,4,3.2,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
137653567,158155,0,None,-1,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,404,4,0,6,3.6,Cc1nc2ccccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.bmc.2017.07.040
CHEMBL4094825,158155,0,None,-1,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,404,4,0,6,3.6,Cc1nc2ccccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,10.1016/j.bmc.2017.07.040
91884611,158872,0,None,-1,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,424,4,1,7,3,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4102670,158872,0,None,-1,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,424,4,1,7,3,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
129186534,159002,0,None,2,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,0,6,3.9,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
CHEMBL4104261,159002,0,None,2,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,0,6,3.9,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
129186544,160380,0,None,2,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,444,4,0,6,4,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
CHEMBL4087132,160380,0,None,2,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,444,4,0,6,4,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
CHEMBL4116744,160380,0,None,2,6,Human,8.5,pIC50,=,8.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,444,4,0,6,4,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
127048540,139547,0,None,-3,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,8,1,6,3.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
CHEMBL3804965,139547,0,None,-3,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,465,8,1,6,3.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
145992523,166314,0,None,-5,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.8,O=C1c2cccc(Cl)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4288388,166314,0,None,-5,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.8,O=C1c2cccc(Cl)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
156018107,177139,0,None,-16,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,425,6,0,7,3.5,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4644352,177139,0,None,-16,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,425,6,0,7,3.5,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
71541177,86622,0,None,-,1,Human,6.5,pIC50,=,6.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,380,3,1,5,3.2,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,10.1016/j.bmcl.2012.11.023
CHEMBL2326481,86622,0,None,-,1,Human,6.5,pIC50,=,6.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,380,3,1,5,3.2,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,10.1016/j.bmcl.2012.11.023
71541079,86632,0,None,-,1,Human,4.5,pIC50,=,4.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,301,1,1,4,2.8,Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326491,86632,0,None,-,1,Human,4.5,pIC50,=,4.5,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,301,1,1,4,2.8,Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,10.1016/j.bmcl.2012.11.023
52944657,18416,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,323,6,2,6,1.5,CCN1CCC[C@H]1CNC(=O)c1cc([N+](=O)[O-])cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276767,18416,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,323,6,2,6,1.5,CCN1CCC[C@H]1CNC(=O)c1cc([N+](=O)[O-])cc(O)c1OC,10.1016/j.ejmech.2010.07.056
3036864,198421,12,None,-295,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1021/acs.jmedchem.8b01096
CHEMBL1256645,198421,12,None,-295,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1021/acs.jmedchem.8b01096
CHEMBL1814790,198421,12,None,-295,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1021/acs.jmedchem.8b01096
CHEMBL62,198421,12,None,-295,6,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,287,1,1,2,3.7,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,10.1021/acs.jmedchem.8b01096
129186527,155648,0,None,-3,2,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,438,4,1,7,3.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
CHEMBL4065710,155648,0,None,-3,2,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,438,4,1,7,3.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
453215,85969,3,None,-7,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1OC)C1Cc3ccc(OC)c(O)c3CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL2314745,85969,3,None,-7,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1OC)C1Cc3ccc(OC)c(O)c3CN1CC2,10.1016/j.bmc.2019.04.014
52947113,18358,0,None,-,1,Human,6.5,pIC50,=,6.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,278,5,2,4,1.6,CCN1CCC[C@H]1CNC(=O)c1cccc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276269,18358,0,None,-,1,Human,6.5,pIC50,=,6.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,278,5,2,4,1.6,CCN1CCC[C@H]1CNC(=O)c1cccc(O)c1OC,10.1016/j.ejmech.2010.07.056
242,467,113,None,-6,12,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2018.01.038
34,467,113,None,-6,12,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2018.01.038
60795,467,113,None,-6,12,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2018.01.038
CHEMBL1112,467,113,None,-6,12,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2018.01.038
DB01238,467,113,None,-6,12,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2018.01.038
127050765,139556,0,None,-1,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805077,139556,0,None,-1,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
52947123,18402,0,None,-,1,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276708,18402,0,None,-,1,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,346,5,2,4,2.9,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
145987659,166550,0,None,3,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,421,5,0,5,3.2,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4292655,166550,0,None,3,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,421,5,0,5,3.2,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
146025813,174864,0,None,2,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4579687,174864,0,None,2,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
146025813,174864,0,None,2,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4579687,174864,0,None,2,2,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4763837,180676,0,None,-8,3,Human,7.5,pIC50,=,7.5,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,466,6,1,5,3.7,O=C1NCC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2cc(F)ccc21,10.1016/j.ejmech.2020.112572
127049847,139659,0,None,-1,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,469,8,1,4,5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1Cl,10.1016/j.bmcl.2016.04.087
CHEMBL3806224,139659,0,None,-1,3,Human,7.5,pIC50,=,7.5,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,469,8,1,4,5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1Cl,10.1016/j.bmcl.2016.04.087
10436285,101390,0,None,-,1,Human,7.5,pIC50,=,7.5,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,507,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,10.1021/jm040190e
CHEMBL301242,101390,0,None,-,1,Human,7.5,pIC50,=,7.5,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,507,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,10.1021/jm040190e
14021682,172683,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1O)C1Cc3cc(OC)c(OC)cc3CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL4528264,172683,0,None,-,1,Human,5.5,pIC50,=,5.5,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,341,3,1,5,3.1,COc1cc2c(cc1O)C1Cc3cc(OC)c(OC)cc3CN1CC2,10.1016/j.bmc.2019.04.014
137629633,160440,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,432,4,0,7,2.6,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4077006,160440,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,432,4,0,7,2.6,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4117235,160440,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,432,4,0,7,2.6,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2,10.1016/j.bmc.2017.07.040
44589594,184452,0,None,-1,2,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,458,4,1,5,3,O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL485755,184452,0,None,-1,2,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,458,4,1,5,3,O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,10.1016/j.bmcl.2008.09.032
127049516,139644,0,None,-29,3,Human,5.4,pIC50,=,5.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,10.1016/j.bmcl.2016.04.087
CHEMBL3806091,139644,0,None,-29,3,Human,5.4,pIC50,=,5.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,10.1016/j.bmcl.2016.04.087
146025812,174170,0,None,1,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4564103,174170,0,None,1,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
52948318,18372,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,296,5,2,4,1.8,CCN1CCC[C@H]1CNC(=O)c1cc(F)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276401,18372,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,296,5,2,4,1.8,CCN1CCC[C@H]1CNC(=O)c1cc(F)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
146025812,174170,0,None,1,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4564103,174170,0,None,1,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
44427822,92703,0,None,-14,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.5,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm0704200
CHEMBL244773,92703,0,None,-14,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.5,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm0704200
137651544,156789,0,None,-1,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,409,4,0,7,2.9,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4079365,156789,0,None,-1,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,409,4,0,7,2.9,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
145967359,163483,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4210637,163483,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
127049849,139587,0,None,3,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,477,9,1,5,4.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)=O)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805434,139587,0,None,3,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,477,9,1,5,4.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)=O)c1,10.1016/j.bmcl.2016.04.087
145991127,166231,0,None,-34,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,4.2,O=C1c2cccc(F)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4286905,166231,0,None,-34,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,4.2,O=C1c2cccc(F)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
52948319,18373,0,None,-,1,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,312,5,2,4,2.3,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276426,18373,0,None,-,1,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,312,5,2,4,2.3,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
71562963,87063,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,359,2,2,4,3.6,COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
CHEMBL2335741,87063,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,359,2,2,4,3.6,COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
127049515,139626,0,None,-5,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
CHEMBL3805884,139626,0,None,-5,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,453,8,1,4,4.5,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
15167698,18401,5,None,-,1,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,290,6,1,3,2.5,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
CHEMBL1276677,18401,5,None,-,1,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,290,6,1,3,2.5,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
127049163,139566,0,None,2,2,Human,8.4,pIC50,=,8.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,8,1,6,3.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805165,139566,0,None,2,2,Human,8.4,pIC50,=,8.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,447,8,1,6,3.3,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)c1,10.1016/j.bmcl.2016.04.087
52947114,18368,0,None,-,1,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,324,6,1,3,3.1,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
CHEMBL1276375,18368,0,None,-,1,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,324,6,1,3,3.1,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,10.1016/j.ejmech.2010.07.056
228,441,21,None,-2,8,Human,8.4,pIC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethodAgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.ejmech.2014.12.045
33,441,21,None,-2,8,Human,8.4,pIC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethodAgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.ejmech.2014.12.045
6005,441,21,None,-2,8,Human,8.4,pIC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethodAgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.ejmech.2014.12.045
CHEMBL53,441,21,None,-2,8,Human,8.4,pIC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethodAgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.ejmech.2014.12.045
DB00714,441,21,None,-2,8,Human,8.4,pIC50,=,8.4,Functional,AgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethodAgonistactivityathumandopamineD2receptorexpressedinCHOK1cellsassessedascalciummobilizationbyradiometricandluminescenceplatecountingmethod,ChEMBL,267,0,2,3,2.9,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O,10.1016/j.ejmech.2014.12.045
10550893,165742,0,None,3,3,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,436,6,0,6,3,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4277532,165742,0,None,3,3,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,436,6,0,6,3,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1,10.1016/j.ejmech.2017.12.099
145990126,166053,0,None,-2,3,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,6,0,5,4,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4283546,166053,0,None,-2,3,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,6,0,5,4,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
133633,2187,40,None,20,4,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1021/jm800532x
177,2187,40,None,20,4,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1021/jm800532x
CHEMBL445102,2187,40,None,20,4,Human,8.4,pIC50,=,8.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,3,2,2,4.3,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2,10.1021/jm800532x
14576389,165932,0,None,1,2,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,6,0,5,4,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCC(c2noc3cc(F)ccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4280940,165932,0,None,1,2,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,439,6,0,5,4,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCC(c2noc3cc(F)ccc23)CC1,10.1016/j.ejmech.2017.12.099
12269810,85970,5,None,15,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,327,2,2,5,2.8,COc1ccc2c(c1OC)CN1CCc3cc(O)c(O)cc3C1C2,10.1016/j.bmc.2019.04.014
CHEMBL2314747,85970,5,None,15,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,327,2,2,5,2.8,COc1ccc2c(c1OC)CN1CCc3cc(O)c(O)cc3C1C2,10.1016/j.bmc.2019.04.014
156011666,176580,0,None,-2,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,409,6,0,7,3.4,O=c1n(CCCCN2CCC(c3cc(F)cc4oncc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
CHEMBL4636764,176580,0,None,-2,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,409,6,0,7,3.4,O=c1n(CCCCN2CCC(c3cc(F)cc4oncc34)CC2)nc2ccccn12,10.1016/j.bmcl.2020.127027
137658253,158936,0,None,-1,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,422,4,0,7,3.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
CHEMBL4103509,158936,0,None,-1,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,422,4,0,7,3.1,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
71541174,86619,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,327,2,1,4,3.6,Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326478,86619,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,327,2,1,4,3.6,Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,10.1016/j.bmcl.2012.11.023
71541175,86620,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,339,3,1,5,3.5,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,10.1016/j.bmcl.2012.11.023
CHEMBL2326479,86620,0,None,-,1,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,339,3,1,5,3.5,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,10.1016/j.bmcl.2012.11.023
156021409,177385,0,None,-4073,3,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,475,6,0,7,4.6,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cc(Cl)cn12,10.1016/j.bmcl.2020.127027
CHEMBL4648027,177385,0,None,-4073,3,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,475,6,0,7,4.6,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cc(Cl)cn12,10.1016/j.bmcl.2020.127027
44427820,92679,0,None,-40,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,2,4,4.5,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,10.1021/jm0704200
CHEMBL244562,92679,0,None,-40,2,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,496,7,2,4,4.5,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,10.1021/jm0704200
1353,1858,83,None,-5,28,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2014.09.024
3559,1858,83,None,-5,28,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2014.09.024
86,1858,83,None,-5,28,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2014.09.024
CHEMBL54,1858,83,None,-5,28,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2014.09.024
DB00502,1858,83,None,-5,28,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2014.09.024
145965041,163557,0,None,-3,3,Human,6.4,pIC50,=,6.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3ccc4ccsc4c3)CC2)n1,10.1016/j.bmcl.2018.01.038
CHEMBL4211473,163557,0,None,-3,3,Human,6.4,pIC50,=,6.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3ccc4ccsc4c3)CC2)n1,10.1016/j.bmcl.2018.01.038
145972382,163988,0,None,2,2,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4217039,163988,0,None,2,2,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
156017859,177163,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,10.1016/j.bmcl.2020.127027
CHEMBL4644742,177163,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,432,6,0,8,3.2,N#Cc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,10.1016/j.bmcl.2020.127027
145968927,164069,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,411,8,1,7,2.8,NC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4217986,164069,0,None,-2,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,411,8,1,7,2.8,NC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
15061351,85967,0,None,2,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,367,2,0,6,3,COc1ccc2c(c1OC(C)=O)CN1CCc3cc4c(cc3C1C2)OCO4,10.1016/j.bmc.2019.04.014
CHEMBL2314734,85967,0,None,2,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,367,2,0,6,3,COc1ccc2c(c1OC(C)=O)CN1CCc3cc4c(cc3C1C2)OCO4,10.1016/j.bmc.2019.04.014
53248258,61645,0,None,1,3,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,441,8,1,5,4.2,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1,10.1021/jm200288r
CHEMBL1774538,61645,0,None,1,3,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesisAntagonistactivityathumandopamineD2receptorexpressedinCHOpcellsassessedasinhibitionofquinpirole-inducedmitogenesis,ChEMBL,441,8,1,5,4.2,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1,10.1021/jm200288r
127048539,139604,0,None,-7,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,441,8,1,5,4.4,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
CHEMBL3805649,139604,0,None,-7,3,Human,7.4,pIC50,=,7.4,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,441,8,1,5,4.4,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccc1F,10.1016/j.bmcl.2016.04.087
6917970,3605,51,None,-40,3,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,327,2,2,5,2.8,COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O,10.1016/j.bmc.2014.09.024
8370,3605,51,None,-40,3,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,327,2,2,5,2.8,COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O,10.1016/j.bmc.2014.09.024
CHEMBL487387,3605,51,None,-40,3,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,327,2,2,5,2.8,COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O,10.1016/j.bmc.2014.09.024
145988006,166422,0,None,-14,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,553,8,0,9,2.9,CC(=O)O[C@H]1[C@H]2C[C@H]([C@@H]3C(=O)N(CCCCN4CCN(c5cccc6sccc56)CC4)C(=O)[C@H]23)[C@H]1OC(C)=O,10.1016/j.ejmech.2017.12.099
CHEMBL4290309,166422,0,None,-14,3,Human,7.4,pIC50,=,7.4,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,553,8,0,9,2.9,CC(=O)O[C@H]1[C@H]2C[C@H]([C@@H]3C(=O)N(CCCCN4CCN(c5cccc6sccc56)CC4)C(=O)[C@H]23)[C@H]1OC(C)=O,10.1016/j.ejmech.2017.12.099
71541280,86614,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,313,2,1,6,2.2,Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,10.1016/j.bmcl.2012.11.023
CHEMBL2326473,86614,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,313,2,1,6,2.2,Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,10.1016/j.bmcl.2012.11.023
213,3763,45,None,-467,18,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,371,5,0,6,2.4,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,10.1016/j.bmcl.2020.127027
2717,3763,45,None,-467,18,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,371,5,0,6,2.4,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,10.1016/j.bmcl.2020.127027
5533,3763,45,None,-467,18,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,371,5,0,6,2.4,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,10.1016/j.bmcl.2020.127027
CHEMBL621,3763,45,None,-467,18,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,371,5,0,6,2.4,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,10.1016/j.bmcl.2020.127027
DB00656,3763,45,None,-467,18,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,371,5,0,6,2.4,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2,10.1016/j.bmcl.2020.127027
14762912,18357,0,None,-,1,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,5,1,3,2.7,CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276268,18357,0,None,-,1,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,340,5,1,3,2.7,CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,10.1016/j.ejmech.2010.07.056
72301,185375,68,None,3,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL487182,185375,68,None,3,2,Human,6.4,pIC50,=,6.4,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,355,4,0,5,3.4,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,10.1016/j.bmc.2019.04.014
25010776,55606,1,None,-2,5,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,333,6,2,4,1.9,CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1,10.1016/j.bmcl.2011.08.084
CHEMBL1559151,55606,1,None,-2,5,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,333,6,2,4,1.9,CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1,10.1016/j.bmcl.2011.08.084
CHEMBL1624037,55606,1,None,-2,5,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,333,6,2,4,1.9,CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1,10.1016/j.bmcl.2011.08.084
71541275,86626,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326485,86626,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,10.1016/j.bmcl.2012.11.023
71541078,86631,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,259,1,1,4,2.4,Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326490,86631,0,None,-,1,Human,5.4,pIC50,=,5.4,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,259,1,1,4,2.4,Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,10.1016/j.bmcl.2012.11.023
2,3181,17,None,-12,7,Human,6.3,pIC50,=,6.3,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,nan
54562,3181,17,None,-12,7,Human,6.3,pIC50,=,6.3,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,nan
CHEMBL240773,3181,17,None,-12,7,Human,6.3,pIC50,=,6.3,Functional,"AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.AffinityAssay:Eachmedicamentwasdissolvedinserum-freeF12culturemediumcontaining100μMofIBMX.CHOcellswhichcanstablyexpressD2receptorwerepre-incubatedat37°C.for10min,andthen10μMForskolineand10μMDopaniewereaddedatthesametimetoreactfor10min.100μL,ofpre-cooled1MofHClO4wasaddedandthereactionwasterminatedat4°C.for1hour.20μLof2MK2CO3wasaddedtoneutralizethereaction.Theresultingmixturewascentrifugatedat3000rpmfor15min,andtheprecipitateKClO4wasdiscarded.AcertainamountofthesupernatantwastakenforcAMPdetection.SpiperoneandQuinpirolewereusedaspositivecontrol.",ChEMBL,219,2,1,2,2,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2,nan
CHEMBL3084502,102725,0,None,-3,2,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,366,3,2,2,4.8,O[C@@]1(c2ccc(Cl)cc2)C[C@@H]2CC[C@H](C1)N2Cc1c[nH]c2ccccc12,10.1021/jm800532x
44537919,193813,0,None,-1,3,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpiroleAntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpirole,ChEMBL,610,11,2,9,4.8,COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,10.1016/j.bmc.2009.06.019
CHEMBL574700,193813,0,None,-1,3,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpiroleAntagonistactivityatdopamineD2receptorexpressedinHEK293cellsbyby[35S]GTPgammaSbindingassayinpresenceofquinpirole,ChEMBL,610,11,2,9,4.8,COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,10.1016/j.bmc.2009.06.019
155555298,173617,0,None,-,1,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,325,1,1,5,2.8,COc1cc2c(cc1O)CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
CHEMBL4551037,173617,0,None,-,1,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,325,1,1,5,2.8,COc1cc2c(cc1O)CC1c3cc4c(cc3CCN1C2)OCO4,10.1016/j.bmc.2019.04.014
10021692,145715,9,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,364,10,1,4,3,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,10.1016/j.bmcl.2008.07.065
CHEMBL392158,145715,9,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,364,10,1,4,3,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,10.1016/j.bmcl.2008.07.065
137629731,160473,0,None,1,2,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,446,4,0,6,4.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
CHEMBL4096467,160473,0,None,1,2,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,446,4,0,6,4.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
CHEMBL4117548,160473,0,None,1,2,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,446,4,0,6,4.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
37459,730,8,None,-3,4,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulationAntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulation,ChEMBL,361,0,1,2,4.8,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C,10.1021/jm401895u
62,730,8,None,-3,4,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulationAntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulation,ChEMBL,361,0,1,2,4.8,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C,10.1021/jm401895u
CHEMBL8514,730,8,None,-3,4,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulationAntagonistactivityathumanrecombinantatD2Sreceptorassessedasinhibitionofdopamine-inducedcAMPaccumulation,ChEMBL,361,0,1,2,4.8,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C,10.1021/jm401895u
52949583,18412,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.9,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1C,10.1016/j.ejmech.2010.07.056
CHEMBL1276763,18412,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,334,7,2,4,2.9,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1C,10.1016/j.ejmech.2010.07.056
15057516,155225,0,None,-1,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4060678,155225,0,None,-1,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
137635294,155415,0,None,3,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,445,4,0,7,3.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
CHEMBL4062992,155415,0,None,3,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,445,4,0,7,3.4,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(F)F,10.1016/j.bmc.2017.07.040
13493789,18397,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,1,4,2.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(C)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276645,18397,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,6,1,4,2.2,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(C)c1OC,10.1016/j.ejmech.2010.07.056
145981408,165800,0,None,-2,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,435,6,0,5,3.6,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3ccsc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4278581,165800,0,None,-2,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,435,6,0,5,3.6,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3ccsc23)CC1,10.1016/j.ejmech.2017.12.099
129186528,156780,0,None,2,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,442,4,0,6,4.2,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
CHEMBL4079251,156780,0,None,2,3,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,442,4,0,6,4.2,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
52944077,18396,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,5,2,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276616,18396,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,370,5,2,4,2.7,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
52945902,18367,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,374,5,1,3,3.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Br,10.1016/j.ejmech.2010.07.056
CHEMBL1276374,18367,0,None,-,1,Human,8.3,pIC50,=,8.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,374,5,1,3,3.3,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Br,10.1016/j.ejmech.2010.07.056
155538443,171666,0,None,2,2,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,295,0,1,4,2.8,Oc1ccc2c(c1)CN1CCc3cc4c(cc3C1C2)OCO4,10.1016/j.bmc.2019.04.014
CHEMBL4476383,171666,0,None,2,2,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,295,0,1,4,2.8,Oc1ccc2c(c1)CN1CCc3cc4c(cc3C1C2)OCO4,10.1016/j.bmc.2019.04.014
145975214,163220,0,None,-2,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,436,8,1,5,3.7,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,10.1016/j.bmcl.2018.01.038
CHEMBL4207328,163220,0,None,-2,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,436,8,1,5,3.7,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,10.1016/j.bmcl.2018.01.038
145964982,163443,0,None,1,2,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4210128,163443,0,None,1,2,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
10092649,189826,47,None,-45,11,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,404,4,1,4,3.9,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
CHEMBL522460,189826,47,None,-45,11,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,404,4,1,4,3.9,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,10.1016/j.bmcl.2008.09.032
15565706,98751,0,None,288,2,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,292,6,1,4,1.9,CCN1CCC[C@H]1CNC(=O)c1c(OC)cccc1OC,10.1016/j.ejmech.2010.07.056
CHEMBL282024,98751,0,None,288,2,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,292,6,1,4,1.9,CCN1CCC[C@H]1CNC(=O)c1c(OC)cccc1OC,10.1016/j.ejmech.2010.07.056
145964622,163648,0,None,-1,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4212622,163648,0,None,-1,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,452,9,1,6,4.3,O=C(NC1CC1)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
145986552,166043,0,None,-11,3,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.8,O=C1c2ccc(Cl)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4283369,166043,0,None,-11,3,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,453,6,0,5,4.8,O=C1c2ccc(Cl)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
127051038,139653,0,None,-2,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,421,8,1,4,4.1,NC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3806169,139653,0,None,-2,3,Human,7.3,pIC50,=,7.3,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,421,8,1,4,4.1,NC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
44309510,101560,0,None,-1,2,Human,7.3,pIC50,=,7.3,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,531,7,1,3,4.9,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm040190e
CHEMBL302374,101560,0,None,-1,2,Human,7.3,pIC50,=,7.3,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,531,7,1,3,4.9,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,10.1021/jm040190e
1353,1858,83,None,-5,28,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2012.12.016
3559,1858,83,None,-5,28,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2012.12.016
86,1858,83,None,-5,28,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2012.12.016
CHEMBL54,1858,83,None,-5,28,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2012.12.016
DB00502,1858,83,None,-5,28,Human,6.3,pIC50,=,6.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassayAntagonistactivityatdopamineD2receptor(unknownorigin)expressedinHEK293cellsassessedasinhibitionof[35S]GTPgammaSbindingbyscintillationproximityassay,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1016/j.bmc.2012.12.016
129186531,155476,0,None,-6,2,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,8,2.3,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL4063748,155476,0,None,-6,2,Human,5.3,pIC50,=,5.3,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,8,2.3,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2,10.1016/j.bmc.2017.07.040
52947124,18404,0,None,-,1,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1c(Br)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276710,18404,0,None,-,1,Human,7.3,pIC50,=,7.3,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1c(Br)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
52941038,18374,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,390,5,2,4,3,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276427,18374,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,390,5,2,4,3,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Cl)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
127049850,139576,0,None,23,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,469,8,1,4,5,CNC(=O)c1ccc(Cl)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805327,139576,0,None,23,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,469,8,1,4,5,CNC(=O)c1ccc(Cl)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
11696813,187173,9,None,-5,3,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,391,7,1,4,4.1,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,10.1021/jm800689g
CHEMBL496739,187173,9,None,-5,3,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,391,7,1,4,4.1,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,10.1021/jm800689g
145969167,164110,0,None,1,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4218526,164110,0,None,1,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
145964299,163434,0,None,-6,6,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4210030,163434,0,None,-6,6,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
71563084,87058,0,None,-1,2,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,409,3,2,5,3.9,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
CHEMBL2335736,87058,0,None,-1,2,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamineAntagonistactivityatdopamineD2receptor(unknownorigin)transfectedinCHOcellmembranesassessedasinhibitionofforskolin-stimulatedcAMPlevelafter10minsbyflashplateassayinpresenceofdopamine,ChEMBL,409,3,2,5,3.9,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2,10.1016/j.bmcl.2012.12.046
145990794,166101,0,None,1,6,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,3.8,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4284346,166101,0,None,1,6,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,3.8,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
137635725,155407,0,None,4,2,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,428,4,0,6,4.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
CHEMBL4062936,155407,0,None,4,2,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,428,4,0,6,4.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
135339817,180741,0,None,1,5,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,437,6,0,5,4.2,CN1CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2C1=O,10.1016/j.ejmech.2020.112709
CHEMBL4764679,180741,0,None,1,5,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsassessedasinhibitionofdopamine-inducedcalciumfluxincubatedfor60minsat37degCfollowedby15minsincubationatroomtemperatureandsubsequentdopamineadditionbycalcium4dyebasedFLIPRassay,ChEMBL,437,6,0,5,4.2,CN1CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2C1=O,10.1016/j.ejmech.2020.112709
145983928,165713,0,None,-1,6,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,435,6,0,5,3.6,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4277101,165713,0,None,-1,6,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,435,6,0,5,3.6,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
71541084,86618,0,None,-,1,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,327,2,1,4,3.6,Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326477,86618,0,None,-,1,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,327,2,1,4,3.6,Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL3946995,148929,0,None,-44,4,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassayAntagonisticactivityatD2receptor(unknownorigin)expressedinCHOK1cellsco-expressingG-alpha15assessedasinhibitionofdopamine-inducedcalciumfluxbyfluo-4dyebasedFLIPRassay,ChEMBL,438,6,1,6,4.4,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,10.1016/j.ejmech.2016.07.038
11224283,132859,0,None,-12,2,Human,7.2,pIC50,=,7.2,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,433,7,1,4,4.1,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm040190e
CHEMBL370713,132859,0,None,-12,2,Human,7.2,pIC50,=,7.2,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,433,7,1,4,4.1,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1021/jm040190e
156014350,176485,0,None,-52,3,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,443,6,0,7,3.6,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cc(F)cn12,10.1016/j.bmcl.2020.127027
CHEMBL4635414,176485,0,None,-52,3,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,443,6,0,7,3.6,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cc(F)cn12,10.1016/j.bmcl.2020.127027
155567118,175135,0,None,-,1,Human,5.2,pIC50,=,5.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,371,4,1,6,3.1,COc1cc2c(cc1OC)C1Cc3c(cc(OC)c(O)c3OC)CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL4585730,175135,0,None,-,1,Human,5.2,pIC50,=,5.2,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,371,4,1,6,3.1,COc1cc2c(cc1OC)C1Cc3c(cc(OC)c(O)c3OC)CN1CC2,10.1016/j.bmc.2019.04.014
52945904,18370,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,312,5,2,4,2.3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276399,18370,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,312,5,2,4,2.3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
145978208,162839,0,None,-10,3,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,451,9,1,7,3.6,O=C(NC1CC1)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4202871,162839,0,None,-10,3,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,451,9,1,7,3.6,O=C(NC1CC1)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
145965433,163408,0,None,1,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4209705,163408,0,None,1,2,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,440,9,1,6,4.2,CCNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
129186530,155549,0,None,-6,2,Human,5.2,pIC50,=,5.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,9,1.7,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4064609,155549,0,None,-6,2,Human,5.2,pIC50,=,5.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,9,1.7,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4751542,179624,0,None,-85,3,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,470,6,1,6,3.8,Nc1ccc2c(c1)N(CCCCN1CCN(c3cccc4sccc34)CC1)S(=O)(=O)CC2,10.1016/j.ejmech.2020.112572
15167693,18364,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,304,7,1,3,2.9,CCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
CHEMBL1276351,18364,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,304,7,1,3,2.9,CCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,10.1016/j.ejmech.2010.07.056
52944653,18393,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,386,6,2,5,2.4,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276587,18393,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,386,6,2,5,2.4,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
44182375,86627,0,None,-,1,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,233,2,2,4,2,CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1,10.1016/j.bmcl.2012.11.023
CHEMBL2326486,86627,0,None,-,1,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,233,2,2,4,2,CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1,10.1016/j.bmcl.2012.11.023
44427841,85627,0,None,-21,2,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.2,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
CHEMBL231156,85627,0,None,-21,2,Human,6.2,pIC50,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,494,7,1,4,5.2,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
156010510,176378,0,None,-70,3,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,426,6,0,8,2.8,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4633397,176378,0,None,-70,3,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,426,6,0,8,2.8,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2c(F)cccn12,10.1016/j.bmcl.2020.127027
52941042,18409,0,None,-,1,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,374,5,2,4,2.5,CCN1CCC[C@H]1CNC(=O)c1c(F)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276740,18409,0,None,-,1,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,374,5,2,4,2.5,CCN1CCC[C@H]1CNC(=O)c1c(F)c(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
2389,3250,110,None,-12,23,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,6,3.6,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,10.1016/j.bmc.2017.07.040
5073,3250,110,None,-12,23,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,6,3.6,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,10.1016/j.bmc.2017.07.040
96,3250,110,None,-12,23,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,6,3.6,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,10.1016/j.bmc.2017.07.040
CHEMBL85,3250,110,None,-12,23,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,6,3.6,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,10.1016/j.bmc.2017.07.040
DB00734,3250,110,None,-12,23,Human,8.2,pIC50,=,8.2,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,410,4,0,6,3.6,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2,10.1016/j.bmc.2017.07.040
145988038,166477,0,None,-4,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,413,6,0,5,4,CC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,10.1016/j.ejmech.2017.12.099
CHEMBL4291215,166477,0,None,-4,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,413,6,0,5,4,CC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,10.1016/j.ejmech.2017.12.099
9887463,200036,0,None,-1,2,Human,8.1,pIC50,=,8.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,403,6,1,3,4.1,O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,10.1021/jm040190e
CHEMBL71865,200036,0,None,-1,2,Human,8.1,pIC50,=,8.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,403,6,1,3,4.1,O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,10.1021/jm040190e
137646568,157262,0,None,-1,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,4,0,8,2.5,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
CHEMBL4084663,157262,0,None,-1,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,4,0,8,2.5,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
242,467,113,None,-6,12,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2012.11.023
34,467,113,None,-6,12,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2012.11.023
60795,467,113,None,-6,12,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2012.11.023
CHEMBL1112,467,113,None,-6,12,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2012.11.023
DB01238,467,113,None,-6,12,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,10.1016/j.bmcl.2012.11.023
52941040,18385,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,5,2,4,2.2,CCN1CCC[C@H]1CNC(=O)c1c(C)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276528,18385,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,306,5,2,4,2.2,CCN1CCC[C@H]1CNC(=O)c1c(C)c(C)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
137640522,156406,0,None,11,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,4,0,7,3.3,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
CHEMBL4074373,156406,0,None,11,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,4,0,7,3.3,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2F,10.1016/j.bmc.2017.07.040
52948326,18407,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,418,5,1,3,3.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1Br,10.1016/j.ejmech.2010.07.056
CHEMBL1276738,18407,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,418,5,1,3,3.4,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1Br,10.1016/j.ejmech.2010.07.056
127049861,139581,0,None,1,3,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1ccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1016/j.bmcl.2016.04.087
CHEMBL3805376,139581,0,None,1,3,Human,7.2,pIC50,=,7.2,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.3,CNC(=O)c1ccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,10.1016/j.bmcl.2016.04.087
52944655,18403,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,342,6,2,5,2.3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276709,18403,0,None,-,1,Human,7.2,pIC50,=,7.2,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,342,6,2,5,2.3,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(OC)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
129186549,158168,0,None,-9,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,4,1,6,4,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4094926,158168,0,None,-9,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,4,1,6,4,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
90899701,169019,0,None,5,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,313,1,3,5,2.5,COc1ccc2c(c1O)CN1CCc3cc(O)c(O)cc3C1C2,10.1016/j.bmc.2019.04.014
CHEMBL4438471,169019,0,None,5,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,313,1,3,5,2.5,COc1ccc2c(c1O)CN1CCc3cc(O)c(O)cc3C1C2,10.1016/j.bmc.2019.04.014
44309509,95985,0,None,-2,2,Human,7.1,pIC50,=,7.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,457,7,1,5,4.3,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,10.1021/jm040190e
CHEMBL262724,95985,0,None,-2,2,Human,7.1,pIC50,=,7.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,457,7,1,5,4.3,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,10.1021/jm040190e
71540967,86628,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,219,0,2,4,1.6,Nc1nc2cc3c(cc2s1)CCNCC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326487,86628,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,219,0,2,4,1.6,Nc1nc2cc3c(cc2s1)CCNCC3,10.1016/j.bmcl.2012.11.023
CHEMBL4749223,179437,0,None,-28,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethodAntagonistactivityatD2receptor(unknownorigin)preincubatedfor60minsfollowedbyadditionofEu-cAMPandmeasuredafter60minsbyplatereadermethod,ChEMBL,448,7,0,7,4.2,COc1ccc2ncc(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)c2c1,10.1016/j.ejmech.2020.112572
145946714,166850,0,None,4,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4213352,166850,0,None,4,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4300399,166850,0,None,4,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1,10.1016/j.bmcl.2018.04.059
71541080,86633,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,304,2,1,5,1.4,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
CHEMBL2326492,86633,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,304,2,1,5,1.4,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,10.1016/j.bmcl.2012.11.023
71508866,85968,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,543,6,0,9,4.6,COc1cc(/C=C/C(=O)Oc2c(OC)ccc3c2CN2CCc4cc5c(cc4C2C3)OCO5)ccc1OC(C)=O,10.1016/j.bmc.2019.04.014
CHEMBL2314740,85968,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,543,6,0,9,4.6,COc1cc(/C=C/C(=O)Oc2c(OC)ccc3c2CN2CCc4cc5c(cc4C2C3)OCO5)ccc1OC(C)=O,10.1016/j.bmc.2019.04.014
145974939,163999,0,None,-11,3,Human,8.1,pIC50,=,8.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,442,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sc(F)cc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
CHEMBL4217182,163999,0,None,-11,3,Human,8.1,pIC50,=,8.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,442,8,1,6,3.8,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sc(F)cc34)CC2)ccn1,10.1016/j.bmcl.2018.01.038
115237,55238,108,None,-1,2,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,7,3.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL1621,55238,108,None,-1,2,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,426,4,1,7,3.1,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
137659145,158743,0,None,7,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,443,4,0,7,3.6,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
CHEMBL4101115,158743,0,None,7,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,443,4,0,7,3.6,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2Cl,10.1016/j.bmc.2017.07.040
11223885,70281,0,None,-8,2,Human,8.1,pIC50,=,8.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,419,6,2,4,3.8,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,10.1021/jm040190e
CHEMBL195057,70281,0,None,-8,2,Human,8.1,pIC50,=,8.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,419,6,2,4,3.8,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,10.1021/jm040190e
14762911,18377,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276459,18377,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,356,5,2,4,2.4,CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(O)c1OC,10.1016/j.ejmech.2010.07.056
145991244,166103,0,None,1,2,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,411,6,0,5,3.4,CC1(C)C2C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)C21,10.1016/j.ejmech.2017.12.099
CHEMBL4284353,166103,0,None,1,2,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,411,6,0,5,3.4,CC1(C)C2C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)C21,10.1016/j.ejmech.2017.12.099
145993172,166297,0,None,-14,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,6,0,5,3.8,O=C1C2CC=CCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4287980,166297,0,None,-14,3,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,423,6,0,5,3.8,O=C1C2CC=CCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
127049862,139598,0,None,1,6,Human,8.1,pIC50,=,8.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,425,8,1,5,4.4,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805559,139598,0,None,1,6,Human,8.1,pIC50,=,8.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,425,8,1,5,4.4,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
21604779,18371,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,308,6,2,5,1.6,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
CHEMBL1276400,18371,0,None,-,1,Human,8.1,pIC50,=,8.1,Functional,AntagonistactivityatdopamineD2receptorAntagonistactivityatdopamineD2receptor,ChEMBL,308,6,2,5,1.6,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(O)c1OC,10.1016/j.ejmech.2010.07.056
137645295,157035,0,None,-8,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,440,4,1,7,3.3,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
CHEMBL4082084,157035,0,None,-8,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,440,4,1,7,3.3,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(C)O,10.1016/j.bmc.2017.07.040
145989181,166529,0,None,1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,3.8,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2ccc3ccsc3c2)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4292250,166529,0,None,1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,5,3.8,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2ccc3ccsc3c2)CC1,10.1016/j.ejmech.2017.12.099
145989183,166531,0,None,-7,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,473,7,0,5,4.4,Cc1ccc(C23CC2C(=O)N(CCCCN2CCN(c4cccc5sccc45)CC2)C3=O)cc1,10.1016/j.ejmech.2017.12.099
CHEMBL4292254,166531,0,None,-7,3,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,473,7,0,5,4.4,Cc1ccc(C23CC2C(=O)N(CCCCN2CCN(c4cccc5sccc45)CC2)C3=O)cc1,10.1016/j.ejmech.2017.12.099
11477180,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
6675,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
CHEMBL180010,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm0704200
11477180,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
6675,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
CHEMBL180010,2996,3,None,-26,2,Human,7.1,pIC50,=,7.1,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,480,7,1,4,5.2,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl,10.1021/jm040190e
71541179,86624,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,10.1016/j.bmcl.2012.11.023
CHEMBL2326483,86624,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,310,2,1,5,2.9,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,10.1016/j.bmcl.2012.11.023
145947937,167015,0,None,-1,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4207653,167015,0,None,-1,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
CHEMBL4302655,167015,0,None,-1,4,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassayAntagonistactivityathumanD2receptorexpressedinCHO-K1cellsco-expressingGalphaqi5assessedasdecreaseinapomorphine-inducedcalciummobilizationpreincubatedfor30minsfollowedbyapomorphinechallengemeasuredfor30secsbyaequorin-derivedluminescenceassay,ChEMBL,398,9,0,5,3.8,COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1,10.1016/j.bmcl.2018.04.059
145976348,163043,0,None,-1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1cncc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4205326,163043,0,None,-1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1cncc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
145976732,162811,0,None,-7,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
CHEMBL4202443,162811,0,None,-7,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,424,8,1,6,3.6,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
71500036,86613,0,None,-,1,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,313,2,1,6,2.2,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,10.1016/j.bmcl.2012.11.023
CHEMBL2326472,86613,0,None,-,1,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,313,2,1,6,2.2,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,10.1016/j.bmcl.2012.11.023
137630811,160416,0,None,1,3,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,504,6,1,7,4.5,Cc1ccc(Sc2ccccc2N2CCN(CCc3c(C)nc4n(c3=O)CCCC4O)CC2)c(C)c1,10.1016/j.bmc.2017.07.040
CHEMBL4082150,160416,0,None,1,3,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,504,6,1,7,4.5,Cc1ccc(Sc2ccccc2N2CCN(CCc3c(C)nc4n(c3=O)CCCC4O)CC2)c(C)c1,10.1016/j.bmc.2017.07.040
CHEMBL4117087,160416,0,None,1,3,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,504,6,1,7,4.5,Cc1ccc(Sc2ccccc2N2CCN(CCc3c(C)nc4n(c3=O)CCCC4O)CC2)c(C)c1,10.1016/j.bmc.2017.07.040
44427836,143296,0,None,-20,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,498,8,2,5,4.4,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
CHEMBL390253,143296,0,None,-20,2,Human,7.1,pIC50,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassayAntagonistactivityathumandopamineD2receptorexpressedinHEK293cellsbymitogenesisassay,ChEMBL,498,8,2,5,4.4,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm0704200
155522744,170095,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,371,4,1,6,3.1,COc1cc2c(cc1OC)C1Cc3c(cc(O)c(OC)c3OC)CN1CC2,10.1016/j.bmc.2019.04.014
CHEMBL4453330,170095,0,None,-,1,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassayAntagonistactivityatD2receptor(unknownorigin)expressedinCHOK1cellsassessedasinhibitionofdopamine-inducedcalciumfluxpreincubatedfor60minsat37degCfollowedby15minsincubationunderroomtemperatureandsubsequentdopamineadditionmeasuredafter20secsfor100secsbycalcium-4dyebasedFLIPRassay,ChEMBL,371,4,1,6,3.1,COc1cc2c(cc1OC)C1Cc3c(cc(O)c(OC)c3OC)CN1CC2,10.1016/j.bmc.2019.04.014
145974143,163838,0,None,-1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1ccnc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
CHEMBL4215048,163838,0,None,-1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,443,8,1,7,3.2,CNC(=O)c1ccnc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,10.1016/j.bmcl.2018.01.038
127049848,139638,0,None,1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cc(C)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3806047,139638,0,None,1,3,Human,7.1,pIC50,=,7.1,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cc(C)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
146025814,172059,0,None,-6,2,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4513262,172059,0,None,-6,2,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
146025814,172059,0,None,-6,2,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
CHEMBL4513262,172059,0,None,-6,2,Human,5.1,pIC50,=,5.1,Functional,AntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassayAntagonistactivityatD2longreceptor(unknownorigin)transfectedinhumanHEK293TcellsassessedasincreaseincAMPaccumulationincubatedfor2hrsbycAMPGlo-sensorassay,ChEMBL,373,2,0,3,4.2,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,10.1021/acsmedchemlett.9b00575
129103318,166614,0,None,2,6,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,475,7,0,5,5,O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,10.1021/acs.jmedchem.8b01096
CHEMBL4293999,166614,0,None,2,6,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassayAntagonistactivityatdopamineD2receptorlongisoform(unknownorigin)expressedinHEK293cellsassessedasinhibitionofdopamine-inducedcalciumfluxafter15minsbycalcium4-dyebasedFLIPRassay,ChEMBL,475,7,0,5,5,O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,10.1021/acs.jmedchem.8b01096
44608359,156660,30,None,1,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,424,4,0,7,3.2,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
CHEMBL4077702,156660,30,None,1,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,424,4,0,7,3.2,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2=O,10.1016/j.bmc.2017.07.040
145975393,163076,0,None,14,2,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
CHEMBL4205772,163076,0,None,14,2,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyLanceUltracAMPassay,ChEMBL,426,8,1,6,3.8,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)n1,10.1016/j.bmcl.2018.01.038
145982353,165886,0,None,1,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,457,6,2,7,1.9,O=C1C2CC(O)C(O)CC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4280084,165886,0,None,1,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,457,6,2,7,1.9,O=C1C2CC(O)C(O)CC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,10.1016/j.ejmech.2017.12.099
129186563,160345,0,None,1,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,406,4,0,6,3.5,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCC=C2,10.1016/j.bmc.2017.07.040
CHEMBL4074326,160345,0,None,1,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,406,4,0,6,3.5,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCC=C2,10.1016/j.bmc.2017.07.040
CHEMBL4116465,160345,0,None,1,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,406,4,0,6,3.5,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCC=C2,10.1016/j.bmc.2017.07.040
145990482,166284,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,436,6,0,6,3,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3scnc23)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4287752,166284,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,436,6,0,6,3,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3scnc23)CC1,10.1016/j.ejmech.2017.12.099
137659728,158507,0,None,-3,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,4,1,8,2,Cc1nc2n(c(=O)c1CCN1CCN(c3noc4cc(F)ccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4098594,158507,0,None,-3,2,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,427,4,1,8,2,Cc1nc2n(c(=O)c1CCN1CCN(c3noc4cc(F)ccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
145992860,166173,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,6,2.2,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3c2OCCO3)CC1,10.1016/j.ejmech.2017.12.099
CHEMBL4285839,166173,0,None,-2,3,Human,8,pIC50,=,8,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,437,6,0,6,2.2,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3c2OCCO3)CC1,10.1016/j.ejmech.2017.12.099
127051041,139562,0,None,7,3,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,10.1016/j.bmcl.2016.04.087
CHEMBL3805120,139562,0,None,7,3,Human,8,pIC50,=,8,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,449,8,1,4,4.6,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,10.1016/j.bmcl.2016.04.087
71541176,86621,0,None,-,1,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,339,3,1,5,3.5,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,10.1016/j.bmcl.2012.11.023
CHEMBL2326480,86621,0,None,-,1,Human,6.1,pIC50,=,6.1,Functional,AntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassayAntagonistactivityathumanD2dopaminereceptorexpressedinCHOcellmembranebyGTPgammaS-bindingassay,ChEMBL,339,3,1,5,3.5,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,10.1016/j.bmcl.2012.11.023
127049866,139612,0,None,-17,3,Human,7,pIC50,=,7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,423,8,1,5,4.2,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805704,139612,0,None,-17,3,Human,7,pIC50,=,7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,423,8,1,5,4.2,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)c1,10.1016/j.bmcl.2016.04.087
72699817,114590,0,None,-1,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,343,4,1,4,4.5,CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,10.1016/j.bmc.2014.09.024
CHEMBL3344458,114590,0,None,-1,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpiroleAntagonistactivityatD2receptor(unknownorigin)after40minsby[35S]GTP-gammaSbindingassayinpresenceofquinpirole,ChEMBL,343,4,1,4,4.5,CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,10.1016/j.bmc.2014.09.024
9826580,199629,5,None,-14,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,482,8,1,4,5.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm040190e
CHEMBL69451,199629,5,None,-14,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,482,8,1,4,5.4,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,10.1021/jm040190e
156013716,176554,0,None,-7,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,441,6,0,7,4,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cccn12,10.1016/j.bmcl.2020.127027
CHEMBL4636321,176554,0,None,-7,3,Human,7,pIC50,=,7,Functional,AntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassayAntagonistactivityatD2receptor(unknownorigin)byHTRFcAMPassay,ChEMBL,441,6,0,7,4,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cccn12,10.1016/j.bmcl.2020.127027
10276451,195955,28,None,-19,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,461,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,10.1021/jm040190e
CHEMBL2112910,195955,28,None,-19,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,461,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,10.1021/jm040190e
CHEMBL59725,195955,28,None,-19,2,Human,7,pIC50,=,7,Functional,Mitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptorMitogenicstimulationorantagonismof30nMquinpirole-stimulatedmitogenesisinCHOcellsexpressinghumandopamineD2receptor,ChEMBL,461,7,1,4,5.5,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,10.1021/jm040190e
129186558,157855,0,None,-14,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3cncc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
CHEMBL4091554,157855,0,None,-14,3,Human,6,pIC50,=,6,Functional,AntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassayAntagonistactivityatdopamineD2receptor(unknownorigin)after60minsbyUltralancecAMPassay,ChEMBL,425,4,1,8,2.4,Cc1nc2n(c(=O)c1CCN1CCN(c3cncc4sccc34)CC1)CCCC2O,10.1016/j.bmc.2017.07.040
127050764,139602,0,None,10,2,Human,7,pIC50,=,7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.9,CC(=O)Nc1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
CHEMBL3805600,139602,0,None,10,2,Human,7,pIC50,=,7,Functional,AntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassayAntagonisticactivityathumandopamineD2receptormeasuredafter60minsbyUltraLancecAMPassay,ChEMBL,435,8,1,4,4.9,CC(=O)Nc1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,10.1016/j.bmcl.2016.04.087
4304615,131478,6,None,-,0,Human,4.7,pKd,=,4.7,Functional,CompetitiveantagonistactivityatrecombinanthumanD2LreceptorexpressedinFlp-InCHOcellsassessedasinhibitionofdopamine-inducedreductioninforskolinstimulatedcAMPaccumulationpreincubatedfor30minsfollowedbyforskolinstimulationandmeasuredafter30minsbyBRETassayCompetitiveantagonistactivityatrecombinanthumanD2LreceptorexpressedinFlp-InCHOcellsassessedasinhibitionofdopamine-inducedreductioninforskolinstimulatedcAMPaccumulationpreincubatedfor30minsfollowedbyforskolinstimulationandmeasuredafter30minsbyBRETassay,ChEMBL,274,1,1,5,2,c1nc(N2CCNCC2)c2c3c(sc2n1)CCCC3,10.1016/j.ejmech.2019.01.061
CHEMBL3696168,131478,6,None,-,0,Human,4.7,pKd,=,4.7,Functional,CompetitiveantagonistactivityatrecombinanthumanD2LreceptorexpressedinFlp-InCHOcellsassessedasinhibitionofdopamine-inducedreductioninforskolinstimulatedcAMPaccumulationpreincubatedfor30minsfollowedbyforskolinstimulationandmeasuredafter30minsbyBRETassayCompetitiveantagonistactivityatrecombinanthumanD2LreceptorexpressedinFlp-InCHOcellsassessedasinhibitionofdopamine-inducedreductioninforskolinstimulatedcAMPaccumulationpreincubatedfor30minsfollowedbyforskolinstimulationandmeasuredafter30minsbyBRETassay,ChEMBL,274,1,1,5,2,c1nc(N2CCNCC2)c2c3c(sc2n1)CCCC3,10.1016/j.ejmech.2019.01.061
11595240,139530,0,None,-,0,Human,9.9,pKi,=,9.9,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1,10.1021/jm051237e
CHEMBL380464,139530,0,None,-,0,Human,9.9,pKi,=,9.9,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1,10.1021/jm051237e
10014057,9665,0,None,-,0,Human,9.5,pKi,=,9.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL11363,9665,0,None,-,0,Human,9.5,pKi,=,9.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
10105311,9115,1,None,-,0,Human,9.3,pKi,=,9.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL11066,9115,1,None,-,0,Human,9.3,pKi,=,9.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
44408818,139508,1,None,-,0,Human,9.3,pKi,=,9.3,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,10.1021/jm051237e
CHEMBL380330,139508,1,None,-,0,Human,9.3,pKi,=,9.3,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,10.1021/jm051237e
44275616,98619,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,289,5,1,4,3.4,CCCN(CCC)[C@@H]1Cc2cccc3nc(S)n(c23)C1,10.1021/jm00062a001
CHEMBL281248,98619,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,289,5,1,4,3.4,CCCN(CCC)[C@@H]1Cc2cccc3nc(S)n(c23)C1,10.1021/jm00062a001
11573806,74988,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,311,2,0,3,3.3,COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2,10.1021/jm051237e
CHEMBL204065,74988,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,311,2,0,3,3.3,COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2,10.1021/jm051237e
46882007,6109,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,355,4,0,2,4.1,O=C1N(CCN2CCCCCC2)CCN1c1cc(Cl)cc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081309,6109,0,None,-,0,Human,9.2,pKi,=,9.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,355,4,0,2,4.1,O=C1N(CCN2CCCCCC2)CCN1c1cc(Cl)cc(Cl)c1,10.1016/j.bmcl.2010.01.090
44275766,99246,0,None,-,0,Human,9.1,pKi,=,9.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,339,3,1,2,3.2,CCN(CC)C(=O)N[C@@H]1C[C@@H]2c3cccc4c3C(=CC4)C[C@H]2N(C)C1,10.1021/jm00062a001
CHEMBL285341,99246,0,None,-,0,Human,9.1,pKi,=,9.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,339,3,1,2,3.2,CCN(CC)C(=O)N[C@@H]1C[C@@H]2c3cccc4c3C(=CC4)C[C@H]2N(C)C1,10.1021/jm00062a001
23653115,90494,0,None,-,0,Human,8.9,pKi,=,8.9,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,392,7,0,6,3,COc1ccccc1N1CCN(CCCCn2cnc3ccccc3c2=O)CC1,10.1016/j.bmc.2007.06.002
CHEMBL239700,90494,0,None,-,0,Human,8.9,pKi,=,8.9,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,392,7,0,6,3,COc1ccccc1N1CCN(CCCCn2cnc3ccccc3c2=O)CC1,10.1016/j.bmc.2007.06.002
44275362,98240,0,None,-,0,Human,8.9,pKi,=,8.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CCC2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL278285,98240,0,None,-,0,Human,8.9,pKi,=,8.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CCC2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
16090814,81087,0,None,-,0,Human,8.8,pKi,=,8.8,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,304,0,1,1,4.2,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm060213k
CHEMBL216258,81087,0,None,-,0,Human,8.8,pKi,=,8.8,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,304,0,1,1,4.2,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm060213k
46882051,6134,0,None,-,0,Human,8.8,pKi,=,8.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,355,4,0,2,3.8,O=C1N(CCN2CCCCCC2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081488,6134,0,None,-,0,Human,8.8,pKi,=,8.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,355,4,0,2,3.8,O=C1N(CCN2CCCCCC2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2010.01.090
131559,95855,4,None,8,2,Human,8.8,pKi,=,8.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,273,5,1,4,2.8,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1,10.1021/jm00062a001
CHEMBL1744080,95855,4,None,8,2,Human,8.8,pKi,=,8.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,273,5,1,4,2.8,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1,10.1021/jm00062a001
CHEMBL26181,95855,4,None,8,2,Human,8.8,pKi,=,8.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,273,5,1,4,2.8,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1,10.1021/jm00062a001
46882004,5501,0,None,-,1,Human,8,pKi,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1077344,5501,0,None,-,1,Human,8,pKi,=,8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
46882458,5874,0,None,-,2,Human,7,pKi,=,7,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,438,8,2,4,4.2,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,10.1016/j.bmcl.2009.09.027
CHEMBL1080046,5874,0,None,-,2,Human,7,pKi,=,7,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,438,8,2,4,4.2,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,10.1016/j.bmcl.2009.09.027
16123140,16079,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,384,6,1,3,4.2,CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,10.1016/j.bmcl.2010.07.073
CHEMBL1224697,16079,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,384,6,1,3,4.2,CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,10.1016/j.bmcl.2010.07.073
45271753,191235,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,417,9,0,4,3.8,COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,10.1016/j.bmcl.2009.06.043
CHEMBL554693,191235,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,417,9,0,4,3.8,COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,10.1016/j.bmcl.2009.06.043
44517726,191702,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,341,4,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL560177,191702,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,341,4,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
45271737,192197,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,2,4.5,CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,10.1016/j.bmcl.2009.06.043
CHEMBL563563,192197,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,2,4.5,CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,10.1016/j.bmcl.2009.06.043
44627127,5775,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1079461,5775,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
44627120,5940,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,10.1021/jm901319p
CHEMBL1080489,5940,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,10.1021/jm901319p
11225043,6120,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1081409,6120,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
44627351,6151,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081587,6151,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
44249745,191126,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,366,4,0,3,3.1,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL552373,191126,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,366,4,0,3,3.1,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL567286,191126,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,366,4,0,3,3.1,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
45267254,191668,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,332,4,0,3,2.8,N#Cc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL559856,191668,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,332,4,0,3,2.8,N#Cc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
44517726,191702,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,341,4,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL560177,191702,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,341,4,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
45273292,192057,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,3.9,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL562624,192057,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,3.9,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
52947694,17270,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,491,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)n1C,10.1021/jm100832d
CHEMBL1257809,17270,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,491,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)n1C,10.1021/jm100832d
52946432,17613,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,427,6,0,7,4,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(F)ccc43)C2)n1C,10.1021/jm100832d
CHEMBL1258949,17613,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,427,6,0,7,4,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(F)ccc43)C2)n1C,10.1021/jm100832d
44275155,98214,0,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,245,3,0,2,2.9,CCCN1CCC2Cc3c(cccc3OC)C[C@H]21,10.1021/jm00062a001
CHEMBL278091,98214,0,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,245,3,0,2,2.9,CCCN1CCC2Cc3c(cccc3OC)C[C@H]21,10.1021/jm00062a001
46882006,5743,0,None,-,1,Human,7,pKi,=,7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1ccc(Cl)cc1,10.1016/j.bmcl.2010.01.090
CHEMBL1079191,5743,0,None,-,1,Human,7,pKi,=,7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,321,4,0,2,3.5,O=C1N(CCN2CCCCCC2)CCN1c1ccc(Cl)cc1,10.1016/j.bmcl.2010.01.090
46881409,6654,1,None,-,1,Human,7,pKi,=,7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
CHEMBL1083814,6654,1,None,-,1,Human,7,pKi,=,7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,10.1016/j.bmcl.2010.01.090
16123464,16083,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,398,5,2,4,3.2,O=S(=O)(Nc1ccc([C@]23CNC[C@H]2C3)cc1)c1ccc(OC(F)(F)F)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1224701,16083,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,398,5,2,4,3.2,O=S(=O)(Nc1ccc([C@]23CNC[C@H]2C3)cc1)c1ccc(OC(F)(F)F)cc1,10.1016/j.bmcl.2010.07.073
11657494,94978,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,644,7,0,8,7.2,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
CHEMBL257369,94978,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,644,7,0,8,7.2,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
CHEMBL564948,192397,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,369,6,0,2,4.4,Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1,10.1016/j.bmcl.2009.06.043
44627351,6151,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081587,6151,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
44627240,6226,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1081966,6226,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
45271516,191209,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,384,4,0,3,3.2,N#Cc1cc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)ccc1F,10.1016/j.bmcl.2009.06.028
CHEMBL554073,191209,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,384,4,0,3,3.2,N#Cc1cc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)ccc1F,10.1016/j.bmcl.2009.06.028
45269000,191573,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,347,4,0,3,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1,10.1016/j.bmcl.2009.06.028
CHEMBL559004,191573,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,347,4,0,3,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1,10.1016/j.bmcl.2009.06.028
24758834,17472,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
CHEMBL1258492,17472,0,None,-,0,Human,6,pKi,=,6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
23630902,92296,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,524,7,0,8,5.9,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
CHEMBL243707,92296,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,524,7,0,8,5.9,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
23631636,92333,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,484,7,0,8,4.9,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C#N)cc4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243896,92333,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,484,7,0,8,4.9,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C#N)cc4)n2C)CC3)no1,10.1021/jm0705612
23631368,92425,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,460,7,0,8,4.4,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccncc4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244085,92425,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,460,7,0,8,4.4,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccncc4)n2C)CC3)no1,10.1021/jm0705612
135846033,152193,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,498,7,1,7,5.5,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cc5ccccc5[nH]4)n2C)CC3)o1,10.1021/jm0705612
CHEMBL397429,152193,0,None,-,0,Human,6,pKi,=,6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,498,7,1,7,5.5,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cc5ccccc5[nH]4)n2C)CC3)o1,10.1021/jm0705612
121315244,148916,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,473,7,0,6,5.3,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,10.1021/acs.jmedchem.6b00972
CHEMBL3946901,148916,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,473,7,0,6,5.3,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,10.1021/acs.jmedchem.6b00972
146755240,185644,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,341,1,1,3,4.9,CN1CC=C(C2=Nc3cc(F)ccc3Nc3ccc(Cl)cc32)CC1,10.1016/j.bmcl.2021.127911
CHEMBL4875709,185644,0,None,-,0,Human,7,pKi,=,7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,341,1,1,3,4.9,CN1CC=C(C2=Nc3cc(F)ccc3Nc3ccc(Cl)cc32)CC1,10.1016/j.bmcl.2021.127911
10014056,99317,1,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,10.1021/jm00062a001
CHEMBL285873,99317,1,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,10.1021/jm00062a001
18988835,79093,0,None,-,0,Human,8,pKi,=,8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CCC2Cc3c(O)cccc3CC21,10.1021/jm00062a001
CHEMBL2114337,79093,0,None,-,0,Human,8,pKi,=,8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CCC2Cc3c(O)cccc3CC21,10.1021/jm00062a001
9882257,192427,1,None,-,1,Human,8,pKi,=,8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,203,0,2,2,2.2,Oc1cccc2c1CC[C@@H]1NCCC[C@@H]21,10.1021/jm00062a001
CHEMBL56519,192427,1,None,-,1,Human,8,pKi,=,8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,203,0,2,2,2.2,Oc1cccc2c1CC[C@@H]1NCCC[C@@H]21,10.1021/jm00062a001
121304569,145543,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,539,8,0,7,6.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1,10.1021/acs.jmedchem.6b00972
CHEMBL3920167,145543,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,539,8,0,7,6.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1,10.1021/acs.jmedchem.6b00972
134150637,150895,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,522,7,1,6,4.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1,10.1021/acs.jmedchem.6b00972
CHEMBL3963243,150895,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,522,7,1,6,4.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1,10.1021/acs.jmedchem.6b00972
44627242,6014,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1080846,6014,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
44627359,6211,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081868,6211,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1204409,6211,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
45269020,191748,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,467,4,0,2,3.8,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(I)c1,10.1016/j.bmcl.2009.06.028
CHEMBL560574,191748,0,None,-,0,Human,7.9,pKi,=,7.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,467,4,0,2,3.8,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(I)c1,10.1016/j.bmcl.2009.06.028
121304437,150296,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,478,7,0,5,6.2,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,10.1021/acs.jmedchem.6b00972
CHEMBL3958201,150296,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,478,7,0,5,6.2,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,10.1021/acs.jmedchem.6b00972
44626929,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1079481,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
11996304,15006,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1210614,15006,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
44626929,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.07.073
CHEMBL1079481,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.07.073
16123353,15811,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,370,7,2,3,3.7,CCCCc1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223601,15811,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,370,7,2,3,3.7,CCCCc1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL563274,192154,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,389,6,0,2,4.7,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,10.1016/j.bmcl.2009.06.043
CHEMBL563435,192179,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,385,7,0,3,4.1,COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,10.1016/j.bmcl.2009.06.043
24815883,197131,0,None,-,1,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,373,3,0,3,5,Cn1c(CN2CCC(c3cccc(C(F)(F)F)c3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL604993,197131,0,None,-,1,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,373,3,0,3,5,Cn1c(CN2CCC(c3cccc(C(F)(F)F)c3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
44626929,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079481,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
44627033,5844,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,10.1021/jm901319p
CHEMBL1079837,5844,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,10.1021/jm901319p
44627355,5862,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
CHEMBL1079938,5862,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
44627025,6256,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1082106,6256,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,10.1021/jm901319p
44626929,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm100832d
CHEMBL1079481,5780,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm100832d
49781255,17543,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(Br)ccc43)C2)n1C,10.1021/jm100832d
CHEMBL1258712,17543,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(Br)ccc43)C2)n1C,10.1021/jm100832d
23630602,92328,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,479,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCC(C)CC4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243860,92328,0,None,-,0,Human,6.9,pKi,=,6.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,479,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCC(C)CC4)n2C)CC3)no1,10.1021/jm0705612
44626738,5798,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,485,8,0,7,5.1,COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,10.1021/jm901319p
CHEMBL1079578,5798,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,485,8,0,7,5.1,COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,10.1021/jm901319p
44626734,6088,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081237,6088,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
45273273,192149,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,3,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1c1csc2ccccc12,10.1016/j.bmcl.2009.06.028
CHEMBL563247,192149,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,3,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1c1csc2ccccc12,10.1016/j.bmcl.2009.06.028
23631172,91704,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,467,7,0,8,4.3,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCOCC4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL242598,91704,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,467,7,0,8,4.3,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCOCC4)n2C)CC3)no1,10.1021/jm0705612
23630901,92586,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,462,7,0,8,4.4,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccn4C)n2C)CC3)o1,10.1021/jm0705612
CHEMBL244277,92586,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,462,7,0,8,4.4,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccn4C)n2C)CC3)o1,10.1021/jm0705612
44428207,92589,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,477,7,0,7,5.2,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(F)c4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244280,92589,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,477,7,0,7,5.2,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(F)c4)n2C)CC3)no1,10.1021/jm0705612
23631544,92748,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,490,8,0,9,4.4,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cn1,10.1021/jm0705612
CHEMBL244945,92748,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,490,8,0,9,4.4,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cn1,10.1021/jm0705612
6604756,98284,10,None,-,1,Human,7.9,pKi,=,7.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,275,6,0,2,4.2,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,10.1021/jm00062a001
CHEMBL278751,98284,10,None,-,1,Human,7.9,pKi,=,7.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,275,6,0,2,4.2,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,10.1021/jm00062a001
121315197,144065,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,491,8,0,7,5.5,Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3908862,144065,0,None,-,0,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,491,8,0,7,5.5,Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
147230103,179412,0,None,-,2,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,323,1,1,3,4.8,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,10.1016/j.bmcl.2021.127911
CHEMBL4748915,179412,0,None,-,2,Human,5.9,pKi,=,5.9,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,323,1,1,3,4.8,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,10.1016/j.bmcl.2021.127911
122334,319,17,None,-,0,Human,7.9,pKi,=,7.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,233,4,1,2,3.1,CCCN[C@@H]1CCc2c([C@@H]1C)cccc2OC,10.1021/jm00062a001
970,319,17,None,-,0,Human,7.9,pKi,=,7.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,233,4,1,2,3.1,CCCN[C@@H]1CCc2c([C@@H]1C)cccc2OC,10.1021/jm00062a001
CHEMBL27441,319,17,None,-,0,Human,7.9,pKi,=,7.9,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,233,4,1,2,3.1,CCCN[C@@H]1CCc2c([C@@H]1C)cccc2OC,10.1021/jm00062a001
9799123,5516,0,None,-61,2,Human,6.9,pKi,=,6.9,Functional,DopamineD2receptorfunctionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecellsDopamineD2receptorfunctionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecells,ChEMBL,363,4,0,3,3.1,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,10.1016/s0960-894x(02)00655-8
CHEMBL107742,5516,0,None,-61,2,Human,6.9,pKi,=,6.9,Functional,DopamineD2receptorfunctionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecellsDopamineD2receptorfunctionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecells,ChEMBL,363,4,0,3,3.1,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,10.1016/s0960-894x(02)00655-8
11504077,168114,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,488,7,0,9,4.6,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(C)(F)F)nc4c3CC2)n1C,10.1016/j.bmcl.2007.12.042
CHEMBL437792,168114,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,488,7,0,9,4.6,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(C)(F)F)nc4c3CC2)n1C,10.1016/j.bmcl.2007.12.042
45271738,191059,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,423,5,0,2,5.2,C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
CHEMBL551927,191059,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,423,5,0,2,5.2,C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
24849462,195430,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,339,3,0,3,4.6,Cn1c(CN2CCC(c3ccc(Cl)cc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL593744,195430,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,339,3,0,3,4.6,Cn1c(CN2CCC(c3ccc(Cl)cc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
45271510,191055,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.3,CC1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
CHEMBL551914,191055,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.3,CC1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
46882005,5742,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,307,3,0,2,3.1,CN1CCCCC1CN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2010.01.090
CHEMBL1079190,5742,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,307,3,0,2,3.1,CN1CCCCC1CN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2010.01.090
46881408,6653,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,339,4,0,2,3.6,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1083813,6653,0,None,-,1,Human,7.8,pKi,=,7.8,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,339,4,0,2,3.6,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2010.01.090
42626293,150455,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,349,6,0,3,3.2,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL395933,150455,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,349,6,0,3,3.2,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
14944884,99507,1,None,-,0,Human,6.8,pKi,=,6.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@H]2c3c(O)cccc3CC[C@H]21,10.1021/jm00062a001
CHEMBL287134,99507,1,None,-,0,Human,6.8,pKi,=,6.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@H]2c3c(O)cccc3CC[C@H]21,10.1021/jm00062a001
11996303,15000,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1210552,15000,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
11699340,94781,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,526,7,0,8,6.1,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
CHEMBL256481,94781,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,526,7,0,8,6.1,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
45270916,190726,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,348,6,0,4,3,Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,10.1016/j.bmcl.2009.06.043
CHEMBL549438,190726,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,348,6,0,4,3,Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,10.1016/j.bmcl.2009.06.043
44627131,5872,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1079980,5872,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,10.1021/jm901319p
44627123,5941,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1080490,5941,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,10.1021/jm901319p
44626632,6082,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,455,7,0,6,5.1,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081203,6082,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,455,7,0,6,5.1,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,10.1021/jm901319p
44627470,6119,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,8,0,8,4.6,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,10.1021/jm901319p
CHEMBL1081408,6119,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,8,0,8,4.6,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,10.1021/jm901319p
44626744,6171,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,458,7,0,5,5.3,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1,10.1021/jm901319p
CHEMBL1081686,6171,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,458,7,0,5,5.3,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1,10.1021/jm901319p
44626530,6223,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081934,6223,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,10.1021/jm901319p
44627240,6226,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1081966,6226,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
44627353,6258,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,10.1021/jm901319p
CHEMBL1082111,6258,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,10.1021/jm901319p
45268141,191674,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,425,5,0,3,4.1,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(OC(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
CHEMBL559919,191674,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,425,5,0,3,4.1,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(OC(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
45268142,191675,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,371,5,0,3,3.2,COc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL559920,191675,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,371,5,0,3,3.2,COc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
45267251,192113,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL562983,192113,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(F)c(Cl)c1,10.1016/j.bmcl.2009.06.028
45268119,192408,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)ccc1F,10.1016/j.bmcl.2009.06.028
CHEMBL565031,192408,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)ccc1F,10.1016/j.bmcl.2009.06.028
23631093,92053,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,439,6,0,7,4.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)(C)C)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243474,92053,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,439,6,0,7,4.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)(C)C)n2C)CC3)no1,10.1021/jm0705612
23631458,92337,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,451,6,0,7,4.4,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(F)(F)F)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243900,92337,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,451,6,0,7,4.4,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(F)(F)F)n2C)CC3)no1,10.1021/jm0705612
CHEMBL564347,192323,0,None,-,0,Human,5.8,pKi,=,5.8,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,399,6,0,4,3.8,CN(CCN1CCN(c2ccc3c(c2)OCO3)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,10.1016/j.bmcl.2009.06.043
44627242,6014,0,None,-,0,Human,5.8,pKi,=,5.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1080846,6014,0,None,-,0,Human,5.8,pKi,=,5.8,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
121315401,152437,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,478,7,0,6,5.9,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1,10.1021/acs.jmedchem.6b00972
CHEMBL3976319,152437,0,None,-,0,Human,6.8,pKi,=,6.8,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,478,7,0,6,5.9,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1,10.1021/acs.jmedchem.6b00972
10466962,98574,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21,10.1021/jm00062a001
CHEMBL280955,98574,0,None,-,0,Human,7.8,pKi,=,7.8,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21,10.1021/jm00062a001
9820304,101507,0,None,-10,2,Human,6.7,pKi,=,6.7,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,360,4,0,2,4.9,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,10.1021/jm990562x
CHEMBL1204116,101507,0,None,-10,2,Human,6.7,pKi,=,6.7,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,360,4,0,2,4.9,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,10.1021/jm990562x
CHEMBL302075,101507,0,None,-10,2,Human,6.7,pKi,=,6.7,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,360,4,0,2,4.9,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,10.1021/jm990562x
121304574,142368,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,503,7,0,7,4.6,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1,10.1021/acs.jmedchem.6b00972
CHEMBL3894853,142368,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,503,7,0,7,4.6,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1,10.1021/acs.jmedchem.6b00972
4350931,168598,33,None,-,1,Human,7.7,pKi,=,7.7,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,290,0,1,1,3.8,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm060213k
CHEMBL441618,168598,33,None,-,1,Human,7.7,pKi,=,7.7,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,290,0,1,1,3.8,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm060213k
11623343,140180,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,283,0,2,3,2.7,CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1,10.1021/jm051237e
CHEMBL381936,140180,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,283,0,2,3,2.7,CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1,10.1021/jm051237e
11716438,140220,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2cc(O)ccc2CC1,10.1021/jm051237e
CHEMBL382010,140220,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2cc(O)ccc2CC1,10.1021/jm051237e
4350931,168598,33,None,-,1,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,290,0,1,1,3.8,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm051237e
CHEMBL441618,168598,33,None,-,1,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,290,0,1,1,3.8,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm051237e
CHEMBL558058,191488,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,423,6,0,2,5.1,CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,10.1016/j.bmcl.2009.06.043
44626530,6223,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081934,6223,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,479,8,0,8,4.4,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,10.1021/jm901319p
45272426,191125,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.3,CC1CCCN(CCN2CCN(c3cccc(Cl)c3)C2=O)C1,10.1016/j.bmcl.2009.06.028
CHEMBL552371,191125,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.3,CC1CCCN(CCN2CCN(c3cccc(Cl)c3)C2=O)C1,10.1016/j.bmcl.2009.06.028
46881466,7156,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,327,3,1,2,3.1,O=C1N(CC2CCCCN2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1085903,7156,0,None,-,0,Human,7.7,pKi,=,7.7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,327,3,1,2,3.1,O=C1N(CC2CCCCN2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2010.01.090
CHEMBL562948,192110,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,355,6,0,2,4.1,CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,10.1016/j.bmcl.2009.06.043
44627022,5816,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,395,7,0,7,3.5,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccccc3)C2)n1C,10.1021/jm901319p
CHEMBL1079667,5816,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,395,7,0,7,3.5,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccccc3)C2)n1C,10.1021/jm901319p
44627131,5872,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1079980,5872,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,10.1021/jm901319p
44626740,5886,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,489,7,0,6,5.7,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1080117,5886,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,489,7,0,6,5.7,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
44626632,6082,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,455,7,0,6,5.1,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081203,6082,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,455,7,0,6,5.1,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,10.1021/jm901319p
11397017,6210,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,460,7,0,7,4,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,10.1021/jm901319p
CHEMBL1081867,6210,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,460,7,0,7,4,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,10.1021/jm901319p
45268148,191764,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,350,5,0,3,2.6,CC(C)N1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
CHEMBL560715,191764,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,350,5,0,3,2.6,CC(C)N1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
52940788,17305,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,505,7,0,7,5.6,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)o1,10.1021/jm100832d
CHEMBL1257925,17305,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,505,7,0,7,5.6,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)o1,10.1021/jm100832d
52949300,17306,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,521,7,0,7,6.1,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)s1,10.1021/jm100832d
CHEMBL1257926,17306,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,521,7,0,7,6.1,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)s1,10.1021/jm100832d
49781040,17401,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,495,8,1,7,5.1,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4F)CC23)n1C,10.1021/jm100832d
CHEMBL1258268,17401,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,495,8,1,7,5.1,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4F)CC23)n1C,10.1021/jm100832d
23630606,91706,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,10.1021/jm0705612
CHEMBL242600,91706,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,10.1021/jm0705612
23631092,92587,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(Cl)c4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244278,92587,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(Cl)c4)n2C)CC3)no1,10.1021/jm0705612
46881412,6752,0,None,-,1,Human,6.7,pKi,=,6.7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,357,4,0,3,2.6,O=S1(=O)N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1084121,6752,0,None,-,1,Human,6.7,pKi,=,6.7,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,357,4,0,3,2.6,O=S1(=O)N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
44626637,6118,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081401,6118,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
23630903,150208,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,524,7,0,8,5.9,Cc1ccc2cc(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)ccc2n1,10.1021/jm0705612
CHEMBL395741,150208,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,524,7,0,8,5.9,Cc1ccc2cc(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)ccc2n1,10.1021/jm0705612
208951,82548,28,None,112,2,Human,8.7,pKi,=,8.7,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,385,4,1,4,4.1,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,10.1016/j.bmc.2010.01.040
CHEMBL218166,82548,28,None,112,2,Human,8.7,pKi,=,8.7,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,385,4,1,4,4.1,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,10.1016/j.bmc.2010.01.040
44275135,94297,0,None,-,0,Human,8.6,pKi,=,8.6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CCC2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL25359,94297,0,None,-,0,Human,8.6,pKi,=,8.6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CCC2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
11718008,74863,0,None,-,0,Human,8.6,pKi,=,8.6,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,349,1,0,2,4.6,COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
CHEMBL203734,74863,0,None,-,0,Human,8.6,pKi,=,8.6,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,349,1,0,2,4.6,COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
46882053,6136,0,None,-,1,Human,8.6,pKi,=,8.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1cccc(F)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081490,6136,0,None,-,1,Human,8.6,pKi,=,8.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1cccc(F)c1,10.1016/j.bmcl.2010.01.090
121304654,148208,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,530,8,1,7,4.7,Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3941520,148208,0,None,-,0,Human,5.7,pKi,=,5.7,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,530,8,1,7,4.7,Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
11500677,140186,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
CHEMBL381946,140186,1,None,-,0,Human,7.7,pKi,=,7.7,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
44266612,4406,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.9,CCCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
CHEMBL10207,4406,0,None,-,0,Human,6.7,pKi,=,6.7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.9,CCCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
44274739,91028,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL24050,91028,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.4,C=CCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
45273523,191347,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,413,6,0,3,4.5,COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,10.1016/j.bmcl.2009.06.043
CHEMBL556496,191347,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,413,6,0,3,4.5,COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,10.1016/j.bmcl.2009.06.043
45267480,192028,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,409,4,0,2,4.5,O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL562464,192028,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,409,4,0,2,4.5,O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
45268438,192208,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,295,6,0,2,2.9,CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.043
CHEMBL563635,192208,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,295,6,0,2,2.9,CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.043
CHEMBL565075,192413,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,347,4,0,2,3.7,O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
24815434,195368,0,None,-,2,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,305,3,0,3,4,Cn1c(CN2CCC(c3ccccc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL593196,195368,0,None,-,2,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,305,3,0,3,4,Cn1c(CN2CCC(c3ccccc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
45267270,191805,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.5,CC1CCCCN1CCN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.028
CHEMBL561054,191805,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,321,4,0,2,3.5,CC1CCCCN1CCN1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.028
46882009,6110,0,None,-,1,Human,7.6,pKi,=,7.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081311,6110,0,None,-,1,Human,7.6,pKi,=,7.6,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
121304649,149974,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,495,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3955505,149974,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,495,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
11996303,15000,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1210552,15000,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,10.1016/j.bmcl.2010.06.018
16123136,16069,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1224638,16069,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL560270,191712,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,369,6,0,2,4.4,Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,10.1016/j.bmcl.2009.06.043
45268345,191816,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,417,5,0,2,5.1,O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL561128,191816,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,417,5,0,2,5.1,O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
24815976,195431,0,None,-,2,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,373,3,0,3,5,Cn1c(CN2CCC(c3ccc(C(F)(F)F)cc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL593745,195431,0,None,-,2,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,373,3,0,3,5,Cn1c(CN2CCC(c3ccc(C(F)(F)F)cc3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
44627033,5844,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,10.1021/jm901319p
CHEMBL1079837,5844,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,10.1021/jm901319p
44627355,5862,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
CHEMBL1079938,5862,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
24743758,6046,11,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/jm901319p
CHEMBL1081023,6046,11,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/jm901319p
44627470,6119,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,8,0,8,4.6,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,10.1021/jm901319p
CHEMBL1081408,6119,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,8,0,8,4.6,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,10.1021/jm901319p
11397777,6184,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,7,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)s1,10.1021/jm901319p
CHEMBL1081746,6184,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,493,7,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)s1,10.1021/jm901319p
45271520,190786,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,400,6,0,4,2.9,CC(C)N1CCN(CCN2CCN(c3cccc(OC(F)(F)F)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
CHEMBL549894,190786,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,400,6,0,4,2.9,CC(C)N1CCN(CCN2CCN(c3cccc(OC(F)(F)F)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
45271491,190864,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4.3,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(Cl)c(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL550502,190864,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4.3,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(Cl)c(Cl)c1,10.1016/j.bmcl.2009.06.028
45272414,191122,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,389,5,0,2,4,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
CHEMBL552366,191122,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,389,5,0,2,4,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
45273272,191342,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,3,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2sccc2c1,10.1016/j.bmcl.2009.06.028
CHEMBL556478,191342,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,3,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2sccc2c1,10.1016/j.bmcl.2009.06.028
49780808,17118,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,8,1,7,4,Cc1ncoc1-c1nnc(SCCCNC2CC3CC3(c3ccccc3)C2)n1C,10.1021/jm100832d
CHEMBL1257335,17118,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,8,1,7,4,Cc1ncoc1-c1nnc(SCCCNC2CC3CC3(c3ccccc3)C2)n1C,10.1021/jm100832d
24758832,17508,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1ccc2c(c1)C1(CCC2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
CHEMBL1258605,17508,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1ccc2c(c1)C1(CCC2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
24758717,17544,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4c(Br)cccc43)C2)n1C,10.1021/jm100832d
CHEMBL1258713,17544,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4c(Br)cccc43)C2)n1C,10.1021/jm100832d
23631540,92327,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,451,7,0,7,5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCC4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243859,92327,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,451,7,0,7,5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCC4)n2C)CC3)no1,10.1021/jm0705612
23630497,92426,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,465,7,0,8,5.1,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244086,92426,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,465,7,0,8,5.1,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)no1,10.1021/jm0705612
23630797,92582,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,465,7,0,8,5.1,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)o1,10.1021/jm0705612
CHEMBL244275,92582,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,465,7,0,8,5.1,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)o1,10.1021/jm0705612
45272437,190846,0,None,-,0,Human,5.6,pKi,=,5.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,346,6,0,4,2,COc1cccc(N2CCN(CCN3CCN(C(C)C)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL550358,190846,0,None,-,0,Human,5.6,pKi,=,5.6,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,346,6,0,4,2,COc1cccc(N2CCN(CCN3CCN(C(C)C)CC3)C2=O)c1,10.1016/j.bmcl.2009.06.028
52940753,17269,0,None,-,0,Human,5.6,pKi,=,5.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4cccc(C(F)(F)F)c4)CC3C2)n1C,10.1021/jm100832d
CHEMBL1257808,17269,0,None,-,0,Human,5.6,pKi,=,5.6,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4cccc(C(F)(F)F)c4)CC3C2)n1C,10.1021/jm100832d
44436308,91239,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,417,6,0,3,4.3,O=C1c2ccccc2CN1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL240996,91239,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,417,6,0,3,4.3,O=C1c2ccccc2CN1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,10.1016/j.bmc.2007.06.002
11558247,74993,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,282,0,2,3,2.6,CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1,10.1021/jm051237e
CHEMBL204098,74993,0,None,-,0,Human,7.6,pKi,=,7.6,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,282,0,2,3,2.6,CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1,10.1021/jm051237e
9992499,72964,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,254,0,0,2,2.6,CN1CCc2ccccc2Cc2ccn(C)c2CC1,10.1021/jm050846j
CHEMBL201483,72964,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,254,0,0,2,2.6,CN1CCc2ccccc2Cc2ccn(C)c2CC1,10.1021/jm050846j
CHEMBL4868181,185133,0,None,-,0,Human,6.6,pKi,=,6.6,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,331,2,1,3,5,CCc1ccc2c(c1)C(C1=CCN(C)CC1)=Nc1cc(C)ccc1N2,10.1016/j.bmcl.2021.127911
10667433,148129,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,379,7,0,4,3.2,COc1ccccc1N1CCN(CCCCN2C(=O)Cc3ccccc32)CC1,10.1016/j.bmc.2007.06.002
CHEMBL394080,148129,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,379,7,0,4,3.2,COc1ccccc1N1CCN(CCCCN2C(=O)Cc3ccccc32)CC1,10.1016/j.bmc.2007.06.002
22849991,93730,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,339,1,2,2,3.4,Cc1[nH]c2cccc3c2c1C[C@@H]1C3C[C@H](NC(=O)C(C)(C)C)CN1C,10.1021/jm00062a001
CHEMBL25013,93730,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,339,1,2,2,3.4,Cc1[nH]c2cccc3c2c1C[C@@H]1C3C[C@H](NC(=O)C(C)(C)C)CN1C,10.1021/jm00062a001
45267491,191672,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,3,4.1,O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL559873,191672,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,3,4.1,O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
44275604,93681,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,284,5,0,3,3,CCCN(CCC)[C@@H]1Cc2cccc3ccc(=O)n(c23)C1,10.1021/jm00062a001
CHEMBL24978,93681,0,None,-,0,Human,8.5,pKi,=,8.5,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,284,5,0,3,3,CCCN(CCC)[C@@H]1Cc2cccc3ccc(=O)n(c23)C1,10.1021/jm00062a001
22849992,93837,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,359,1,2,2,3.7,CN1C[C@@H](NC(=O)C(C)(C)C)CC2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,10.1021/jm00062a001
CHEMBL25074,93837,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,359,1,2,2,3.7,CN1C[C@@H](NC(=O)C(C)(C)C)CC2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,10.1021/jm00062a001
45267471,192244,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,319,4,0,2,3.1,O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL563860,192244,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,319,4,0,2,3.1,O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
44627133,6225,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1081957,6225,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
11996304,15006,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
CHEMBL1210614,15006,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassayAntagonistactivityatdopamineD2receptorassessedasinhibitionofdopamine-induced[35S]GTPgammaSbindingbyFLIPRassay,ChEMBL,521,8,0,7,6.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,10.1016/j.bmcl.2010.06.018
45272616,192394,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,2,4.3,CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
CHEMBL564930,192394,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,375,4,0,2,4.3,CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
44627242,6014,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1080846,6014,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,10.1021/jm901319p
44627351,6151,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081587,6151,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
44627359,6211,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081868,6211,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1204409,6211,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
44627133,6225,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1081957,6225,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,463,7,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1021/jm901319p
45273266,191309,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(F)cc(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL556272,191309,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,359,4,0,2,3.7,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(F)cc(Cl)c1,10.1016/j.bmcl.2009.06.028
16123347,15808,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,355,5,1,3,3.6,CC(C)c1ccc(S(=O)(=O)Cc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223598,15808,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,355,5,1,3,3.6,CC(C)c1ccc(S(=O)(=O)Cc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
11584660,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.042
CHEMBL244946,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.042
44454190,97527,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1cc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2cn1,10.1016/j.bmcl.2007.12.066
CHEMBL273199,97527,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1cc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2cn1,10.1016/j.bmcl.2007.12.066
11584660,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1016/j.bmcl.2009.06.043
CHEMBL244946,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1016/j.bmcl.2009.06.043
45268333,190603,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,377,6,0,3,3.2,COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
CHEMBL541435,190603,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,377,6,0,3,3.2,COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,10.1016/j.bmcl.2009.06.043
45267492,192087,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,387,4,0,2,4.5,CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,10.1016/j.bmcl.2009.06.043
CHEMBL562833,192087,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,387,4,0,2,4.5,CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,10.1016/j.bmcl.2009.06.043
44627129,5776,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079462,5776,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
44627123,5941,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1080490,5941,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,10.1021/jm901319p
44626637,6118,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081401,6118,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
11751828,6172,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,6,5,Cc1ncccc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1081687,6172,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,6,5,Cc1ncccc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
44627468,6185,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,447,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,10.1021/jm901319p
CHEMBL1081747,6185,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,447,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,10.1021/jm901319p
11584660,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL244946,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm901319p
45268990,191608,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,365,6,0,3,3.7,CC(C)Oc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL559386,191608,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,365,6,0,3,3.7,CC(C)Oc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
45272434,193400,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,341,5,0,4,1.8,CC(C)N1CCN(CCN2CCN(c3cccc(C#N)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
CHEMBL571456,193400,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,341,5,0,4,1.8,CC(C)N1CCN(CCN2CCN(c3cccc(C#N)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
52941427,17234,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccc(C(F)(F)F)cc4)CC3C2)n1C,10.1021/jm100832d
CHEMBL1257686,17234,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccc(C(F)(F)F)cc4)CC3C2)n1C,10.1021/jm100832d
52947516,17235,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1021/jm100832d
CHEMBL1257687,17235,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,10.1021/jm100832d
24758830,17435,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,501,6,0,7,5,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4ccc(Br)cc43)C2)n1C,10.1021/jm100832d
CHEMBL1258381,17435,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,501,6,0,7,5,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4ccc(Br)cc43)C2)n1C,10.1021/jm100832d
24758947,17583,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,473,6,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(Cl)cc54)C3)n2C)s1,10.1021/jm100832d
CHEMBL1258834,17583,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,473,6,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(Cl)cc54)C3)n2C)s1,10.1021/jm100832d
23630499,92427,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4Cl)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244087,92427,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4Cl)n2C)CC3)no1,10.1021/jm0705612
11584660,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
CHEMBL244946,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
11584660,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTPgammaSfromhumanrecombinantdopamineD2receptorexpressedinCHOcellsafter30minsat10uMDisplacementof[35S]GTPgammaSfromhumanrecombinantdopamineD2receptorexpressedinCHOcellsafter30minsat10uM,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
CHEMBL244946,92749,5,None,-,5,Human,6.5,pKi,=,6.5,Functional,Displacementof[35S]GTPgammaSfromhumanrecombinantdopamineD2receptorexpressedinCHOcellsafter30minsat10uMDisplacementof[35S]GTPgammaSfromhumanrecombinantdopamineD2receptorexpressedinCHOcellsafter30minsat10uM,ChEMBL,537,7,0,8,5.6,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,10.1021/jm0705612
52947507,17194,0,None,-,0,Human,5.5,pKi,=,5.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,7,0,7,3.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccccc4)CC3C2)n1C,10.1021/jm100832d
CHEMBL1257565,17194,0,None,-,0,Human,5.5,pKi,=,5.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,7,0,7,3.9,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccccc4)CC3C2)n1C,10.1021/jm100832d
CHEMBL4855524,184320,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,333,2,1,4,4.4,COc1ccc2c(c1)C(C1=CCN(C)CC1)=Nc1cc(C)ccc1N2,10.1016/j.bmcl.2021.127911
11558055,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm051237e
CHEMBL1204122,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm051237e
CHEMBL201170,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm051237e
11558055,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm050846j
CHEMBL1204122,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm050846j
CHEMBL201170,72730,1,None,-,0,Human,7.5,pKi,=,7.5,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2ccc(O)cc2CC1,10.1021/jm050846j
121304441,151714,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,515,8,1,6,5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,10.1021/acs.jmedchem.6b00972
CHEMBL3970323,151714,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,515,8,1,6,5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,10.1021/acs.jmedchem.6b00972
42626289,147410,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,379,7,0,4,3.3,COc1ccccc1N1CCN(CCCCN2Cc3ccccc3C2=O)CC1,10.1016/j.bmc.2007.06.002
CHEMBL393492,147410,0,None,-,0,Human,7.5,pKi,=,7.5,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,379,7,0,4,3.3,COc1ccccc1N1CCN(CCCCN2Cc3ccccc3C2=O)CC1,10.1016/j.bmc.2007.06.002
CHEMBL4853957,184221,0,None,-,0,Human,6.5,pKi,=,6.5,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,355,2,1,3,5.3,CCN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CC1,10.1016/j.bmcl.2021.127911
16094699,81651,3,None,-,1,Human,5.5,pKi,=,5.5,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,309,4,1,3,3,Cc1cccc(C(=O)NCN2CCC(c3ccccn3)CC2)c1,10.1021/jm060662k
CHEMBL216794,81651,3,None,-,1,Human,5.5,pKi,=,5.5,Functional,AgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPRAgonistactivityathumanD2receptorinHEK293cellscoexpressingG-alpha-qo5byFLIPR,ChEMBL,309,4,1,3,3,Cc1cccc(C(=O)NCN2CCC(c3ccccn3)CC2)c1,10.1021/jm060662k
11493746,140659,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,335,0,1,2,4.3,CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1,10.1021/jm051237e
CHEMBL383451,140659,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,335,0,1,2,4.3,CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1,10.1021/jm051237e
23653176,90685,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,383,6,0,3,3.8,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL239917,90685,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,383,6,0,3,3.8,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,10.1016/j.bmc.2007.06.002
16090821,81339,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,304,0,1,1,4.2,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,10.1021/jm060213k
CHEMBL216439,81339,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,ActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassayActivityathumanD2LdopaminereceptorexpressedinHEK293cellsbycalciumfluorescenceassay,ChEMBL,304,0,1,1,4.2,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,10.1021/jm060213k
135398737,938,86,None,-95,37,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,326,0,1,4,3.7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,10.1016/j.bmcl.2021.127911
38,938,86,None,-95,37,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,326,0,1,4,3.7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,10.1016/j.bmcl.2021.127911
722,938,86,None,-95,37,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,326,0,1,4,3.7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,10.1016/j.bmcl.2021.127911
CHEMBL42,938,86,None,-95,37,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,326,0,1,4,3.7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,10.1016/j.bmcl.2021.127911
DB00363,938,86,None,-95,37,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,326,0,1,4,3.7,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,10.1016/j.bmcl.2021.127911
121304597,145757,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,441,7,0,6,4.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,10.1021/acs.jmedchem.6b00972
CHEMBL3921885,145757,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,441,7,0,6,4.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,10.1021/acs.jmedchem.6b00972
24815439,197605,0,None,-,2,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,323,3,0,3,4.1,Cn1c(CN2CCC(c3ccccc3F)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL607689,197605,0,None,-,2,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,323,3,0,3,4.1,Cn1c(CN2CCC(c3ccccc3F)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
46225581,197657,0,None,-,1,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,339,3,0,3,4.6,Cn1c(CN2CCC(c3cccc(Cl)c3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL608103,197657,0,None,-,1,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,339,3,0,3,4.6,Cn1c(CN2CCC(c3cccc(Cl)c3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
45268113,192406,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,391,5,0,3,3.8,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(OC(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
CHEMBL565017,192406,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,391,5,0,3,3.8,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(OC(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
45271511,193146,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,357,4,1,3,2.9,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL569846,193146,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,357,4,1,3,2.9,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(O)c1,10.1016/j.bmcl.2009.06.028
24758715,17582,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4ccc(Br)cc43)C2)n1C,10.1021/jm100832d
CHEMBL1258833,17582,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,487,6,0,7,4.6,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4ccc(Br)cc43)C2)n1C,10.1021/jm100832d
46882050,6133,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,317,5,0,3,2.8,COc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1081487,6133,0,None,-,0,Human,7.4,pKi,=,7.4,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,317,5,0,3,2.8,COc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,10.1016/j.bmcl.2010.01.090
11536995,138898,1,None,-,0,Human,7.4,pKi,=,7.4,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1cccc2c1Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
CHEMBL379662,138898,1,None,-,0,Human,7.4,pKi,=,7.4,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,281,1,0,2,3.3,COc1cccc2c1Cc1ccccc1CCN(C)CC2,10.1021/jm051237e
44266611,161672,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,"Compoundwasevaluatedforthebindingaffinityagainst[3H]U-86,170-labeleddopaminereceptorD2inclonedCHOcellsCompoundwasevaluatedforthebindingaffinityagainst[3H]U-86,170-labeleddopaminereceptorD2inclonedCHOcells",ChEMBL,307,4,0,2,4,COc1cccc2c1C1CCN(CCc3ccccc3)[C@H]1CC2,10.1021/jm00060a014
CHEMBL416519,161672,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,"Compoundwasevaluatedforthebindingaffinityagainst[3H]U-86,170-labeleddopaminereceptorD2inclonedCHOcellsCompoundwasevaluatedforthebindingaffinityagainst[3H]U-86,170-labeleddopaminereceptorD2inclonedCHOcells",ChEMBL,307,4,0,2,4,COc1cccc2c1C1CCN(CCc3ccccc3)[C@H]1CC2,10.1021/jm00060a014
46882520,5752,0,None,-,2,Human,6.4,pKi,=,6.4,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,430,5,2,4,3.8,Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1Cl,10.1016/j.bmcl.2009.09.027
CHEMBL1079311,5752,0,None,-,2,Human,6.4,pKi,=,6.4,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,430,5,2,4,3.8,Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1Cl,10.1016/j.bmcl.2009.09.027
143,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.042
143,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.066
5311096,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.042
5311096,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.066
CHEMBL85606,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.042
CHEMBL85606,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2007.12.066
11569996,94780,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,525,7,0,8,5.4,CCc1nn(C)c2cc3c(cc12)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
CHEMBL256477,94780,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,525,7,0,8,5.4,CCc1nn(C)c2cc3c(cc12)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
11585248,94782,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,604,8,0,8,6.8,CCc1nc2cc3c(c(Br)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
CHEMBL256482,94782,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,604,8,0,8,6.8,CCc1nc2cc3c(c(Br)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
143,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2009.06.043
5311096,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2009.06.043
CHEMBL85606,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1016/j.bmcl.2009.06.043
46225582,197284,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,362,3,0,5,4.6,Cn1c(CN2CCC(c3nc4ccccc4s3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL605831,197284,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,362,3,0,5,4.6,Cn1c(CN2CCC(c3nc4ccccc4s3)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
143,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm901319p
5311096,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm901319p
CHEMBL85606,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm901319p
44627129,5776,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079462,5776,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
44626527,5783,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,459,8,0,8,4.2,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,10.1021/jm901319p
CHEMBL1079494,5783,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,459,8,0,8,4.2,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,10.1021/jm901319p
11305766,5809,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,462,7,0,6,5.2,Cc1ccoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079639,5809,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,462,7,0,6,5.2,Cc1ccoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm901319p
44626734,6088,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081237,6088,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
45269860,190977,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,355,5,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1Cl,10.1016/j.bmcl.2009.06.028
CHEMBL551386,190977,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,355,5,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1Cl,10.1016/j.bmcl.2009.06.028
24758945,17086,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,457,6,0,7,4.8,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(F)cc54)C3)n2C)s1,10.1021/jm100832d
CHEMBL1257214,17086,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,457,6,0,7,4.8,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(F)cc54)C3)n2C)s1,10.1021/jm100832d
CHEMBL1257215,17087,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,479,7,0,7,6,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2ccc(C(C)(C)C)cc2)C3)n1C,10.1021/jm100832d
CHEMBL1257336,17119,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,491,7,0,7,5.7,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2ccc(C(F)(F)F)cc2)C3)n1C,10.1021/jm100832d
52948653,17154,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,7,0,7,3.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccccc3)C2)n1C,10.1021/jm100832d
CHEMBL1257447,17154,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,409,7,0,7,3.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccccc3)C2)n1C,10.1021/jm100832d
52940961,17334,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,488,7,0,7,4.8,Cn1c(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)nnc1-c1ccnnc1,10.1021/jm100832d
CHEMBL1258034,17334,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,488,7,0,7,4.8,Cn1c(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)nnc1-c1ccnnc1,10.1021/jm100832d
24758836,17473,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1cccc2c1CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
CHEMBL1258493,17473,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,453,7,0,8,4.2,COc1cccc2c1CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,10.1021/jm100832d
24758481,17612,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,473,6,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5cc(Cl)ccc54)C3)n2C)s1,10.1021/jm100832d
CHEMBL1258948,17612,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,473,6,0,7,5.3,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5cc(Cl)ccc54)C3)n2C)s1,10.1021/jm100832d
143,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm0705612
5311096,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm0705612
CHEMBL85606,3429,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,438,5,1,4,4.8,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2,10.1021/jm0705612
23630999,92298,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,459,7,0,7,5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243709,92298,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,459,7,0,7,5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4)n2C)CC3)no1,10.1021/jm0705612
23631454,92588,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)cc4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL244279,92588,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,493,7,0,7,5.7,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)cc4)n2C)CC3)no1,10.1021/jm0705612
23631366,150210,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,473,7,0,7,5.3,Cc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,10.1021/jm0705612
CHEMBL395742,150210,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,473,7,0,7,5.3,Cc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,10.1021/jm0705612
46881411,6656,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,319,4,0,4,3.2,O=c1n(CCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1083816,6656,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,319,4,0,4,3.2,O=c1n(CCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
44626639,5784,0,None,-,0,Human,5.4,pKi,=,5.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,533,7,0,6,5.9,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Br)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1079497,5784,0,None,-,0,Human,5.4,pKi,=,5.4,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,533,7,0,6,5.9,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Br)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
44436300,148167,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,399,6,0,5,2.4,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL394110,148167,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,399,6,0,5,2.4,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
44266636,4531,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
CHEMBL10289,4531,0,None,-,0,Human,8.4,pKi,=,8.4,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
11573628,74273,0,None,-,0,Human,8.3,pKi,=,8.3,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1,10.1021/jm051237e
CHEMBL203047,74273,0,None,-,0,Human,8.3,pKi,=,8.3,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1,10.1021/jm051237e
137284323,184110,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,341,1,1,3,4.9,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CC1,10.1016/j.bmcl.2021.127911
CHEMBL4852403,184110,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,341,1,1,3,4.9,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CC1,10.1016/j.bmcl.2021.127911
44436306,96664,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,417,6,0,3,4.2,O=C1Cc2ccccc2N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL268371,96664,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,417,6,0,3,4.2,O=C1Cc2ccccc2N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,10.1016/j.bmc.2007.06.002
5311346,199807,21,None,-,5,Human,7.4,pKi,=,7.4,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligand",ChEMBL,249,2,1,4,1.9,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,10.1021/jm0000113
CHEMBL1256778,199807,21,None,-,5,Human,7.4,pKi,=,7.4,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligand",ChEMBL,249,2,1,4,1.9,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,10.1021/jm0000113
CHEMBL70565,199807,21,None,-,5,Human,7.4,pKi,=,7.4,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]N-0437asradioligand",ChEMBL,249,2,1,4,1.9,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,10.1021/jm0000113
121304408,142889,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,515,8,1,6,5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,10.1021/acs.jmedchem.6b00972
CHEMBL3899125,142889,0,None,-,0,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,515,8,1,6,5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,10.1021/acs.jmedchem.6b00972
149505732,185488,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,321,1,1,3,4.6,Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(F)ccc1N2,10.1016/j.bmcl.2021.127911
CHEMBL4873426,185488,0,None,-,1,Human,6.4,pKi,=,6.4,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,321,1,1,3,4.6,Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(F)ccc1N2,10.1016/j.bmcl.2021.127911
10355219,9697,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,259,3,0,2,3.3,CCCN1[C@@H](C)C[C@@H]2Cc3cccc(OC)c3C[C@@H]21,10.1021/jm00062a001
CHEMBL11386,9697,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,259,3,0,2,3.3,CCCN1[C@@H](C)C[C@@H]2Cc3cccc(OC)c3C[C@@H]21,10.1021/jm00062a001
121304538,149336,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,516,8,1,7,4.4,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,10.1021/acs.jmedchem.6b00972
CHEMBL3950254,149336,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,516,8,1,7,4.4,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,10.1021/acs.jmedchem.6b00972
135409468,1982,58,None,-,5,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,312,1,2,4,1.7,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1,10.1016/j.bmcl.2021.127911
333,1982,58,None,-,5,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,312,1,2,4,1.7,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1,10.1016/j.bmcl.2021.127911
CHEMBL845,1982,58,None,-,5,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,312,1,2,4,1.7,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1,10.1016/j.bmcl.2021.127911
45273522,192201,0,None,-,0,Human,8.3,pKi,=,8.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,333,4,0,2,3.6,O=C1N(CCN2[C@H]3CCC[C@@H]2CC3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL563580,192201,0,None,-,0,Human,8.3,pKi,=,8.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,333,4,0,2,3.6,O=C1N(CCN2[C@H]3CCC[C@@H]2CC3)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
44266623,98049,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3cccc(OC)c3CC[C@@H]21,10.1021/jm00062a001
CHEMBL276825,98049,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3cccc(OC)c3CC[C@@H]21,10.1021/jm00062a001
16123462,15812,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,384,6,2,3,4,CCC(C)(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223602,15812,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,384,6,2,3,4,CCC(C)(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
16123247,16081,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,386,6,2,4,3.5,COc1cc([C@]23CNC[C@H]2C3)ccc1NS(=O)(=O)c1ccc(C(C)C)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1224699,16081,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,386,6,2,4,3.5,COc1cc([C@]23CNC[C@H]2C3)ccc1NS(=O)(=O)c1ccc(C(C)C)cc1,10.1016/j.bmcl.2010.07.073
45271760,191241,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,399,6,0,3,4.9,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,10.1016/j.bmcl.2009.06.043
CHEMBL554738,191241,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,399,6,0,3,4.9,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,10.1016/j.bmcl.2009.06.043
45273530,192257,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,387,8,0,3,3.8,COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,10.1016/j.bmcl.2009.06.043
CHEMBL563926,192257,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,387,8,0,3,3.8,COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,10.1016/j.bmcl.2009.06.043
44627127,5775,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1079461,5775,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
45271548,191574,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
CHEMBL559029,191574,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(C(F)(F)F)c1,10.1016/j.bmcl.2009.06.028
46882049,5503,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1ccc(N2CCN(CCN3CCCCCC3)C2=O)cc1,10.1016/j.bmcl.2010.01.090
CHEMBL1077348,5503,0,None,-,0,Human,7.3,pKi,=,7.3,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,301,4,0,2,3.1,Cc1ccc(N2CCN(CCN3CCCCCC3)C2=O)cc1,10.1016/j.bmcl.2010.01.090
49865589,15809,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,328,4,1,3,2.4,CN(c1ccc([C@]23CNC[C@H]2C3)cc1)S(=O)(=O)c1ccccc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223599,15809,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,328,4,1,3,2.4,CN(c1ccc([C@]23CNC[C@H]2C3)cc1)S(=O)(=O)c1ccccc1,10.1016/j.bmcl.2010.07.073
49865623,15824,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223657,15824,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
45268346,191852,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,451,6,0,5,4.5,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL561326,191852,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,451,6,0,5,4.5,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
44627127,5775,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
CHEMBL1079461,5775,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,429,7,0,7,4.2,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,10.1021/jm901319p
44627129,5776,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079462,5776,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,413,7,0,7,3.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,10.1021/jm901319p
11260032,5779,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,474,7,0,7,4.4,Cc1cnc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,10.1021/jm901319p
CHEMBL1079480,5779,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,474,7,0,7,4.4,Cc1cnc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,10.1021/jm901319p
44626527,5783,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,459,8,0,8,4.2,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,10.1021/jm901319p
CHEMBL1079494,5783,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,459,8,0,8,4.2,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,10.1021/jm901319p
44627120,5940,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,10.1021/jm901319p
CHEMBL1080489,5940,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,425,8,0,8,3.5,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,10.1021/jm901319p
45270678,191140,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,327,4,0,3,3.3,Cc1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)s1,10.1016/j.bmcl.2009.06.028
CHEMBL552460,191140,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,327,4,0,3,3.3,Cc1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)s1,10.1016/j.bmcl.2009.06.028
45272438,193370,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,322,4,0,3,1.8,CN1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
CHEMBL571221,193370,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,322,4,0,3,1.8,CN1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,10.1016/j.bmcl.2009.06.028
45271499,193371,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,355,5,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL571229,193371,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,355,5,0,2,3.6,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(Cl)c1,10.1016/j.bmcl.2009.06.028
49836026,17195,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm100832d
CHEMBL1257566,17195,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,7,0,7,4.9,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/jm100832d
49780809,17335,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,8,1,7,5,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,10.1021/jm100832d
CHEMBL1258035,17335,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,477,8,1,7,5,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,10.1021/jm100832d
24758828,17434,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,501,6,0,7,5,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4cc(Br)ccc43)C2)n1C,10.1021/jm100832d
CHEMBL1258380,17434,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbindingAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellsassessedasinhibitionofquinelorane-induced[35S]GTPgammaSbinding,ChEMBL,501,6,0,7,5,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4cc(Br)ccc43)C2)n1C,10.1021/jm100832d
121315259,147632,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,463,6,0,7,4.8,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3936812,147632,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,463,6,0,7,4.8,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
23631000,92334,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,527,7,0,7,6,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243897,92334,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,527,7,0,7,6,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)no1,10.1021/jm0705612
11584694,143779,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,540,7,0,7,5.8,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)n(C)n1,10.1021/jm0705612
CHEMBL390649,143779,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,540,7,0,7,5.8,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)n(C)n1,10.1021/jm0705612
23630501,151959,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,527,7,0,7,6.3,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)c(Cl)c4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL397222,151959,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,527,7,0,7,6.3,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)c(Cl)c4)n2C)CC3)no1,10.1021/jm0705612
46190877,1820,1,None,-,1,Human,5.3,pKi,=,5.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,409,3,0,5,4,Clc1cc(cnc1N1CCN(CC1)Cc1nc2c(n1C)cccc2)C(F)(F)F,10.1016/j.bmcl.2009.11.032
6252,1820,1,None,-,1,Human,5.3,pKi,=,5.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,409,3,0,5,4,Clc1cc(cnc1N1CCN(CC1)Cc1nc2c(n1C)cccc2)C(F)(F)F,10.1016/j.bmcl.2009.11.032
CHEMBL605836,1820,1,None,-,1,Human,5.3,pKi,=,5.3,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,409,3,0,5,4,Clc1cc(cnc1N1CCN(CC1)Cc1nc2c(n1C)cccc2)C(F)(F)F,10.1016/j.bmcl.2009.11.032
44626734,6088,0,None,-,0,Human,5.3,pKi,=,5.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081237,6088,0,None,-,0,Human,5.3,pKi,=,5.3,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,10.1021/jm901319p
121304417,143466,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,506,7,0,6,5.6,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2,10.1021/acs.jmedchem.6b00972
CHEMBL3903779,143466,0,None,-,0,Human,6.3,pKi,=,6.3,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,506,7,0,6,5.6,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2,10.1021/acs.jmedchem.6b00972
121304551,150962,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,427,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3963783,150962,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,427,7,0,7,4.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
44274687,91261,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,287,5,1,2,2.8,CCCN(CCC)[C@@H]1Cc2cccc3c2N(C1)C(=O)NC3,10.1021/jm00062a001
CHEMBL24110,91261,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,287,5,1,2,2.8,CCCN(CCC)[C@@H]1Cc2cccc3c2N(C1)C(=O)NC3,10.1021/jm00062a001
14944887,192569,1,None,-,0,Human,7.2,pKi,=,7.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@@H]2c3cccc(O)c3CC[C@@H]21,10.1021/jm00062a001
CHEMBL566133,192569,1,None,-,0,Human,7.2,pKi,=,7.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CC[C@@H]2c3cccc(O)c3CC[C@@H]21,10.1021/jm00062a001
11681599,74745,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,10.1021/jm051237e
CHEMBL203637,74745,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,301,0,1,2,3.7,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,10.1021/jm051237e
44436302,90116,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,429,7,0,6,2.4,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,10.1016/j.bmc.2007.06.002
CHEMBL238917,90116,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,429,7,0,6,2.4,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,10.1016/j.bmc.2007.06.002
57533,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligand",ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1021/jm0000113
CHEMBL1288585,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligand",ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1021/jm0000113
CHEMBL2106804,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligand",ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1021/jm0000113
CHEMBL69271,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,"HumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligandHumanDopaminereceptorD2Laffinitiestodetermineagonistactivity,using[3H]spipasradioligand",ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1021/jm0000113
57533,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,AgonisticactivityatDRD2receptorAgonisticactivityatDRD2receptor,ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1016/j.bmcl.2009.07.055
CHEMBL1288585,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,AgonisticactivityatDRD2receptorAgonisticactivityatDRD2receptor,ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1016/j.bmcl.2009.07.055
CHEMBL2106804,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,AgonisticactivityatDRD2receptorAgonisticactivityatDRD2receptor,ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1016/j.bmcl.2009.07.055
CHEMBL69271,199595,23,None,-,1,Human,8.2,pKi,=,8.2,Functional,AgonisticactivityatDRD2receptorAgonisticactivityatDRD2receptor,ChEMBL,247,2,1,3,2.5,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,10.1016/j.bmcl.2009.07.055
45268112,191890,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4.3,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)cc(Cl)c1,10.1016/j.bmcl.2009.06.028
CHEMBL561512,191890,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,375,4,0,2,4.3,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)cc(Cl)c1,10.1016/j.bmcl.2009.06.028
10105844,95750,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
CHEMBL26118,95750,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
42625354,91080,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,349,6,0,3,3.2,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
CHEMBL240774,91080,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponseAntagonistactivityathumanDopaminereceptorD2isoformlongexpressedinHEK293cellsassessedaschangeinquinpirole-inducedintracellularcalciumresponse,ChEMBL,349,6,0,3,3.2,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,10.1016/j.bmc.2007.06.002
10615684,17823,0,None,-9,2,Human,7.2,pKi,=,7.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,320,4,0,2,4.2,Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,10.1021/jm990562x
CHEMBL1202208,17823,0,None,-9,2,Human,7.2,pKi,=,7.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,320,4,0,2,4.2,Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,10.1021/jm990562x
CHEMBL126493,17823,0,None,-9,2,Human,7.2,pKi,=,7.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,320,4,0,2,4.2,Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,10.1021/jm990562x
121304464,143679,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,480,7,0,8,4.7,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,10.1021/acs.jmedchem.6b00972
CHEMBL3905582,143679,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,480,7,0,8,4.7,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,10.1021/acs.jmedchem.6b00972
10157556,119613,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,"D2receptorfunctionalactivitywasmeasuredthroughreversalofquinpiroleinhibited,forskolinstimulatedcAMPproductionfromwholecellsD2receptorfunctionalactivitywasmeasuredthroughreversalofquinpiroleinhibited,forskolinstimulatedcAMPproductionfromwholecells",ChEMBL,395,3,0,3,3.4,O=C1C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2cccc3c2N1CC3,10.1016/s0960-894x(02)01056-9
CHEMBL352207,119613,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,"D2receptorfunctionalactivitywasmeasuredthroughreversalofquinpiroleinhibited,forskolinstimulatedcAMPproductionfromwholecellsD2receptorfunctionalactivitywasmeasuredthroughreversalofquinpiroleinhibited,forskolinstimulatedcAMPproductionfromwholecells",ChEMBL,395,3,0,3,3.4,O=C1C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2cccc3c2N1CC3,10.1016/s0960-894x(02)01056-9
16123241,16070,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,370,5,1,3,3.8,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@@]34C[C@@H]3CN(C)C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1224639,16070,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,370,5,1,3,3.8,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@@]34C[C@@H]3CN(C)C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
16123138,16080,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,396,7,1,3,4.4,C=CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,10.1016/j.bmcl.2010.07.073
CHEMBL1224698,16080,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,396,7,1,3,4.4,C=CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,10.1016/j.bmcl.2010.07.073
44627355,5862,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
CHEMBL1079938,5862,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,10.1021/jm901319p
46882054,6137,0,None,-,1,Human,7.2,pKi,=,7.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)cc1,10.1016/j.bmcl.2010.01.090
CHEMBL1081491,6137,0,None,-,1,Human,7.2,pKi,=,7.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,305,4,0,2,2.9,O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)cc1,10.1016/j.bmcl.2010.01.090
46882521,5608,0,None,-,2,Human,6.2,pKi,=,6.2,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,458,6,2,4,4.5,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccc2)cc1,10.1016/j.bmcl.2009.09.027
CHEMBL1078207,5608,0,None,-,2,Human,6.2,pKi,=,6.2,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,458,6,2,4,4.5,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccc2)cc1,10.1016/j.bmcl.2009.09.027
46882522,5609,0,None,-,2,Human,6.2,pKi,=,6.2,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,440,7,2,5,3.6,CC(C)Oc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,10.1016/j.bmcl.2009.09.027
CHEMBL1078208,5609,0,None,-,2,Human,6.2,pKi,=,6.2,Functional,AgonistactivityatdopamineD2receptorAgonistactivityatdopamineD2receptor,ChEMBL,440,7,2,5,3.6,CC(C)Oc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,10.1016/j.bmcl.2009.09.027
11692376,96896,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,540,8,0,8,6.3,CCc1nc2cc3c(c(C)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
CHEMBL269994,96896,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,540,8,0,8,6.3,CCc1nc2cc3c(c(C)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,10.1016/j.bmcl.2007.12.066
11548755,97118,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,580,7,0,8,6.8,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
CHEMBL271097,97118,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,580,7,0,8,6.8,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,10.1016/j.bmcl.2007.12.066
CHEMBL562836,192089,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,373,6,0,2,4.2,CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,10.1016/j.bmcl.2009.06.043
11477018,5810,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,6,5,Cc1ccc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,10.1021/jm901319p
CHEMBL1079640,5810,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,473,7,0,6,5,Cc1ccc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,10.1021/jm901319p
44627357,5887,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1080126,5887,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,10.1021/jm901319p
24743758,6046,11,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/jm901319p
CHEMBL1081023,6046,11,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/jm901319p
11272440,6170,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.1,Cc1ccc2c(-c3nnc(SCCCN4C[C@@H]5C[C@]5(c5ccc(C(F)(F)F)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081685,6170,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,523,7,0,6,6.1,Cc1ccc2c(-c3nnc(SCCCN4C[C@@H]5C[C@]5(c5ccc(C(F)(F)F)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
44627466,6212,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,427,7,0,7,4,Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,10.1021/jm901319p
CHEMBL1081869,6212,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,427,7,0,7,4,Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,10.1021/jm901319p
45268120,192314,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,2,4.2,CC(C)(C)c1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)cc1,10.1016/j.bmcl.2009.06.028
CHEMBL564298,192314,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,363,4,0,2,4.2,CC(C)(C)c1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)cc1,10.1016/j.bmcl.2009.06.028
23630505,92338,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,425,7,0,7,4.5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)C)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243901,92338,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,425,7,0,7,4.5,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)C)n2C)CC3)no1,10.1021/jm0705612
23630900,92585,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,498,7,1,7,5.5,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5[nH]ccc5c4)n2C)CC3)o1,10.1021/jm0705612
CHEMBL244276,92585,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,498,7,1,7,5.5,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5[nH]ccc5c4)n2C)CC3)o1,10.1021/jm0705612
46881410,6655,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1ccncc1,10.1016/j.bmcl.2010.01.090
CHEMBL1083815,6655,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,288,4,0,3,2.2,O=C1N(CCN2CCCCCC2)CCN1c1ccncc1,10.1016/j.bmcl.2010.01.090
46881464,7113,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.6,O=C1N(CC2CCCNC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1085673,7113,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.6,O=C1N(CC2CCCNC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
46881465,7114,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.6,O=C1N(CC2CCNCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1085674,7114,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.6,O=C1N(CC2CCNCC2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
46881413,7273,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,333,5,0,4,3.6,O=c1n(CCCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1086395,7273,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,333,5,0,4,3.6,O=c1n(CCCN2CCCCCC2)ccn1-c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
44626641,5797,0,None,-,0,Human,5.2,pKi,=,5.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,480,7,0,7,5,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C#N)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1079577,5797,0,None,-,0,Human,5.2,pKi,=,5.2,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,480,7,0,7,5,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C#N)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
23630998,92297,0,None,-,0,Human,5.2,pKi,=,5.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,539,7,0,9,5.6,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5nc(C)c(C)nc5c4)n2C)CC3)no1,10.1021/jm0705612
CHEMBL243708,92297,0,None,-,0,Human,5.2,pKi,=,5.2,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,539,7,0,9,5.6,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5nc(C)c(C)nc5c4)n2C)CC3)no1,10.1021/jm0705612
11566745,74268,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,283,0,2,3,2.7,CN1CCc2ccccc2Cc2cc(O)c(O)cc2CC1,10.1021/jm050846j
CHEMBL1202298,74268,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,283,0,2,3,2.7,CN1CCc2ccccc2Cc2cc(O)c(O)cc2CC1,10.1021/jm050846j
CHEMBL203029,74268,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,283,0,2,3,2.7,CN1CCc2ccccc2Cc2cc(O)c(O)cc2CC1,10.1021/jm050846j
121304527,146373,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,445,7,0,7,4.4,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3926847,146373,0,None,-,0,Human,7.2,pKi,=,7.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,445,7,0,7,4.4,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
121304452,148249,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,539,8,0,7,6.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,10.1021/acs.jmedchem.6b00972
CHEMBL3941818,148249,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,539,8,0,7,6.5,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,10.1021/acs.jmedchem.6b00972
121304458,153319,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,409,7,0,7,4.1,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3983937,153319,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,409,7,0,7,4.1,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C,10.1021/acs.jmedchem.6b00972
121304500,149085,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,480,7,0,6,5.1,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1,10.1021/acs.jmedchem.6b00972
CHEMBL3948167,149085,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,480,7,0,6,5.1,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1,10.1021/acs.jmedchem.6b00972
147200197,184971,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,317,1,1,3,4.7,Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(C)ccc1N2,10.1016/j.bmcl.2021.127911
CHEMBL4865663,184971,0,None,-,0,Human,6.2,pKi,=,6.2,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,317,1,1,3,4.7,Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(C)ccc1N2,10.1016/j.bmcl.2021.127911
1353,1858,83,None,-5,28,Human,8.2,pKi,=,8.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1021/jm990562x
3559,1858,83,None,-5,28,Human,8.2,pKi,=,8.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1021/jm990562x
86,1858,83,None,-5,28,Human,8.2,pKi,=,8.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1021/jm990562x
CHEMBL54,1858,83,None,-5,28,Human,8.2,pKi,=,8.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1021/jm990562x
DB00502,1858,83,None,-5,28,Human,8.2,pKi,=,8.2,Functional,Antagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcellsAntagonismofdopamine-stimulated[35S]GTP-gamma-SbindingagainsthumanDopaminereceptorD2inCHOcells,ChEMBL,375,6,1,3,4.4,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,10.1021/jm990562x
10105844,95750,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
CHEMBL26118,95750,0,None,-,0,Human,8.2,pKi,=,8.2,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
11522339,74824,1,None,-,0,Human,8.1,pKi,=,8.1,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2c(O)cccc2CC1,10.1021/jm051237e
CHEMBL203689,74824,1,None,-,0,Human,8.1,pKi,=,8.1,Functional,InhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassayInhibitionofD2LdopaminereceptorinHEK293cellsbyintracellularcalciumassay,ChEMBL,267,0,1,2,3,CN1CCc2ccccc2Cc2c(O)cccc2CC1,10.1021/jm051237e
23631173,91705,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1cccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)c1,10.1021/jm0705612
CHEMBL242599,91705,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1cccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)c1,10.1021/jm0705612
46882052,6135,0,None,-,1,Human,8.1,pKi,=,8.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,287,4,0,2,2.8,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,10.1016/j.bmcl.2010.01.090
CHEMBL1081489,6135,0,None,-,1,Human,8.1,pKi,=,8.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,287,4,0,2,2.8,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,10.1016/j.bmcl.2010.01.090
121304485,147506,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,477,7,0,7,5.2,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3935692,147506,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,477,7,0,7,5.2,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,10.1021/acs.jmedchem.6b00972
44266636,4531,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
CHEMBL10289,4531,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,229,2,1,2,2.7,C=CCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
10377224,9700,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,245,3,0,2,2.9,CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21,10.1021/jm00062a001
CHEMBL11388,9700,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,245,3,0,2,2.9,CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21,10.1021/jm00062a001
10105844,95750,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
CHEMBL26118,95750,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,10.1021/jm00062a001
44266689,5036,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3cccc(OC)c3CC[C@H]21,10.1021/jm00062a001
CHEMBL10570,5036,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3cccc(OC)c3CC[C@H]21,10.1021/jm00062a001
45273510,191281,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,309,4,0,3,2.6,COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.043
CHEMBL555744,191281,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,309,4,0,3,2.6,COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,10.1016/j.bmcl.2009.06.043
45273529,191404,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,413,7,0,3,4.3,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
CHEMBL557110,191404,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsby[35S]GTPgammaSbindingassay,ChEMBL,413,7,0,3,4.3,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2009.06.043
46225583,195844,0,None,-,1,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,362,3,0,5,4.6,Cn1c(CN2CCC(c3nsc4ccccc34)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL596527,195844,0,None,-,1,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,362,3,0,5,4.6,Cn1c(CN2CCC(c3nsc4ccccc34)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
44627023,5839,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,451,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(C)(C)C)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079822,5839,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,451,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(C)(C)C)cc3)C2)n1C,10.1021/jm901319p
11213136,5841,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,451,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(C)(C)C)cc3)C2)n1C,10.1021/jm901319p
CHEMBL1079824,5841,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,451,7,0,7,4.8,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(C)(C)C)cc3)C2)n1C,10.1021/jm901319p
44627357,5887,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,10.1021/jm901319p
CHEMBL1080126,5887,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,10.1021/jm901319p
45273334,190556,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,349,5,0,2,4.1,CC(C)c1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
CHEMBL540241,190556,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,349,5,0,2,4.1,CC(C)c1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,10.1016/j.bmcl.2009.06.028
23630604,143530,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1ccccc1-c1nnc(SCCCN2CCc3ccc(-c4cc(C)on4)cc3CC2)n1C,10.1021/jm0705612
CHEMBL390429,143530,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,489,8,0,8,5,COc1ccccc1-c1nnc(SCCCN2CCc3ccc(-c4cc(C)on4)cc3CC2)n1C,10.1021/jm0705612
46881463,7112,0,None,794,3,Human,7.1,pKi,=,7.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.7,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
CHEMBL1085672,7112,0,None,794,3,Human,7.1,pKi,=,7.1,Functional,PartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassayPartialagonisticactivityathumandopamineD2receptorexpressedinCHOcellsbyassay[35S]GTPgammaassaywithscintillationproximityaffinityassay,ChEMBL,293,3,1,2,2.7,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,10.1016/j.bmcl.2010.01.090
49865623,15824,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
CHEMBL1223657,15824,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassayAntagonistactivityatdopamineD2receptorbyGTPgammaSbindingassay,ChEMBL,356,5,2,3,3.5,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,10.1016/j.bmcl.2010.07.073
46225584,195347,0,None,-,1,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,408,3,0,4,5,Cn1c(CN2CCC(c3ncc(C(F)(F)F)cc3Cl)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
CHEMBL593056,195347,0,None,-,1,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassayAntagonistactivityathumanD2receptorexpressedinCHOcellsco-expressingG0by[35S]GTPgammaSbindingassay,ChEMBL,408,3,0,4,5,Cn1c(CN2CCC(c3ncc(C(F)(F)F)cc3Cl)CC2)nc2ccccc21,10.1016/j.bmcl.2009.11.032
44626740,5886,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,489,7,0,6,5.7,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1080117,5886,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,489,7,0,6,5.7,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
44626637,6118,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
CHEMBL1081401,6118,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,511,7,0,6,6.4,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,10.1021/jm901319p
44627353,6258,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,10.1021/jm901319p
CHEMBL1082111,6258,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassayAntagonistactivityathumanDopamineD2receptorexpressedinCHOcellbyGTPgammaSbindingassay,ChEMBL,481,7,0,7,4.7,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,10.1021/jm901319p
45272415,191123,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,389,5,0,2,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cc(Cl)ccc1Cl,10.1016/j.bmcl.2009.06.028
CHEMBL552367,191123,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,389,5,0,2,4.2,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cc(Cl)ccc1Cl,10.1016/j.bmcl.2009.06.028
45268987,191985,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,350,4,0,3,3,N#Cc1cc(N2CCN(CCN3Cc4ccccc4C3)C2=O)ccc1F,10.1016/j.bmcl.2009.06.028
CHEMBL562176,191985,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometryAntagonistactivityathumandopamineD2receptorexpressedinCHOcellsby[35S]GTP-gamma-S-basedscintillationspectrometry,ChEMBL,350,4,0,3,3,N#Cc1cc(N2CCN(CCN3Cc4ccccc4C3)C2=O)ccc1F,10.1016/j.bmcl.2009.06.028
121304424,143179,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,495,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL3901587,143179,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysisAntagonistactivityathumandopamineD2LreceptorexpressedinCHOcellscoexpressingGalpha16assessedasinhibitionofdopamine-inducedCa2+stimulationpre-incubatedfor10minsfollowedbydopaminechallengebyFluo-4AMbasedfluorometricanalysis,ChEMBL,495,7,0,7,5.3,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,10.1021/acs.jmedchem.6b00972
CHEMBL244083,92423,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,536,7,1,7,4.2,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,10.1021/jm0705612
CHEMBL3084616,92423,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,Displacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30minsDisplacementof[35S]GTP-gamma-SfromhumancloneddopamineD2receptorexpressedinCHOcellsafter30mins,ChEMBL,536,7,1,7,4.2,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,10.1021/jm0705612
5249956,72973,1,None,-,0,Human,8.1,pKi,=,8.1,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,251,0,0,1,3.3,CN1CCc2ccccc2Cc2ccccc2CC1,10.1021/jm050846j
CHEMBL201525,72973,1,None,-,0,Human,8.1,pKi,=,8.1,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,251,0,0,1,3.3,CN1CCc2ccccc2Cc2ccccc2CC1,10.1021/jm050846j
18988817,97559,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3c(cccc3OC)CCC21,10.1021/jm00062a001
CHEMBL273412,97559,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,243,3,0,2,3,C=CCN1CCC2c3c(cccc3OC)CCC21,10.1021/jm00062a001
11716449,140551,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,304,1,1,1,4.2,CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm050846j
CHEMBL382850,140551,0,None,-,0,Human,7.1,pKi,=,7.1,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,304,1,1,1,4.2,CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,10.1021/jm050846j
148724650,184392,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,307,1,2,3,4.2,Cc1ccc2c(c1)N=C(C1=CCNCC1)c1cc(F)ccc1N2,10.1016/j.bmcl.2021.127911
CHEMBL4856628,184392,0,None,-,0,Human,6.1,pKi,=,6.1,Functional,AntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulationAntagonistactivityathumanD2receptorexpressedinCHOcellsassessedasinhibitionofdopamine-inducedcalciumaccumulation,ChEMBL,307,1,2,3,4.2,Cc1ccc2c(c1)N=C(C1=CCNCC1)c1cc(F)ccc1N2,10.1016/j.bmcl.2021.127911
9952003,5264,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,DopaminereceptorD2functionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecellsDopaminereceptorD2functionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecells,ChEMBL,383,4,0,3,3.4,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,10.1016/s0960-894x(02)00655-8
CHEMBL106916,5264,0,None,-,0,Human,8.1,pKi,=,8.1,Functional,DopaminereceptorD2functionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecellsDopaminereceptorD2functionalactivitywasassessedviainhibitionofforskolinstimulatedcAMPproductionfromWholecells,ChEMBL,383,4,0,3,3.4,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,10.1016/s0960-894x(02)00655-8
44275015,98678,1,None,-,0,Human,6,pKi,=,6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
CHEMBL281614,98678,1,None,-,0,Human,6,pKi,=,6,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.6,CCCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,10.1021/jm00062a001
11637457,72665,1,None,-,0,Human,7,pKi,=,7,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,257,0,0,2,3.4,CN1CCc2ccccc2Cc2ccsc2CC1,10.1021/jm050846j
CHEMBL201093,72665,1,None,-,0,Human,7,pKi,=,7,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,257,0,0,2,3.4,CN1CCc2ccccc2Cc2ccsc2CC1,10.1021/jm050846j
44266612,4406,0,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.9,CCCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
CHEMBL10207,4406,0,None,-,0,Human,7,pKi,=,7,Functional,"CompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligandCompoundwastestedforagonisticactivityagainstD2receptorfromclonedCHOcells,used[3H]U-86170asradioligand",ChEMBL,231,2,1,2,2.9,CCCN1CCC2c3cccc(O)c3CCC21,10.1021/jm00062a001
5249952,72986,6,None,-,0,Human,6,pKi,=,6,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,304,1,1,1,4.4,CN1CCc2c([nH]c3ccccc23)CC(c2ccccc2)CC1,10.1021/jm050846j
CHEMBL201584,72986,6,None,-,0,Human,6,pKi,=,6,Functional,InhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassayInhibitionofbindingtohumanD2LreceptorexpressedinHEK293cellsbyfunctionalcalciumassay,ChEMBL,304,1,1,1,4.4,CN1CCc2c([nH]c3ccccc23)CC(c2ccccc2)CC1,10.1021/jm050846j
1225,1430,18,None,-3,11,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,279,3,0,2,4,CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C,None
3958,1430,18,None,-3,11,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,279,3,0,2,4,CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C,None
667477,1430,18,None,-3,11,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,279,3,0,2,4,CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C,None
CHEMBL860,1430,18,None,-3,11,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,279,3,0,2,4,CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C,None
DB01142,1430,18,None,-3,11,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,279,3,0,2,4,CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C,None
119570,3081,84,None,-10,6,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,None
2233,3081,84,None,-10,6,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,None
953,3081,84,None,-10,6,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,None
CHEMBL301265,3081,84,None,-10,6,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,None
DB00413,3081,84,None,-10,6,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,211,3,2,4,1.6,CCCN[C@H]1CCc2c(C1)sc(n2)N,None
4236,27851,66,None,-,1,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,273,5,1,2,2,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,None
CHEMBL1373,27851,66,None,-,1,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,273,5,1,2,2,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,None
9690109,14296,30,None,-,1,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,273,5,1,2,2,NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1,None
CHEMBL1201192,14296,30,None,-,1,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,273,5,1,2,2,NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1,None
1621,2375,16,None,1,2,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,323,3,1,2,2.9,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,None
17,2375,16,None,1,2,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,323,3,1,2,2.9,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,None
5761,2375,16,None,1,2,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,323,3,1,2,2.9,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,None
CHEMBL263881,2375,16,None,1,2,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,323,3,1,2,2.9,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,None
DB04829,2375,16,None,1,2,Human,8.2,pEC50,=,8.2,Functional,NoneNone,DrugCentral,323,3,1,2,2.9,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC,None
1042,1534,19,None,-23,13,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,325,3,3,3,1.5,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C,None
148,1534,19,None,-23,13,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,325,3,3,3,1.5,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C,None
443884,1534,19,None,-23,13,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,325,3,3,3,1.5,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C,None
CHEMBL119443,1534,19,None,-23,13,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,325,3,3,3,1.5,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C,None
DB01253,1534,19,None,-23,13,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,325,3,3,3,1.5,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C,None
2105,2977,32,None,-1,19,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,314,4,1,2,4.3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3,None
47811,2977,32,None,-1,19,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,314,4,1,2,4.3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3,None
48,2977,32,None,-1,19,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,314,4,1,2,4.3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3,None
CHEMBL531,2977,32,None,-1,19,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,314,4,1,2,4.3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3,None
DB01186,2977,32,None,-1,19,Human,8.1,pEC50,=,8.1,Functional,NoneNone,DrugCentral,314,4,1,2,4.3,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3,None
56597938,3849,0,None,204,2,Human,8.9,pEC50,=,8.9,Functional,BiasedagonistofD<sub>2</sub>-mediated&beta,GuidetoPharmacology,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
7651,3849,0,None,204,2,Human,8.9,pEC50,=,8.9,Functional,BiasedagonistofD<sub>2</sub>-mediated&beta,GuidetoPharmacology,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
CHEMBL2165126,3849,0,None,204,2,Human,8.9,pEC50,=,8.9,Functional,BiasedagonistofD<sub>2</sub>-mediated&beta,GuidetoPharmacology,461,7,1,4,5.2,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
242,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,MeasuringcAMPproductionviatheGi-coupledsignalingpathwayMeasuringcAMPproductionviatheGi-coupledsignalingpathway,GuidetoPharmacology,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,22025698
34,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,MeasuringcAMPproductionviatheGi-coupledsignalingpathwayMeasuringcAMPproductionviatheGi-coupledsignalingpathway,GuidetoPharmacology,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,22025698
60795,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,MeasuringcAMPproductionviatheGi-coupledsignalingpathwayMeasuringcAMPproductionviatheGi-coupledsignalingpathway,GuidetoPharmacology,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,22025698
CHEMBL1112,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,MeasuringcAMPproductionviatheGi-coupledsignalingpathwayMeasuringcAMPproductionviatheGi-coupledsignalingpathway,GuidetoPharmacology,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,22025698
DB01238,467,113,None,-6,12,Human,7.4,pEC50,=,7.4,Functional,MeasuringcAMPproductionviatheGi-coupledsignalingpathwayMeasuringcAMPproductionviatheGi-coupledsignalingpathway,GuidetoPharmacology,447,7,1,4,4.9,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl,22025698
56599142,3851,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,22025698
7652,3851,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,22025698
CHEMBL2165138,3851,2,None,-,1,Human,8.2,pEC50,=,8.2,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,420,6,0,4,6.3,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2,22025698
56593482,3850,0,None,602,2,Human,9,pEC50,=,9,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
7650,3850,0,None,602,2,Human,9,pEC50,=,9,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
CHEMBL2165119,3850,0,None,602,2,Human,9,pEC50,=,9,Functional,ThiscompoundshowsbiasedagonismtowardsD<sub>2</sub>-mediated&beta,GuidetoPharmacology,462,7,1,5,4.6,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl,22025698
92329211,211912,0,None,-,1,Human,8.4,pIC50,=,8.4,Functional,NoneNone,DrugCentral,453,8,4,10,-0.5,NC1=NC(=CS1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O,None
319,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
321,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
444031,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
784,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
CHEMBL1346,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
DB00496,1288,35,None,-338,6,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,426,7,1,3,4,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2,None
30699,211915,0,None,-1,14,Human,8.3,pIC50,=,8.3,Functional,NoneNone,DrugCentral,423,7,2,8,0.5,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSC1=CC=NC=C1)C2=O)C(O)=O,None
1830,2530,37,None,4570,2,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,276,3,1,3,2,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,None
207,2530,37,None,4570,2,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,276,3,1,3,2,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,None
23897,2530,37,None,4570,2,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,276,3,1,3,2,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,None
CHEMBL460,2530,37,None,4570,2,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,276,3,1,3,2,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,None
DB01618,2530,37,None,4570,2,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,276,3,1,3,2,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1,None
4223,3901,85,None,-380,16,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,None
6918314,3901,85,None,-380,16,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,None
7427,3901,85,None,-380,16,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,None
CHEMBL439849,3901,85,None,-380,16,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,None
DB06684,3901,85,None,-380,16,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,None
2337,3176,68,None,-13,22,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,383,5,1,6,2.9,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,None
50,3176,68,None,-13,22,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,383,5,1,6,2.9,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,None
5002,3176,68,None,-13,22,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,383,5,1,6,2.9,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,None
CHEMBL716,3176,68,None,-13,22,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,383,5,1,6,2.9,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,None
DB01224,3176,68,None,-13,22,Human,8.2,pIC50,=,8.2,Functional,NoneNone,DrugCentral,383,5,1,6,2.9,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,None
100,3716,47,None,-3,28,Human,8.1,pIC50,=,8.1,Functional,NoneNone,DrugCentral,370,4,0,4,5.9,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,None
2637,3716,47,None,-3,28,Human,8.1,pIC50,=,8.1,Functional,NoneNone,DrugCentral,370,4,0,4,5.9,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,None
5452,3716,47,None,-3,28,Human,8.1,pIC50,=,8.1,Functional,NoneNone,DrugCentral,370,4,0,4,5.9,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,None
CHEMBL479,3716,47,None,-3,28,Human,8.1,pIC50,=,8.1,Functional,NoneNone,DrugCentral,370,4,0,4,5.9,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,None
DB00679,3716,47,None,-3,28,Human,8.1,pIC50,=,8.1,Functional,NoneNone,DrugCentral,370,4,0,4,5.9,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1,None
4223,3901,85,None,-380,16,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,15341484
6918314,3901,85,None,-380,16,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,15341484
7427,3901,85,None,-380,16,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,15341484
CHEMBL439849,3901,85,None,-380,16,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,15341484
DB06684,3901,85,None,-380,16,Human,6.2,pIC50,=,6.2,Functional,UnclassifiedUnclassified,GuidetoPharmacology,441,7,2,5,4,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2,15341484
7694,3425,0,None,-,1,Human,6.4,pKB,=,6.4,Functional,AllostericreductionofdopaminebindinginaradioligandbindingassayAllostericreductionofdopaminebindinginaradioligandbindingassay,GuidetoPharmacology,426,5,2,3,4.8,N#Cc1ccc2c(c1)CN(CC2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1cc2c([nH]1)cccc2,25108820
9910352,3425,0,None,-,1,Human,6.4,pKB,=,6.4,Functional,AllostericreductionofdopaminebindinginaradioligandbindingassayAllostericreductionofdopaminebindinginaradioligandbindingassay,GuidetoPharmacology,426,5,2,3,4.8,N#Cc1ccc2c(c1)CN(CC2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1cc2c([nH]1)cccc2,25108820
CHEMBL2219578,3425,0,None,-,1,Human,6.4,pKB,=,6.4,Functional,AllostericreductionofdopaminebindinginaradioligandbindingassayAllostericreductionofdopaminebindinginaradioligandbindingassay,GuidetoPharmacology,426,5,2,3,4.8,N#Cc1ccc2c(c1)CN(CC2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1cc2c([nH]1)cccc2,25108820